WO2013136801A1 - Drug administration device - Google Patents

Drug administration device Download PDF

Info

Publication number
WO2013136801A1
WO2013136801A1 PCT/JP2013/001719 JP2013001719W WO2013136801A1 WO 2013136801 A1 WO2013136801 A1 WO 2013136801A1 JP 2013001719 W JP2013001719 W JP 2013001719W WO 2013136801 A1 WO2013136801 A1 WO 2013136801A1
Authority
WO
WIPO (PCT)
Prior art keywords
cylinder
piston
flow path
chemical solution
puncture
Prior art date
Application number
PCT/JP2013/001719
Other languages
French (fr)
Japanese (ja)
Inventor
孝博 相馬
Original Assignee
テルモ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by テルモ株式会社 filed Critical テルモ株式会社
Publication of WO2013136801A1 publication Critical patent/WO2013136801A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/148Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons flexible, e.g. independent bags
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14244Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14248Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
    • A61M2005/14252Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type with needle insertion means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/35Communication
    • A61M2205/3576Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/50General characteristics of the apparatus with microprocessors or computers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/82Internal energy supply devices
    • A61M2205/8206Internal energy supply devices battery-operated

Definitions

  • the present invention relates to a drug solution administration device, which is suitable for application when, for example, insulin is administered into the body.
  • type 1 diabetes is a chronic disease that requires treatment to inject an appropriate amount of insulin at an appropriate time.
  • manual administration using a syringe or manual administration using an injector has been performed.
  • an automatic drug solution administration system capable of programming the dose and administration time has been developed.
  • This system consists of an infusion pump, a dedicated infusion set, and a catheter.
  • a system in which a drug administration device is made portable is also used.
  • a small and lightweight infusion pump that is fixed to the body surface with a double-sided tape without using the infusion set.
  • a patch-type drug solution administration device has been introduced in which a catheter is directly inserted from the device (for example, see Patent Document 1).
  • the liquid medicine is delivered from the liquid medicine storage section filled with the liquid medicine into the patient's body using a pump.
  • a cylinder part is provided with a suction port for suctioning a chemical solution and a discharge port for discharging a chemical solution, and a check valve is provided at each of the suction port and the discharge port.
  • a piston type pump is known in which one of check valves provided at each of the suction port and the discharge port is opened by changing the internal pressure of the pump.
  • the present invention has been made in consideration of the above points, and intends to propose a small-sized chemical solution administration device capable of quantitatively delivering a chemical solution.
  • a housing portion provided with an inflow side flow path used when inhaling the chemical liquid and an outflow side flow path used when discharging the chemical liquid
  • a cylinder portion that is rotatably fitted in the housing portion, a piston that is rotatable and slidable in the cylinder portion, a stopper that limits a rotation range of the cylinder portion relative to the housing portion, and a fixed to the piston.
  • the cylinder portion is connected to the inflow side flow path when the cylinder portion rotates to one end of a rotation range limited by the stopper, and the cylinder portion is connected to the rotation range.
  • One cylinder port that is connected to the outflow side flow path when rotated to the end is provided, and the piston is configured so that the cylinder portion is in a period until the cylinder portion reaches one end or the other end of the rotation range. And the cylinder part reaches one end or the other end of the rotation range so that the cylinder port is stopped after being connected to the inflow side flow path or the outflow side flow path.
  • the piston shaft is slid in the cylinder portion by rotating with respect to the cylinder portion.
  • the piston can be slid in the cylinder part after rotating the cylinder part together with the piston and switching the cylinder port to the inflow side flow path or the outflow side flow path only by controlling the rotation of the piston shaft. It is possible to deliver a fixed amount of a chemical solution while having a simple configuration without providing a valve.
  • the piston can be slid in the cylinder part after rotating the cylinder part together with the piston and switching the cylinder port to the inflow side flow path or the outflow side flow path only by the rotation control of the piston. It is possible to deliver a fixed amount of a chemical solution with a simple configuration without providing a check valve. Thus, it is possible to realize a small-sized pump and a chemical solution administration device capable of quantitatively delivering the chemical solution.
  • a drug solution administration system 1 wirelessly communicates a signal corresponding to a user's input instruction with a portable drug solution administration device 2 that is held and used by being affixed to the user's skin.
  • the controller 3 that transmits to the drug solution administration device 2 and the charger 4 (FIG. 21) that charges the rechargeable battery 206 (FIG. 11) provided inside the drug solution administration device 2 are configured.
  • the chemical liquid administration device 2 stores therein a chemical liquid (for example, insulin), and administers the chemical liquid into the user's body in accordance with a control signal transmitted from the controller 3.
  • a chemical liquid for example, insulin
  • the drug solution administration device 2 includes a drug solution storage and delivery unit 10, a drive control unit 20, and a puncture channel unit 30 that are detachable from each other.
  • the puncture channel unit 30 is slid from the front with respect to the drug solution storage / delivery unit 10 and the drive control unit 20.
  • the medicinal solution administration device 2 is used by being attached to the skin of the user in such a state.
  • the size of the medicinal solution administration device 2 may be small enough to be attached to the user's skin, for example, a substantially rectangular parallelepiped shape having a width of 34 mm, a length of 43 mm, and a height of 12 mm.
  • the chemical storage / delivery unit 10 includes a lower casing part 101 that is open on the upper side and has a space inside, and an upper casing that is screwed into the opening of the lower casing part 101.
  • the portion 102 is formed into a flat and substantially rectangular parallelepiped shape.
  • the chemical solution storage and delivery unit 10 is provided with a chemical solution bag 110, a filter unit 120, a delivery unit 130, a compression unit 150, and the like in a space formed by the lower casing unit 101 and the upper casing unit 102.
  • the lower housing part 101 is provided with a sticking part 103 made of double-sided tape or the like on the bottom face 101A.
  • the medicinal solution administration device 2 is held by the user when the sticking portion 103 is stuck on the user's skin.
  • the bottom surface 101 ⁇ / b> A of the lower housing 101 is formed of a transparent material so that the amount of the chemical stored in the chemical bag 110 can be seen from the outside. This makes it possible to check the remaining amount of the chemical solution even after the chemical solution administration device 2 is attached to the user's skin.
  • Engagement portions 101B to E which are protrusions extending in the direction in which the drive control unit 20 is arranged, are provided on the side surfaces along the longitudinal direction (hereinafter also referred to as the front-rear direction) of the lower housing unit 101. It has been.
  • the engaging portions 101B to E are brought into close contact with the chemical solution storage and delivery portion 10 and the drive control portion 20 by engaging with engagement receiving portions 201A to 201D (FIG. 11) described later.
  • the lower casing unit 101 is provided with a waterproof packing 101F on a surface in close contact with the upper casing unit 102, and the lower casing unit 101 is screwed to the upper casing unit 102 via the waterproof packing 101F (not shown). Since it is screwed or ultrasonically fused, it is possible to prevent liquid from entering the internal space from between the lower casing portion 101 and the upper casing portion 102.
  • a hole 101G for inserting the leaf spring release rod 154 is provided on the side surface of the lower casing portion 101 along the front-rear direction.
  • a duckbill-like valve packing (not shown) is inserted into the hole 101G, and the hole is closed when the leaf spring release rod 154 is removed.
  • a bottom 101 ⁇ / b> A of the lower housing part 101 is provided with a hole 101 ⁇ / b> K into which the injection part 104 is fitted to inject a chemical liquid into the chemical liquid bag 110.
  • the peripheral part of the hole 104K realizes a waterproof function by fitting the injection part 104, which is an elastic member fused to the chemical solution bag 110, and the lower housing part 101.
  • the lower casing portion 101 is provided with a concave portion 101H on the front side, which is a space into which a part of the puncture channel portion 30 is fitted when the puncture channel portion 30 is engaged with the drug solution storage and delivery unit 10. . Further, the lower casing portion 101 is provided with projections 101I and 101J protruding in opposite directions to guide the puncture flow path portion 30 so as to be slid and engaged with the medicinal solution storage / delivery portion 10 from the front direction. It is provided along.
  • the upper housing part 102 is provided with projecting parts 102A and 102B protruding in the front-rear direction so as to be continuous with the projecting parts 101I and 101J of the lower housing part 101 in the front-rear direction.
  • the upper housing portion 102 is formed such that the central portion 102C sandwiched between the protrusion portions 102A and 102B is one step lower than the other portions in order to form the protrusion portions 102A and 102B.
  • Waterproof gaskets are inserted into the joints of the protrusions 101I and 101J of the lower housing part 101 and the protrusions 102A and 102B and the central part 102C of the upper housing part.
  • the chemical solution bag 110 as the chemical solution storage unit is formed from a rectangular sheet 111 made of, for example, polyurethane, vinyl chloride, or polyethylene.
  • the sheet 111 is a central portion in the longitudinal direction and is a portion (hereinafter also referred to as a central portion) 112 that becomes the bottom surface of the chemical solution bag 110 that is a flexible thermoplastic resin.
  • At least three odd or more (five in the present embodiment) fold lines 113 and 114 are provided at equal intervals on both sides of the sheet.
  • an even number of portions (hereinafter also referred to as folding portions) 115 and 116 having a predetermined width are formed on the sheet 111 between the adjacent folds 113 and 114, respectively.
  • the sheet 111 has portions (hereinafter also referred to as end portions) 117 and 118 that are longer than half of the length in the longitudinal direction in the central portion 112 on the further end side than the folds 113 and 114 from the most ends in the longitudinal direction. Provided.
  • the folds 113 and 114 are alternately folded into a mountain fold and a valley fold so that the fold portions 115 and 116 overlap the center portion 112, and as shown in FIG. Part of the end side overlaps.
  • the overlapping portions of the end portions 117 and 118 are fused, and the edges in the width direction are fused.
  • the edge in the width direction of the sheet 111 is fused, the edge is fused so that the nozzle 105 that connects the space surrounded by the sheet 111 and the external space is sandwiched between the edges.
  • an injection portion 104 having a check valve (not shown) formed of, for example, synthetic rubber or the like is provided to inject a chemical solution into the chemical solution bag 110 from the outside.
  • a chemical solution bag 110 as shown in FIG. 5C is formed.
  • the medical solution bag 110 formed in this way is folded so that the adjacent folding portions 115 and 116 are in contact with each other in a state where the medical solution is not filled, and the central portion 112 and the end portions 117 and 118 are Overlap.
  • the chemical solution bag 110 is not crushed so that the central portion 112 and the end portions 117 and 118 are in contact with each other without leaving the chemical solution inside when the chemical solution filled therein is sent to the outside through the nozzle 105. Can be sent to the outside.
  • the conventional chemical solution bag is generally formed by fusing the edges of two films, and the chemical solution is injected into the space formed by the two films. As the distance approaches, the distance between the two films becomes shorter.
  • the conventional chemical solution administration device using the chemical solution bag in the space where the chemical solution bag is stored, when the chemical solution is injected near the edge of the chemical solution bag, a useless space is formed in the portion where the chemical solution bag does not expand. It will be.
  • the conventional drug solution bag has a problem in that the drug solution administration device is enlarged.
  • the chemical solution bag 110 has the folding portions 115 and 116 in the longitudinal direction, the folding portions 115 and 116 separate the center portion 112 and the end portions 117 and 118 when the chemical solution is injected. It spreads in the direction (vertical direction).
  • the chemical solution bag 110 can expand in the vertical direction even when it is near the edge of the chemical solution bag 110 when the chemical solution is injected by expanding the folding parts 115 and 116.
  • the space formed with the casing 102 when the chemical solution is injected, a wasteful space is not formed even in a portion near the edge of the chemical solution bag 110, and the chemical solution administration device 2 can be downsized. Yes, thus improving usability.
  • the filter unit 120 is connected to a side surface of the upper lid 121 having an opening on the lower side and a space in the interior, and a nozzle 105 communicating the inner space and the chemical solution bag 110.
  • a channel pipe 106 communicating with the delivery unit 130 is connected.
  • the filter unit 120 is provided with an air vent filter 122 that allows gas to pass but not liquid to close the opening of the upper lid 121.
  • the air vent filter 122 is fixed between the upper lid 121 and the lower lid 123 that closes the opening of the upper lid 121 so as to be sandwiched between the O-rings 124 and 125 along the circumferential direction.
  • the upper lid 121 and the lower lid 123 are in close contact with each other by, for example, ultrasonic fusion.
  • the lower lid 123 is provided with a hole 123A penetrating in the vertical direction.
  • the filter unit 120 can discharge only the gas from the inner space of the upper lid 121 through the hole 123A provided in the lower lid 123 without discharging the chemical solution.
  • the delivery unit 130 is a valveless pump that does not have a valve, and is an internal space provided inside the housing unit 131 (this is the interior of the housing).
  • a cylindrical cylinder part 132 is fitted into 131 ⁇ / b> A so as to be rotatable in the circumferential direction.
  • the cylinder part 132 has a cylindrical shape with one end opened, and a columnar piston 133 is inserted into the internal space 132A of the cylinder part 132 (also referred to as a cylinder internal space) from this one end side.
  • each part of the delivery part 130 will be described by defining one end side of the cylinder part 132 as a lower side and the other end side as an upper side.
  • a female thread 132B is formed on the inner peripheral surface of the cylinder part 132 from the center to the lower end.
  • the female screw 132B is configured to mesh with a male screw 133C formed on the outer peripheral surface of a boss 133B fixed to the piston shaft 133A of the piston 133.
  • the disc-shaped lid portion 132C that forms the upper end portion of the cylinder portion 132 has a cylindrical shape that projects upward on the upper surface along the central axis of the lid portion 132C (coaxial with the central axis of the cylinder portion 132).
  • a protrusion 132D is provided.
  • the protrusion 132D serves as an axis when the cylinder part 132 rotates. Therefore, hereinafter, the protrusion 132D is referred to as a shaft portion 132D.
  • one rectangular parallelepiped protrusion 132E protruding outward is formed on the outer peripheral surface of the lid 132C.
  • this lid portion 132C is provided with one cylinder port 132F communicating with the cylinder internal space 132A.
  • the cylinder port 132F has a center on a line segment (not shown) connecting the center axis of the lid portion 132C (coaxial with the center axis of the cylinder portion 132) and the protrusion 132E. It is provided at a position displaced from the shaft by a predetermined amount.
  • the casing 131 is fixed to the lower casing 101 (FIG. 3) of the chemical storage / delivery unit 10.
  • the housing part 131 is provided with a housing internal space 131A that is substantially the same diameter as the outer diameter of the cylinder part 132 and slightly longer than the cylinder part 132, and the cylinder part 132 is fitted into the housing internal space 131A. Is done.
  • a recess 131B is formed on the upper surface of the inner wall forming the housing inner space 131A (also referred to as the inner wall upper surface) along the central axis of the housing inner space 131A.
  • a cylindrical protruding portion 142 whose height is shorter than the base portion 137B by the thickness of the sliding nylon washer 143 is formed at the center of the lower surface of the inner wall forming the housing internal space 131A (also referred to as the inner wall lower surface).
  • the protruding portion 142 is formed with a hole 131C having a diameter larger than that of the piston shaft 133A.
  • a coil spring having a shape along the circumferential direction of the housing internal space 131A between the lower surface of the inner wall having the protruding portion 142 forming the housing internal space 131A and the lower end of the cylinder part 132 fitted in the housing internal space 131A. 134 is arranged.
  • This coil spring 134 pushes up the lower end of the cylinder part 132 via the washer 135, thereby urging the cylinder part 132 upward (that is, on the cylinder port 132F side).
  • the cylinder portion 132 is always fitted into the recess 131B on the upper surface of the inner wall forming the housing internal space 131A in the shaft portion 132D of the lid portion 132C, and the upper surface of the lid portion 132C. Is in close contact with the upper surface of the inner wall.
  • the portion facing the outer peripheral surface of the lid portion 132C of the cylinder portion 132 that is, the upper end of the inner wall peripheral surface
  • a semicircular arc-shaped groove 131 ⁇ / b> D extending along a half circumference along the rotation direction of the cylinder portion 132 is formed.
  • a protrusion 132E formed on the outer peripheral surface of the lid portion 132C of the cylinder portion 132 is slidably fitted into the groove 131D.
  • the groove 131D and the protruding portion 132E function as a stopper that restricts the rotation of the cylinder portion 132 relative to the housing portion 131 to a half rotation.
  • the rotation range of the cylinder part 132 is limited to a half rotation from the position where the protrusion 132E contacts the one end 131E of the groove 131D to the position where the other end 131F contacts.
  • the channel 131G is a channel used when a chemical solution is drawn into the cylinder part 132 from the outside, and is hereinafter referred to as an in-channel 131G.
  • the channel 131H is a channel used when the chemical liquid is discharged from the cylinder part 132 to the outside, and is hereinafter referred to as an out channel 131H.
  • the in-flow path 131G is connected to the flow path pipe 106, and the out flow path 131H is connected to the flow path pipe 107.
  • the in-flow channel 131G is a groove extending from the central axis of the housing internal space 131A on a line segment (not shown) connecting the one end 131E and the other end 131F of the groove 131D. It is provided at a position shifted by a predetermined amount on the one end 131E side of 131D.
  • the out channel 131H is provided at a position opposite to the in channel 131G across the central axis of the housing internal space 131A.
  • shift amount from the center axis of the in-flow path 131G and the out-flow path 131H is equal to the deviation
  • the cylinder port 132F is positioned directly below the in-flow path 131G. In this case, the cylinder port 132F and the in-flow path 131G are connected.
  • the cylinder port 132F is blocked by the upper surface of the inner wall.
  • the cylinder portion 132 fitted in the housing internal space 131A has a rotation range in the circumferential direction limited to a half rotation, and the cylinder port 132F is connected to the in-flow path 131G when rotating to one end of the rotation range. When rotating to the other end of the rotation range, the cylinder port 132F is connected to the out flow path 131H.
  • X ring or O ring packing along the circumferential direction so that there is no gap between the piston 133 and the inner wall peripheral surface of the cylinder internal space 132A on the outer peripheral surface of the piston 133 inserted into the cylinder internal space 132A. 136 is provided.
  • the piston shaft 133A fixed to the piston 133 has a coil spring 141 sandwiched from the tip end portion 137A of the drive shaft 137 inserted through the hole 131C of the protruding portion 142 formed on the lower surface of the inner wall of the housing inner space 131A from the lower end side. And is connected to the drive shaft 137.
  • the drive shaft 137 includes a tip portion 137A having a predetermined length having an inner diameter substantially the same as the outer shape of the piston shaft 133A, and a base portion 137B having an outer diameter substantially the same as the outer diameter of the piston shaft 133A.
  • the drive shaft 137 is provided with a bevel gear 137C at the end opposite to the tip 137A, and sandwiches the tip of the protruding portion 142 formed on the lower surface of the inner wall of the housing internal space 131A and the nylon washer 143 for sliding.
  • the bevel gear 137 ⁇ / b> C attached in (1) is engaged with the bevel gear 139 ⁇ / b> A provided on the rotation shaft 139 of the drive magnet 138 (FIG. 7), thereby being connected to the rotation shaft 139.
  • a rotation detection magnet 140 for detecting the rotation of the drive shaft 137 is provided on the side surface of the drive magnet 138.
  • the driving magnet 138 is provided at a position facing the power transmission magnet 209 (FIGS. 11 and 12) across the upper casing 102 and the lower casing 202 (FIG. 11) of the drive controller 20, and will be described later. In this manner, it is attracted to and rotated by the power transmission magnet 209 that rotates through the motor 207 and the gear head 208.
  • the rotation ratio of the bevel gears 139A and 137C is determined so that when the rotation shaft 139 makes one rotation, the drive shaft 137 also makes one rotation.
  • the drive shaft 137 has a tip 137A connected to the piston shaft 133A via the coil spring 141, and can transmit a rotational force to the piston shaft 133A.
  • the coil spring 141 extends to the drive shaft 137, and the piston
  • the shaft 133A can slide in the axial direction (vertical direction).
  • the coil spring 141 extends as much as the piston shaft 133A is pushed upward. Further, the fitting of the male screw 133C of the piston shaft 133A and the female screw 132B of the cylinder part 132 is urged.
  • the frictional force between the male screw 133C of the piston shaft 133A and the female screw 132B of the cylinder part 132 is set to be larger than the frictional force between the cylinder part 132 and the inner wall forming the housing internal space 131A.
  • the piston 133 slides in the cylinder internal space 132A in the axial direction (vertical direction) by the internal thread 132B of the cylinder portion 132 and the external thread 133C of the piston shaft 133A.
  • the piston shaft 133A rotates via the drive shaft 137, until the projection 132E of the cylinder part 132 contacts the one end part 131E or the other end part 131F of the groove 131D, the cylinder After the part 132 and the piston 133 rotate together, the protrusion 132E of the cylinder part 132 contacts the one end part 131E or the other end part 131F of the groove 131D and the rotation of the cylinder part 132 stops, and then the coil spring 141 The piston 133 slides in the cylinder inner space 132A of the stopped cylinder part 132.
  • the cylinder part 132 has a protruding part 132E that contacts the other end part 131F of the groove 131D.
  • the piston 133 is stopped at the contact position, and the piston 133 is located at the top dead center.
  • the cylinder port 132F is connected to the outflow path 131H by being positioned directly below the outflow path 131H.
  • the cylinder part 132 and the piston 133 rotate together until the protrusion part 132E of the cylinder part 132 comes into contact with the one end part 131E from the other end part 131F of the groove 131D. During this time, the piston 133 does not slide with respect to the cylinder part 132.
  • the cylinder port 132F is connected to the in-flow path 131G by being positioned directly below the in-flow path 131G.
  • a flow path is switched from the out flow path 131H to the in flow path 131G first.
  • the cylinder internal space 132A is connected to the filter unit 120 (FIG. 3) via the cylinder port 132F, the in-flow path 131G, and the flow-path pipe 106.
  • the chemical solution loaded in the chemical solution bag 110 passes through the filter unit 120, the flow channel pipe 106, the in-flow channel 131 ⁇ / b> G, and the cylinder port 132 ⁇ / b> F, and between the lid portion 132 ⁇ / b> C and the piston 133 in the cylinder unit 132. Is injected into the cylinder inner space 132A.
  • the prescribed number of rotations is set to the number of rotations of the drive shaft 137 required until the piston 133 reaches the bottom dead center after the cylinder part 132 and the piston 133 start to rotate together. Therefore, when the rotation of the drive shaft 137 stops, the piston 133 is located at the bottom dead center.
  • the delivery unit 130 sucks the chemical into the cylinder internal space 132A.
  • the cylinder port 132F is connected to the outflow path 131H by being positioned directly below the outflow path 131H. In this manner, the delivery unit 130 switches the flow path from the in-flow path 131G to the out-flow path 131H.
  • the cylinder internal space 132A is connected to the valve body 108 (FIG. 3) provided in the upper housing portion 102 via the cylinder port 132F, the out flow path 131H, and the flow path pipe 107.
  • the cylinder portion 132 is biased upward by the coil spring 134, so that the upper surface of the lid portion 132C always rotates in close contact with the upper surface of the inner wall of the housing internal space 131A. Thereby, the delivery unit 130 can avoid a situation in which a gap is formed between the lid 132C and the upper surface of the inner wall and the chemical liquid flows out into the gap.
  • the chemical injected into the cylinder internal space 132A between the lid portion 132C in the cylinder portion 132 and the piston 133 passes through the cylinder port 132F, the out flow path 131H, and the flow path pipe 107 to the valve body 108. Discharged.
  • the valve body 108 closes the flow path when nothing is inserted, and opens the flow path when the nozzle 302 (FIG. 15) provided in the puncture flow path section 30 is inserted to open the flow path tube 107. And the nozzle 302 are communicated with each other.
  • the drive shaft 137 is rotated as shown in FIG. Stop.
  • the specified number of rotations is the same as the number of rotations at the time of suction, and the drive shaft 137 required until the piston 133 reaches the top dead center after the cylinder part 132 and the piston 133 start to rotate together.
  • the number of rotations is set. Therefore, when the rotation of the drive shaft 137 stops, the piston 133 is located at the top dead center.
  • the delivery unit 130 discharges the chemical solution from the cylinder unit 132.
  • the delivery unit 130 delivers the drug solution stored in the drug solution bag 110 to the user's body through the flow channel provided in the puncture flow channel unit 30.
  • the delivery unit 130 is until the protrusion 132E of the cylinder 132 reaches the one end 131E or the other end 131F of the groove 131D.
  • the connection destination of the cylinder port 132F is switched to the in-flow path 131G or the out-flow path 131H.
  • the delivery unit 130 rotates the cylinder part 132 together with the piston 133 only by controlling the rotation of the piston shaft 133A (that is, controlling the number of rotations and the direction of rotation), so that the cylinder port 132F is connected to the in-flow path 131G or the out-flow path.
  • the piston 133 can be slid in the cylinder part 132 after switching to 131H.
  • the delivery unit 130 can perform the quantitative delivery of the chemical liquid only by the rotation control of the piston shaft 133A, for example, the switching of the connection destination of the cylinder port 132F and the sliding of the piston 133 are separately controlled. Compared with a pump that must be, it is possible to deliver a fixed amount with simple control.
  • the compression unit 150 includes a press plate 151, a support unit 152, and a plate spring 153.
  • the holding plate 151 is a plate material having an area larger than the central portion 112 of the chemical solution bag 110 and is provided on the upper side of the chemical solution bag 110.
  • the holding plate 151 is supported by a support portion 152 fixed to the lower casing portion 101 so as to be rotatable in a direction away from and approaching the chemical solution bag 110 around the connecting portions 151A and 152A formed of, for example, a hinge mechanism.
  • the plate spring 153 is a plate material provided in a state of being bent in a substantially V shape between the holding plate 151 and the upper housing portion 102, and the plate portions that are bent in a substantially V shape and are opposed to each other are separated from each other.
  • the force works in the direction to open (the direction to open). Therefore, when the leaf spring 153 is disposed between the holding plate 151 and the upper housing portion 102, the holding plate 151 is always pressed against the chemical solution bag 110 side with a constant force.
  • the compression portion 150 is a plate spring release rod between the holding plate 151 and the plate spring 153 through the hole 101G of the lower housing portion 101 before the chemical solution is injected into the chemical solution bag 110 (FIG. 4A). 154 is inserted. At this time, in the compression unit 150, the presser plate 151 can freely rotate without the plate spring 153 pressing the presser plate 151.
  • the compression portion 150 presses the holding plate 151 against the chemical solution bag 110 side.
  • the pressing plate 151 sandwiches the chemical solution bag 110 with the lower housing 101 and the presser plate 151 applies a constant positive pressure to the chemical solution bag 110 (FIG. 4B).
  • the compression unit 150 can discharge the dissolved gas to the outside through the filter unit 120.
  • the compression unit 150 presses the chemical solution bag 110 in a direction to be crushed, so that the chemical solution stored in the chemical solution bag 110 is pushed out without leaving inside. Thus, it can be sent out.
  • the drive control unit 20 is formed in a substantially U-shape having a recess 20 ⁇ / b> A that matches the shape of the puncture flow channel portion 30 so that the puncture flow channel portion 30 is inserted from the front direction. Is done.
  • the drive control unit 20 is a space formed between an upper housing part 201 that is open on the lower side and has a space inside, and a lower housing part 202 that is screwed into the opening of the upper housing part 201.
  • a charging antenna 203 a substrate 204, a communication antenna 205, a rechargeable battery 206, a motor 207, a gear head 208, a power transmission magnet 209, magnetic sensors 210 and 211, and the like.
  • the outer surface along the front-rear direction of the upper housing part 201 is provided with engagement receiving parts 201A to 201D that are grooves for engaging with the engagement parts 101B to E provided in the chemical solution storage and delivery part 10, respectively.
  • a bolus switch 201E that is pressed down by the user when a certain amount of chemical solution is temporarily administered (bolus administration) is provided.
  • the bolus switch 201E is provided at a position recessed from the upper surface of the upper housing portion 201, and can be prevented from being accidentally pressed by the user, for example, by turning over.
  • the lower casing 202 is provided with a waterproof packing 202A on the surface that is in close contact with the upper casing 201, and the upper casing 201 is screwed to the lower casing 202 via the waterproof packing 202A (not shown). Since it is screwed or ultrasonically fused, it is possible to prevent liquid from entering the internal space from between the upper casing portion 201 and the lower casing portion 202.
  • the charging antenna 203 is affixed on the upper surface of the lower housing
  • a CPU Central A board unit 204 on which a communication antenna 205 for transmitting and receiving signals to and from an electrical circuit such as a processing unit (RAM), a random access memory (RAM), and a read only memory (ROM) and the controller 3 is disposed above the charging antenna 203. It is provided to overlap.
  • RAM processing unit
  • RAM random access memory
  • ROM read only memory
  • a rechargeable battery 206 is provided on the upper surface of the lower casing unit 202, which is charged by electricity supplied from the charging antenna 203 and supplies electricity to each unit during driving.
  • a motor 207 for example, a motor 207, a gear head 208, and a power transmission magnet 209 are provided so as to overlap in order from the top at a position facing the driving magnet 138 of the drug solution storage and delivery unit 10.
  • a magnetic sensor 210 is provided on the upper surface of the lower housing unit 202.
  • the motor 207 rotates the power transmission magnet 209 via the gear head 208. As shown in FIG. 12, the power transmission magnet 209 is opposed to the driving magnet 138 so as to have a polarity attracting the driving magnet 138 in a state where the chemical storage / delivery unit 10 and the drive control unit 20 are in close contact with each other. To be placed.
  • the power transmission magnet 209 When the power transmission magnet 209 is rotated by the motor 207 via the gear head 208, the power transmission magnet 209 rotates with its own rotation while attracting the driving magnet 138 by magnetic force.
  • the motor 207 rotates the rotating shaft 139 in a non-contact manner via the gear head 208, the power transmission magnet 209, and the driving magnet 138 to rotate the driving shaft 137 connected to the piston shaft 133A, thereby The piston 133 is rotated and the piston 133 is slid.
  • the motor 207 rotates the rotating shaft 139 and the driving shaft 137 in a non-contact manner through the magnetic force of the power transmission magnet 209 and the driving magnet 138, the rotating shaft 139 and the driving shaft 137 rotate following the rotation of the motor 207. It is necessary to detect whether or not Therefore, the magnetic sensor 210 that detects that the rotation shaft 139 and the drive shaft 137 are rotating is disposed on the circumference on which the rotation detection magnet 140 moves.
  • the magnetic sensor 210 detects the magnetic force of the rotation detecting magnet 140, it detects that the rotating shaft 139 and the drive shaft 137 have made one rotation by detecting the magnetic force again.
  • the magnetic sensor 210 can detect the rotation of the cylinder part 132 and the piston 133 and the sliding of the piston 133 by detecting that the rotation shaft 139 and the drive shaft 137 are rotating.
  • the number of rotations is detected in units of one rotation, but the number of rotations may be detected more finely by increasing the number of magnetic sensors 210.
  • the microcomputer 220 (FIG. 21) is a magnetic sensor 210 provided in the same space formed by the upper housing portion 201 and the lower housing portion 202 and is a different space. It is possible to check the drive of the sending unit 130 provided in the space formed by the lower housing unit 101 and the upper housing unit 102 without contact.
  • a connector unit 212 for transmitting and receiving various signals is provided. As shown in FIGS. 13A and 13B, the connector portion 212 has a structure in which a waterproof rubber 212B covers the outside of the electrical connector portion 212A in which a plurality of spring connectors 212C for transmitting and receiving electricity and various signals are collected. It becomes.
  • the connector part 350 (FIG. 15) of the puncture flow path part 30 connected to the connector part 212 also has a waterproof rubber outside the electric connector part 350A in which a plurality of connector parts 350C for transmitting and receiving electricity and various signals are collected. The structure is covered with 350B.
  • the waterproof rubber 212B and 350B can prevent the liquid from touching the electrical connector units 212A and 350B.
  • the length is not contacted at the limit where insertion is permitted (when sufficient insertion is not performed).
  • This pin is provided and connected to the ground potential on the puncture flow path section 30 side, and it is checked whether the potential of this pin is the ground potential or not on the drive control section 20 side. In this case, the insertion of the puncture channel 30 is monitored by displaying an alarm indicating that the puncture channel 30 is insufficiently inserted.
  • the puncture channel portion 30 is fitted in the space between the recess 101H and the recess 20A formed in a state where the drug solution storage / delivery unit 10 and the drive control unit 20 are engaged. It has an elongated shape.
  • the puncture flow path part 30 is provided with each part in the internal space of the housing part 301 that forms the outer shell. 14A shows an external configuration, and FIG. 14B shows an internal configuration. Further, in FIG. 15, for convenience of explanation, a part is shown in cross section.
  • the housing unit 301 When the puncture flow path unit 30 is fitted to the drug solution storage and delivery unit 10, the housing unit 301 includes a bottom surface 301 ⁇ / b> A located on the same plane as the bottom surface 101 ⁇ / b> A of the lower housing unit 101 and the center of the upper housing unit 102. A bottom surface 301B located at a height facing and adjacent to the portion 102C.
  • the housing portion 301 is provided at a position where a convex portion 301C that fits into the concave portion 102D of the upper housing portion 102 when the puncture flow path portion 30 is fitted to the drug solution storage and delivery portion 10 faces the concave portion 102D in the bottom surface 301B. .
  • the casing 301 includes a protrusion 101I of the lower casing 101 and a protrusion 102A of the upper casing 102, a protrusion 101J of the lower casing 101, and a protrusion of the upper casing 102.
  • Guide grooves 301D and 301E that respectively engage with the portion 102B are formed on the side surfaces along the front-rear direction.
  • the casing 301 is provided with a recess 301Q on the upper surface 301F for hooking a user's finger when removing the puncture channel 30 from the drug solution storage / delivery unit 10 and the drive controller 20 that are fitted.
  • the casing 301 is curved from the upper surface 301F to the front surface 301G, and an angle adjustment mechanism 340, which will be described in detail later, is provided on the curved surface 301H.
  • the casing 301 is provided with a hole 301I at a position facing the valve body 108 of the chemical liquid storage / delivery section 10 in a state where the puncture flow path section 30 is fitted to the chemical liquid storage / delivery section 10.
  • the nozzle 302 to be inserted is fixed so as to penetrate the hole 301I.
  • the nozzle 302 is fixed without providing a gap with the hole 301I.
  • One end of the nozzle 302 is inserted into the valve body 108 in a state where the puncture flow path section 30 is fitted to the drug solution storage and delivery section 10 and communicates with the flow path pipe 107.
  • the nozzle 302 is connected to a running water sensor 303 at the other end.
  • the flowing water sensor 303 detects whether or not the passing chemical solution is flowing.
  • a heating source and a temperature sensor are used separately.
  • a combination of a resistor, a heater wire, a semiconductor, and a temperature sensor as a source, a thermo file, a platinum resistor, a semiconductor, and the like can be applied.
  • the flowing water sensor 303 has a puncture channel needle 304 connected to the end opposite to the end to which the nozzle 302 is connected, and allows the nozzle 302 and the puncture channel needle 304 to communicate with each other.
  • the puncture flow path needle 304 is bent so that one end side connected to the running water sensor 303 is folded back on the S-shape, is arranged along the front-rear direction therefrom, and reaches the bottom surface 301A on the other end side.
  • the puncture channel needle 304 is made of a metal member, but is a 28 gauge hollow tube, for example, which can be easily bent.
  • the puncture channel needle 304 is fixed by a fixing portion 305 that protrudes inward from the housing portion 301 at a position immediately after being folded back on the S-shape.
  • the puncture flow path needle 304 is spirally wound with a part (hereinafter also referred to as an elastic portion) 304A on the front side from the position fixed to the fixing portion 305.
  • the elastic portion 304A is extendable in the front-rear direction.
  • the puncture channel needle 304 has a sharply sharp shape at a tip portion (hereinafter also referred to as a tip portion) 304B that is bent so as to reach the bottom surface 301A.
  • the puncture flow path needle 304 having such a shape sends the drug solution flowing from the flowing water sensor 303 to the outside through the inner space from the distal end portion 304B.
  • the puncture channel needle 304 is covered with, for example, the sheath portion 310 from the distal end portion 304B to the elastic portion 304A.
  • the sheath part 310 is made of, for example, Teflon (registered trademark) or polyethylene, and the sheath 311 has flexibility, and is soft, for example, made of Teflon (registered trademark), polyolefin, or polyurethane. It is comprised by the expansion
  • the material that is soft and easily deformed and has the property of not returning to the extension 312 include a material that is crosslinked by ultraviolet rays at a high temperature, such as a heat-shrinkable tube, such as polyolefin, Teflon (registered trademark), silicon.
  • Polyvinyl chloride, polyvinyl fluoride fluoride, etc. can be used.
  • the sheath 311 covers most of the puncture channel needle 304 from the distal end 304B to the front of the elastic portion 304A, and is not fixed to the puncture channel needle 304.
  • the extending portion 312 covers the puncture channel needle 304 from a position overlapping one end side of the elastic portion 304A side of the sheath 311 to just before the elastic portion 304A, and one end on the fixed portion 305 side is the puncture channel needle. The other end is fixed to the sheath 311.
  • the extending portion 312 is fixed so as to seal the gap between the puncture flow path needle 304 and the sheath 311 along the circumferential direction so that the liquid does not leak from the gap at both fixed ends.
  • a caulking 306 that fixes the puncture flow path needle 304 and the sheath 311 together is provided at a predetermined position closer to the distal end portion 304B than the elastic portion 304A of the puncture flow path needle 304.
  • the caulking 306 is made of a material that deforms when a certain force is applied, such as aluminum or copper.
  • the caulking 306 is crushed from the left and right direction after the puncture flow path needle 304 and the sheath 311 are inserted into the ring hole from the ring shape, and a part of the vertical direction overlaps, and the puncture flow path needle 304 and the sheath 311 are overlapped. Tighten and fix. Thereby, the sheath 311 is fixed so as not to slip with respect to the puncture flow path needle 304.
  • the caulking 306 is bonded to the sheath 311 and does not leave the sheath 311 even when the caulking 306 is loosened.
  • the puncture flow path part 30 is provided in front of the caulking 306 and a movement restricting part 307 at a position away from the caulking 306 by a predetermined distance.
  • the predetermined distance is a distance at which the puncture flow path needle 304 and the sheath 311 protrude from the bottom surface 301A of the housing 301, that is, a depth at which the puncture flow path needle 304 and the sheath 311 are punctured to the user. It is the same distance as the distance, and is set to 10 mm in the present embodiment.
  • the movement restricting portion 307 is fixed to the housing portion 301 and is arranged so that the puncture flow path needle 304 and the sheath portion 310 can be inserted into a hole provided in the center without contacting.
  • the puncture flow path section 30 is provided with a puncture mechanism 320 at a position behind the caulking 306 and ahead of the extension section 312.
  • the puncture mechanism 320 includes a fixed plate 321, a spring 322, a support plate 323, and a pressing portion 324.
  • the fixing plate 321 is fixed to the housing part 301 and is arranged so that the puncture flow path needle 304 and the sheath part 310 can be inserted into a hole provided in the center without contact.
  • a spring 322 is disposed in front of the fixed plate 321.
  • the spring 322 is arranged so as to pass through the inner space without contact between the puncture flow path needle 304 and the sheath portion 310, and is arranged in a state where it is sandwiched between the fixed plate 321 and the support plate 323 and compressed more than the natural length. Is done.
  • the support plate 323 is arranged so that the puncture flow path needle 304 and the sheath portion 310 are inserted without contacting each other, and is a surface on the opposite side to the surface where the spring 322 is in contact with the puncture flow path needle 304 and the sheath portion.
  • the push portion 324 is supported below 310.
  • the support plate 323 is held so as not to move forward by the puncture release mechanism 330 at a position lower than a position where the pressing portion 324 is supported on the same surface as the surface supporting the pressing portion 324.
  • the pressing portion 324 has a substantially cylindrical shape, and has a negative shape (one character type) whose tip is long in the vertical direction and short in the horizontal direction.
  • the pressing portion 324 is supported by the support plate 323 so that the tip is located between members overlapping on the lower side of the portion of the caulking 306 extending in the vertical direction.
  • the puncture release mechanism 330 includes a limiting portion 331, a spring 332, and an actuator 333.
  • the restricting portion 331 has a portion extending in the front-rear direction and a portion extending in the up-down direction so that the cross section has a substantially L shape, and is provided near the center of the portion extending in the front-rear direction.
  • the rotary shaft 331A is held rotatably.
  • the restricting portion 331 is disposed so as to support the support plate 323 with the surface on the rotating shaft 331A side of the portion extending in the vertical direction, and restricts the support plate 323 from moving in the forward direction.
  • the restriction portion 331 has a spring 332 connected to the lower surface on the front side of the rotation shaft 331A of the portion extending in the front-rear direction, and the protrusion 333A of the actuator 333 is in contact with the upper surface on the rear side of the rotation shaft 331A.
  • the spring 332 has one end connected to the restricting portion 331 and the other end connected to the bottom surface 301B side of the housing portion 301, and is arranged in a state in which a force is always applied in the direction of contraction.
  • the actuator 333 is configured to move the protruding portion 333A in the front-rear direction when electric power is supplied, and is disposed in a state where the protruding portion 333A is in contact with the limiting portion 331.
  • the spring 322 is sandwiched between the fixed plate 321 and the support plate 323 and compressed more than the natural length, the limiting portion 331 is in contact with the support plate 323, and the projection 333A of the actuator 333 is disposed in contact with the limiting portion 331.
  • the state is also referred to as an initial state (FIGS. 15 and 17A).
  • the puncture flow path needle 304 and the sheath 311 are illustrated in a straight state that is not bent, but in reality, a part thereof is bent as described above.
  • the contracted spring 322 extends to return to the natural length and pushes the support plate 323 and the pressing portion 324 in the forward direction.
  • the pushing portion 324 pushed in the forward direction pushes the caulking 306 forward together with the puncture channel needle 304 and the sheath 311 until the caulking 306 comes into contact with the movement restricting portion 307.
  • the caulking 306 moves in the forward direction while sandwiching the puncture channel needle 304 and the sheath 311 along the caulking guide 308 in which the upper portion of the portions extending in the vertical direction overlaps on the upper side.
  • the cross section of the caulking guide 308 has a U-shape with an opening at the bottom, and the caulking 306 fits from the direction in which the caulking guide 308 is opened in the overlapping portion on the upper side. Is retained.
  • the elastic portion 304A of the puncture channel needle 304 is extended (FIG. 17B).
  • the puncture flow path needle 304 and the sheath 311 protrude from the bottom surface 301A of the housing 301, and the distal end 304B punctures the user and enters the user's body together with the sheath 311.
  • the spring 322 continues to extend even after the caulking 306 comes into contact with the movement restricting portion 307, and the tip of the pressing portion 324 enters between the members overlapping below the caulking 306. At this time, the pusher 324 opens the overlapping members below the caulking 306 on both sides, and loosens the tightening of the caulking 306 with respect to the puncture channel needle 304 and the sheath 311.
  • the sheath 311 is fixed to the caulking 306 and cannot move, so the extension portion 312 having one end fixed to the puncture channel needle 304 extends as the elastic portion 304A contracts.
  • the sheath portion 310 is maintained in a state in which the distal end portion of the sheath 311 protrudes from the bottom surface 301A because the elongated portion 312 that extends at one end does not return to the original shape (FIG. 17C).
  • the puncture channel section 30 punctures with the metal puncture channel needle 304 having a sharp tip 304B, and then inserts only the flexible sheath 311 into the body. Subsequently, the puncture channel needle 304 made of metal can be returned to the outside of the body.
  • the medicinal solution administration device 2 does not leave the metal puncture channel needle 304 in the body while the user is using it, and can continue to insert only the flexible sheath 311 into the body. It is possible to reduce pain and discomfort to the user, thus improving usability.
  • one end of the sheath is connected to the needle through a packing, and after the needle and the sheath are punctured into the skin, the sheath is inserted into the packing portion when the needle is pulled out of the body. It was made to slide and stay in that position.
  • the gap between the needle and the sheath is closed with the packing, so that the liquid medicine leaks, or when the seal is strengthened, the friction between the needle and the packing increases and the needle does not return sufficiently. There was a possibility.
  • the medicinal solution administration device 2 since the medicinal solution administration device 2 is fixed without providing a gap with the puncture channel needle 304 at one end of the extending portion 312, the medicinal solution does not leak. In addition, there is no hindrance to the puncturing operation due to the friction between the packing and the needle.
  • the puncture flow path section 30 (FIGS. 14 and 15) is forward of the movement restricting section 307 and on the curved surface 301H of the housing section 301, the angle at which the puncture flow path needle 304 and the sheath 311 project with respect to the bottom surface 301A (
  • an angle adjustment mechanism 340 for adjusting the projection angle is also provided. Since the bottom surface 301A is in contact with the user's skin, the protruding angle is the same as the angle of the puncture flow path needle 304 and the sheath 311 with respect to the user's skin (hereinafter also referred to as the puncture angle).
  • the angle adjustment mechanism 340 is supported by a support portion 341 made of an L-shaped column whose one end is fixed to the housing portion 301.
  • the support portion 341 is a concentric circular shape at the end surface arranged to be orthogonal to the left-right direction on the side opposite to the one end fixed to the housing portion 301, and a plurality of (four in this embodiment) concave portions at a predetermined angle. 341A is provided.
  • the concave portion 341A is provided at a position where the puncture angle of the puncture channel needle 304 and the sheath 311 is 20 ° to 90 °, as will be described in detail later.
  • the angle adjusting mechanism 340 is provided with a central portion 342 having a convex portion 342A projecting so as to be concentric with the concave portion 341A and fitted into the concave portion 341A at a position facing the end surface of the support portion 341.
  • the central portion 342 is supported by the support portion 341 at a position where the protruding convex portion 342A fits into the concave portion 341A while being pressed toward the support portion 341 by the screw 345 through the spring 343 and the spring pressing plate 344.
  • the central portion 342 is provided with a shaft portion 346 in a direction orthogonal to the rotation axis when the center portion 342 rotates.
  • the shaft portion 346 has a cylindrical shape, one end is connected to the holding portion 347 that holds the puncture channel needle 304 and the sheath 311, and the other end is connected to the knob portion 348 that is held when the angle is adjusted by the user. Is done.
  • the holding portion 347 is a tube having an inner diameter that is thicker than the outer shape of the sheath 311, and the puncture flow path needle 304 and the sheath 311 are inserted therethrough, and the puncture flow path needle 304 and the sheath 311 are held without being fixed.
  • the knob portion 348 includes a knob 348A held by the user and a knob support portion 348B that supports the knob 348A.
  • the knob portion 348 is placed so that both ends of the knob support portion 348B are hooked on rail portions 301K and 301M whose left and right sides of the opening 301J provided on the curved surface 301H of the housing portion 301 are L-shaped in cross section.
  • the knob support portion 348B is placed so as to be sandwiched between the housing portion 301 and the panel portion 349 provided on the curved surface 301H of the housing portion 301.
  • the panel portion 349 opens so that the knob 348A can move in a direction along the curved surface 301H (hereinafter also referred to as a curved direction), and has a shape that is longer in the curved direction than the rail portions 301K and 301M. is doing.
  • a waterproof packing 348C is provided on the edge of the upper surface of the knob support portion 348B, and prevents liquid from entering the housing portion 301 from between the knob support portion 348B and the panel portion 349.
  • the holding portion 347 is rotated according to the rotation of the shaft portion 346 around the center portion 342 when the knob portion 348 is moved in the bending direction by the user. .
  • the angle adjusting mechanism 340 sets the protrusion angle of the puncture flow path needle 304 held by the holding portion 347 and the bottom surface 301A of the sheath 311 to 20 ° to 90 °.
  • Change in range. 20A shows a case where the protrusion angle is 90 °
  • FIG. 20B shows a case where the protrusion angle is 20 °.
  • the angle adjusting mechanism 340 can change the puncture angle of the puncture flow path needle 304 and the sheath 311 with respect to the user's epidermis arranged in parallel with the bottom surface 301A in the range of 20 ° to 90 °.
  • the puncture channel needle 304 and the sheath 311 are set so that the tip 304B does not come out of the bottom 301A at a puncture angle at which the distance between the tip 304B and the bottom surface 301A varies depending on the puncture angle.
  • distal end portion 304B of the puncture channel needle 304 and the distal end of the sheath 311 are arranged so as to close the opening 301N provided in the bottom surface 301A and come into contact with the outer periphery of the sheath 311. Held by the unit 309.
  • the tip holding portion 309 is fitted to an L-shaped rib provided inside the bottom surface 301A, and both sides are shifted in the front-rear direction along the inside of the front surface 301G and the back surface 301V of the 301. Due to the flexibility, even if the distal end portion 304B of the puncture flow path needle 304 and the distal end of the sheath 311 are moved to the angle adjusting mechanism 340, they can follow it and continue to close the opening 301N. Accordingly, liquid can be prevented from entering the housing portion 301.
  • the tip holding portion 309 includes an air vent filter 309A that covers the tip portion 304B of the puncture channel needle 304 and the tip of the sheath 311 at a position further ahead of the tip portion 304B of the puncture channel needle 304. Provided.
  • the air vent filter 309A can discharge only the air present in the puncture channel needle 304 to the outside without leaking the drug solution flowing through the puncture channel needle 304 before use by the user. .
  • the angle adjustment mechanism 340 can change the protrusion angle of the puncture flow path needle 304 and the bottom surface 301A of the sheath 311 with respect to the bottom surface 301A within a range of 20 ° to 90 ° according to the operation of the user.
  • the human body has skins such as epidermis and dermis from about 1.5 mm to 4 mm from the body surface, and there is subcutaneous tissue at a depth of about 4 mm to 9 mm from the body surface inside, and further inside Have muscles.
  • insulin when administered from the outside, it is generally administered to a subcutaneous tissue at a depth of about 4 mm to 9 mm from the surface in consideration of burden on the user, pain, absorption rate of insulin, and the like.
  • the medicinal-solution administration device 2 can change the puncture angle of the puncture flow path needle 304 and the sheath 311 with respect to the user's epidermis within the range of 20 ° to 90 ° by the angle adjusting mechanism 340.
  • the angle adjusting mechanism 340 By adjusting, it is possible to puncture to an arbitrary depth, and it is possible to reliably puncture the subcutaneous tissue that is optimal for all users.
  • by administering a drug solution to the dermis layer it is possible to obtain the same medicinal effect with a small amount of drug solution compared to when administered subcutaneously, and therefore it is possible to set the puncture distance to the dermis.
  • the medicinal solution administration device 2 can improve usability.
  • the connector unit 350 is adhered to the hole 301P provided at a position facing the connector unit 212 of the drive control unit 20 without a gap.
  • the connector portion 350 covers the outside of the electrical connector portion 350A in which a plurality of connector portions 350C for transmitting and receiving electricity and various signals are collected with a waterproof rubber 350B. Constructed.
  • the medicinal solution administration device 2 includes the puncture channel unit 30 provided with the puncture channel needle 304 for puncturing the user's skin, the medicinal solution storage and delivery unit 10 provided with the medicinal solution bag 110 for storing the medicinal solution, and the delivery.
  • the drive control unit 20 provided with the motor 207 for operating the unit 130 and the substrate unit 204 is provided separately.
  • the conventional medicinal solution administration device since the needle for puncturing the user's skin, the medicinal solution bag for storing the medicinal solution, the motor, etc. are all provided in the same housing, for example, when puncture fails, When itching and inflammation occur, the entire device must be replaced, which is not only convenient but also increases the economic burden.
  • the controller 3 includes a microcomputer 361, a battery 362, a battery monitoring unit 363, a mode switch 364, a numerical value setting switch 365, a display unit 366, a transmission unit 367, a reception unit 368, and a communication antenna 369.
  • the microcomputer 361 is a computer including a CPU, a RAM, a ROM, and the like.
  • the CPU reads and executes a basic program stored in the ROM and executes the overall control, and the CPU is stored in the ROM.
  • Various processes are executed by reading various programs into the RAM and executing them.
  • the battery 362 supplies power to each unit.
  • the battery monitoring unit 363 monitors the presence / absence and remaining amount of the battery 362 and notifies the microcomputer 361 of it.
  • the mode switch 364 is a switch for setting a basal mode in which a chemical solution is continuously administered for a long time and a bolus mode in which a chemical solution is temporarily administered.
  • the numerical value setting switch 365 is a switch for setting the dose per hour and the administration time of the drug solution.
  • the microcomputer 361 displays the contents corresponding to the operation on the mode switch 364 and the numerical value setting switch 365 on the display unit 366 and transmits a signal indicating the contents to the drug solution administration device 2 via the transmission unit 367 and the communication antenna 369. To do.
  • the microcomputer 361 when the microcomputer 361 receives the signal transmitted from the drug solution administration device 2 by the communication antenna 369, the microcomputer 361 acquires the signal via the receiving unit 368, and displays the contents corresponding to the signal on the display unit 366 to the user. Notification is performed and processing corresponding to the content is executed.
  • the electric circuit is operated by the power supply supplied from the rechargeable battery 206, and the microcomputer 220 provided in the drive control unit 20 performs overall control.
  • the microcomputer 220 is a computer including a CPU, a RAM, a ROM, and the like.
  • the CPU reads and executes a basic program stored in the ROM and executes the overall control, and the CPU is stored in the ROM.
  • Various processes are executed by reading various programs into the RAM and executing them.
  • the microcomputer 220 When the microcomputer 220 receives the signal transmitted from the controller 3 received by the communication antenna 205 via the receiving unit 222, the microcomputer 220 operates each unit according to the content of the signal.
  • the puncture angle is adjusted by filling the drug solution bag with a necessary amount of insulin and operating the angle adjustment mechanism 340, and the controller 3 sets the dose and administration time of the basal mode and the bolus mode.
  • the microcomputer 220 After being sent to the administration device 2 and stored in the RAM of the drug solution administration device, the microcomputer 220 signals that the administration of the drug solution is started with the drug solution administration device 2 attached to the user via the application unit 103. Is supplied from the controller 3, it is confirmed by connection of the connector parts 212 and 350 whether or not the puncture flow path part 30 is connected to the drive control part 20.
  • the microcomputer 220 drives the puncture release mechanism 330 to puncture the user with the puncture channel needle 304 and the sheath 311. Then, a prescribed amount of insulin is rotated so as to fill the space of the sheath portion inserted into the living body with priming (priming), the motor 207 is rotated, and the delivery unit 130 is driven to send the solution.
  • the microcomputer 220 sends the stored medicinal solution dosage or the medicinal solution administration set by the controller 3 when the arbitrary administration of the bolus is transmitted from the controller 3.
  • the motor 207 is rotated to drive the delivery unit 130 to administer the drug solution into the user's body.
  • the drug solution stored in advance in the drug solution bag 110 via the injection unit 104 is used via the filter unit 120, the delivery unit 130, the running water sensor 303, the puncture channel needle 304, the sheath 311, and the like. It is administered to the body of a person.
  • the microcomputer 220 monitors the number of rotations of the motor 207 via the encoder 223 and detects whether or not the chemical solution is flowing via the flow detection control unit 224.
  • the flow detection control unit 224 heats the thermistor of the flowing water sensor 303 and monitors the temperature change of the thermistor.
  • microcomputer 220 detects whether or not the sending unit 130 is driven based on the magnetic force detected by the magnetic sensor 210.
  • the microcomputer 220 performs again when the motor 207 is not rotating normally, when the delivery unit 130 is not normally driven, or when no chemical is flowing, and when the state does not change, Each unit is stopped, and a message to that effect is transmitted to the controller 3 via the transmission unit 221 and the communication antenna 205.
  • the microcomputer 220 controls the receiving / charging circuit 225 to receive the electromagnetic wave supplied from the charger 4 via the charging antenna 203 to charge the rechargeable battery 206.
  • the rechargeable battery 206 is provided with a battery safety circuit unit 226.
  • the battery safety circuit unit 226 monitors overcharge, overdischarge and battery temperature during charging to prevent thermal runaway.
  • the charger 4 includes an outlet 401, an AC / DC converter 402, a high frequency converter 403, and a transmission antenna 404.
  • the charger 4 converts alternating current sent from the outlet 401 into direct current by the AC / DC converter 402, converts it to high frequency by the high frequency conversion unit 403 for transmission by the transmission antenna 404, and then passes through the transmission antenna 404. Then, electromagnetic waves are transmitted to the drug solution administration device 2.
  • the drug solution storage and delivery unit 10 including the drug solution bag 110 and the puncture channel unit 30 including the puncture channel needle 304 and the sheath 311 are used only once from the hygiene viewpoint that the drug solution is used.
  • the drive control unit 20 that does not use the chemical solution can be used many times by attaching and detaching the chemical solution storage and delivery unit 10 and the puncture flow path unit 30. At this time, since the rechargeable battery 206 of the drive control unit 20 is charged by the charger, it can be used multiple times.
  • the present invention is not limited to this, and a mechanism different from such a mechanism may be used to switch the connection destination of the cylinder port to suck and discharge the chemical liquid.
  • the delivery unit 500 shown in FIG. 22 is a valveless pump that does not have a valve, like the delivery unit 130, and is in the internal space (cylinder internal space) 501A of the cylindrical cylinder portion 501 that is open at one end.
  • a cylindrical piston 502 is inserted from one end side.
  • each part of the sending part 500 will be described by defining one end side of the cylinder part 501 as a lower side and the other end side as an upper side.
  • An annular groove 503 is formed at the center of the inner peripheral surface of the cylinder portion 501.
  • the groove 503 includes a semicircular arc-shaped first semicircular arc-shaped groove 503A extending from the predetermined position S1 at the center of the inner peripheral surface along the circumferential direction, and the first semicircular arc-shaped groove 503A.
  • a first linear groove 503B having a predetermined length extending downward in the axial direction from the end position S2 of the first end, and a circumferential direction from the end position S3 of the first straight groove 503B.
  • first semicircular groove 503 ⁇ / b> A and the second semicircular groove 503 ⁇ / b> C are positioned to face each other across the central axis of the cylinder portion 501. Therefore, as shown in FIG. 22C, when the cylinder portion 501 is viewed from directly above, the groove 503 looks like an annular shape.
  • the first semicircular groove 503A is located slightly lower at the end position S2 than at the end position S1, and from the end position S1 to the end position S1. It is gently inclined downward toward the position S2.
  • the second semicircular groove 503C is located slightly higher at the distal end position S4 than at the distal end position S3, and is gently upward from the distal end position S3 toward the distal end position S4. Tilted.
  • a disc-shaped lid portion 501B that forms the upper end portion of the cylinder portion 501 is provided with a cylinder port 501C, which is a semicircular arc-shaped long hole, in communication with the cylinder internal space 501A.
  • the cylinder port 501C is provided at a position shifted by a predetermined amount from the central axis of the lid portion 501B (coaxial with the central axis of the cylinder portion 501).
  • this cylinder port 501C is located between the front end position S1 and the front end position S2 of the first semicircular arc groove 503A when the cylinder portion 501 is viewed from directly above. Located inside the arc.
  • the piston 502 is provided with, for example, an X ring or O ring packing 504 along the circumferential direction so that there is no gap between the piston 502 and the inner wall peripheral surface of the cylinder internal space 501A at the upper part of the outer peripheral surface. .
  • the piston 502 is formed with one protrusion 502A protruding outward at the lower part of the outer peripheral surface.
  • the protrusion 502A is slidably fitted into the groove 503 of the cylinder 501 with a structure in which a rubber or the like is prevented from slipping around the bearing that rotates only to the right.
  • the protrusion 502A slides along the second semicircular groove 503C and the first semicircular groove 503A which are substantially orthogonal to the axial direction of the piston 502 and slightly inclined, the protrusion 502A
  • the axial force that is added is transmitted to the cylinder portion 501 as a rotational force orthogonal to the axial direction.
  • the cylinder portion 501 rotates halfway while the protrusion 502A slides along the first semicircular groove 503A and the second semicircular groove 503C.
  • the sending section 500 switches the connection destination of the cylinder port 501C to the suction flow pipe 106 or the discharge flow pipe 107 by rotating the cylinder 501 halfway in this way.
  • the piston 502 slides in the axial direction without rotating the cylinder portion 501 while the protrusion 502A slides along the first linear groove 503B and the second linear groove 503D. become.
  • the piston 502 when the chemical solution is sucked into the cylinder part 501 of the delivery part 500, the piston 502 is first located at the top dead center as an initial state. At this time, the protrusion 502A of the piston 502 is located at the position S1 of the tip of the first semicircular arc groove 503A.
  • the cylinder portion 501 When the piston 502 further slides toward the bottom dead center, the cylinder portion 501 further rotates while the inside of the cylinder portion 501 and the flow path pipe 106 are in communication with each other, and the flow path pipe 106 and the cylinder port 501C are connected at the bottom dead center. Communicate at the end and stop.
  • the chemical solution loaded in the chemical solution bag 110 is injected into the space between the lid portion 501B in the cylinder portion 501 and the piston 502 through the filter portion 120, the flow path pipe 106, and the cylinder port 501C.
  • the delivery unit 500 sucks the chemical into the cylinder unit 501.
  • the protrusion 502A slides along the second linear groove 503D and the piston 502 slides from the bottom dead center to the top dead center.
  • the delivery unit 500 discharges the chemical solution from the cylinder unit 501.
  • the delivery unit 500 switches the connection destination of the cylinder port 501 and sucks and discharges the chemical solution.
  • the piston 502 is linearly moved in the axial direction by being connected to the rotating shaft 139 of the driving magnet 138 via a crank mechanism or the like, for example.
  • the delivery portion 500 needs to slide not on the second linear groove 503D side but on the first semicircular groove 503A side. .
  • the delivery unit 500 has a structure in which the outer periphery of the projecting portion 502A is rotated only to the right, and is provided with a slip stopper such as rubber on the outer periphery, or the width of the end of the second linear groove 503D is reduced.
  • the protrusion 502A is made difficult to slide from the position S1 to the second linear groove 503D by providing a protrusion at the end or by forming the end narrower than the other parts.
  • 502A is slid not on the second linear groove 503D side but on the first semicircular groove 503A side.
  • the delivery portion 500 needs to be slid not to the first linear groove 503B but to the second semicircular groove 503C.
  • the protrusion 502A has a structure in which the outer periphery turns only to the right, and a rubber or the like is provided on the outer periphery, or the end of the first linear groove 503B is narrowed at the end.
  • the protrusion 502A is made difficult to slide from the position S3 to the first linear groove 503B side by providing a protrusion or by forming the end narrower than the other parts.
  • the second semicircular groove 503C is slid.
  • connection destination of the cylinder port 132F is switched to the in-flow path 131G or the out-flow path 131H by rotating the cylinder part 132 halfway (180 degrees).
  • the rotation of the cylinder part 132 is not limited to a half rotation, for example, 1/4 rotation as long as the connection destination of the cylinder port 132F can be switched by rotating the cylinder part 132. Or 2/3 rotation.
  • the groove 131D that functions as a stopper that restricts the rotation of the cylinder part 132 to a half rotation is provided on the housing part 131 side, and the protruding part 132E that fits into the groove 131D is provided on the cylinder part 132 side. I tried to provide it.
  • a groove that functions in the same manner as the groove 131D is provided at the upper end of the outer peripheral surface of the cylinder portion 132, and a protrusion that fits into the groove is provided at the upper end of the inner wall peripheral surface of the housing portion 131. Good.
  • various other mechanisms may be used as long as the mechanism functions as a stopper capable of limiting the rotation of the cylinder part 132.
  • the frictional force between the piston 133 and the inner wall forming the cylinder inner space 132A causes the cylinder part 132 and the housing inner space 131A to move.
  • the cylinder part 132 and the piston 133 may be rotated integrally so as to be larger than the frictional force with the inner wall to be formed.
  • the coil spring 141 that urges the piston shaft 133A upward can be omitted.
  • the lubricant may be applied to the inner wall forming the housing internal space 131A.
  • X-ring or O-ring packing may be provided along the circumferential direction on the inner wall circumferential surface side of the cylinder inner space 132A, not on the piston 133 side, and silicon rubber may be provided on the piston 133.
  • a gasket made of butadiene rubber or the like may be attached.
  • the coil spring 141 is used as the biasing member that biases the piston shaft 133A upward (in the axial direction).
  • the present invention is not limited thereto, and any member other than the coil spring may be used instead of the coil spring as long as the member can bias the piston shaft 133A upward.
  • the coil spring 134 is used as a biasing member that biases the cylinder portion 132 upward (on the cylinder port 132F side).
  • any member other than the coil spring may be used instead of the coil spring as long as the member can bias the cylinder portion 132 upward.
  • the present invention can be applied to the medical field, for example.

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Achieved is a drug administration device that can deliver a fixed quantity of a drug while being compact. When a piston shaft (133A) is rotated, until a protrusion (132E) of a cylinder (132) reaches one end (131E or 131F) of a groove (131D), the connection subject of the cylinder (132) is switched to an in duct (131G) or an out duct (131H) by means of the cylinder (132) and a piston (133) rotating as one, and thereafter, the piston (133) is caused to slide by means of the piston shaft (133A) rotating with respect to the cylinder (132) that is stopped.

Description

薬液投与装置Chemical solution administration device
 本発明は、薬液投与装置に関し、例えばインスリンを体内に投与する場合に適用して好適なものである。 The present invention relates to a drug solution administration device, which is suitable for application when, for example, insulin is administered into the body.
 近年、糖尿病は日本を始め世界中で患者数が増大の傾向を示している。また、これに伴う治療費用の増大が懸念されている。糖尿病の中でも、1型糖尿病は、適切な時間に適切量のインスリンの注入する治療が必要となる慢性疾患である。古くからシリンジを用いた手動投与か、インジェクタを用いた手動投与が行われてきた。これらに対してより簡便に安全に、適切な治療を行うために、投与量および投与時期をプログラムが可能な自動の薬液投与システムが開発されてきた。 In recent years, diabetes has shown an increasing trend in the number of patients worldwide, including Japan. In addition, there is a concern about the associated increase in treatment costs. Among diabetes, type 1 diabetes is a chronic disease that requires treatment to inject an appropriate amount of insulin at an appropriate time. For a long time, manual administration using a syringe or manual administration using an injector has been performed. In order to carry out appropriate treatment more simply, safely, and automatically, an automatic drug solution administration system capable of programming the dose and administration time has been developed.
 このシステムは輸液ポンプ、専用の輸液セット、カテ-テルからなり、現在、薬液投与装置を携帯可能にしたシステムも使用されてきている。最近、この携帯型のシステムにおいて、輸液セットのチューブのわずらわしさを排除し、扱い勝手を向上するため輸液セットを用いずに、体表に両面テ-プで貼り付け固定した小型軽量な輸液ポンプから直接カテ-テルを挿入して投与を行うパッチタイプの薬液投与装置が登場している(例えば、特許文献1参照)。 This system consists of an infusion pump, a dedicated infusion set, and a catheter. At present, a system in which a drug administration device is made portable is also used. Recently, in this portable system, in order to eliminate the troublesomeness of the tube of the infusion set and to improve handling, a small and lightweight infusion pump that is fixed to the body surface with a double-sided tape without using the infusion set. A patch-type drug solution administration device has been introduced in which a catheter is directly inserted from the device (for example, see Patent Document 1).
特表2010-501283公報Special table 2010-501283
 ところで、従来の薬液投与装置では、薬液が充填された薬液貯蔵部から薬液をポンプを使って患者の体内に送出する。 By the way, in the conventional liquid medicine administration device, the liquid medicine is delivered from the liquid medicine storage section filled with the liquid medicine into the patient's body using a pump.
 薬液投与装置では、患者の体内に定量の薬液を投与する必要があるため、薬液の定量吸引及び定量排出が可能なポンプを用いなくてはならない。 Since a chemical solution administration device needs to administer a fixed amount of chemical solution into the body of a patient, a pump capable of quantitative suction and discharge of the chemical solution must be used.
 このようなポンプとしては、シリンダ部に薬液吸引用の吸引口と薬液排出用の排出口とを設けると共に、吸引口と排出口のそれぞれに逆止弁を設け、ピストンを摺動させてシリンダ部の内圧を変化させることで、吸引口と排出口のそれぞれに設けられた逆止弁のうちの一方を開くようにしたピストン式のポンプが知られている。 As such a pump, a cylinder part is provided with a suction port for suctioning a chemical solution and a discharge port for discharging a chemical solution, and a check valve is provided at each of the suction port and the discharge port. A piston type pump is known in which one of check valves provided at each of the suction port and the discharge port is opened by changing the internal pressure of the pump.
 しかしながら、このような従来のポンプは、シリンダ部の内圧の変化によって開閉する逆止弁を設けなくてはならず、小型化が難しかった。 However, such a conventional pump has to be provided with a check valve that opens and closes due to a change in the internal pressure of the cylinder portion, and is difficult to reduce in size.
 本発明は以上の点を考慮してなされたもので、小型で薬液の定量送出が可能な薬液投与装置を提案しようとするものである。 The present invention has been made in consideration of the above points, and intends to propose a small-sized chemical solution administration device capable of quantitatively delivering a chemical solution.
 かかる課題を解決するため本発明の薬液投与装置においては、薬液を吸入するときに使用する流入側流路と薬液を排出するときに使用する流出側流路とが設けられた筐体部と、前記筐体部内に回転可能に嵌入されたシリンダ部と、前記シリンダ部内で回転及び摺動可能なピストンと、前記筐体部に対する前記シリンダ部の回転範囲を制限するストッパと、前記ピストンに固定されたピストン軸と前記シリンダ部の内壁とのそれぞれに互いに噛み合うように形成され、前記シリンダ部に対して前記ピストン軸が回転したときに、前記ピストンを軸方向に摺動させるネジとを有し、前記シリンダ部には、該シリンダ部が前記ストッパにより制限される回転範囲の一端まで回転したときに前記流入側流路と接続し、該シリンダ部が前記回転範囲の他端まで回転したときに前記流出側流路と接続する1個のシリンダ口が設けられ、前記ピストンは、前記シリンダ部が前記回転範囲の一端又は他端に到達するまでの間は、前記シリンダ部と一体になって回転し、前記シリンダ部が前記回転範囲の一端又は他端に到達することで前記シリンダ口が前記流入側流路又は前記流出側流路と接続した以降は、停止している前記シリンダ部に対して前記ピストン軸が回転することにより前記シリンダ部内を摺動するようにした。 In order to solve such a problem, in the chemical liquid administration device of the present invention, a housing portion provided with an inflow side flow path used when inhaling the chemical liquid and an outflow side flow path used when discharging the chemical liquid, A cylinder portion that is rotatably fitted in the housing portion, a piston that is rotatable and slidable in the cylinder portion, a stopper that limits a rotation range of the cylinder portion relative to the housing portion, and a fixed to the piston. A screw that slides in the axial direction when the piston shaft rotates with respect to the cylinder portion, and is formed to mesh with each of the piston shaft and the inner wall of the cylinder portion; The cylinder portion is connected to the inflow side flow path when the cylinder portion rotates to one end of a rotation range limited by the stopper, and the cylinder portion is connected to the rotation range. One cylinder port that is connected to the outflow side flow path when rotated to the end is provided, and the piston is configured so that the cylinder portion is in a period until the cylinder portion reaches one end or the other end of the rotation range. And the cylinder part reaches one end or the other end of the rotation range so that the cylinder port is stopped after being connected to the inflow side flow path or the outflow side flow path. The piston shaft is slid in the cylinder portion by rotating with respect to the cylinder portion.
 これにより、ピストン軸の回転制御のみで、ピストンと共にシリンダ部を回転させてシリンダ口を流入側流路又は流出側流路に切り替えてからピストンをシリンダ部内で摺動させることができるので、逆止弁を設けることなく簡易な構成でありながら薬液の定量送出が可能となる。 As a result, the piston can be slid in the cylinder part after rotating the cylinder part together with the piston and switching the cylinder port to the inflow side flow path or the outflow side flow path only by controlling the rotation of the piston shaft. It is possible to deliver a fixed amount of a chemical solution while having a simple configuration without providing a valve.
 本発明によれば、ピストンの回転制御のみで、ピストンと共にシリンダ部を回転させてシリンダ口を流入側流路又は流出側流路に切り替えてからピストンをシリンダ部内で摺動させることができるので、逆止弁を設けることなく簡易な構成でありながら薬液の定量送出が可能となる。かくして小型で薬液の定量送出が可能なポンプ及び薬液投与装置を実現できる。 According to the present invention, the piston can be slid in the cylinder part after rotating the cylinder part together with the piston and switching the cylinder port to the inflow side flow path or the outflow side flow path only by the rotation control of the piston. It is possible to deliver a fixed amount of a chemical solution with a simple configuration without providing a check valve. Thus, it is possible to realize a small-sized pump and a chemical solution administration device capable of quantitatively delivering the chemical solution.
薬液投与システムの構成を示す略線図である。It is a basic diagram which shows the structure of a chemical | medical solution administration system. 薬液投与装置の構成を示す略線図である。It is a basic diagram which shows the structure of a chemical | medical solution administration apparatus. 薬液貯蔵送出部の分解斜視図である。It is a disassembled perspective view of a chemical | medical solution storage delivery part. 薬液の貯蔵前及び貯蔵後を示す略線図である。It is a basic diagram which shows before and after storage of a chemical | medical solution. 薬液バッグの形成工程を示す略線図である。It is a basic diagram which shows the formation process of a chemical | medical solution bag. フィルタ部の構成を示す略線図である。It is a basic diagram which shows the structure of a filter part. 送出部の構成を示す略線図である。It is a basic diagram which shows the structure of a sending part. 送出部の構成を示す略線図である。It is a basic diagram which shows the structure of a sending part. 送出部による薬液の吸入の説明にともなう略線図である。It is a basic diagram accompanying description of inhalation of the chemical | medical solution by a sending part. 送出部による薬液の排出の説明にともなう略線図である。It is a basic diagram accompanying description of discharge | emission of the chemical | medical solution by a sending part. 駆動制御部の分解斜視図である。It is a disassembled perspective view of a drive control part. 動力伝達の機構を示す略線図である。It is a basic diagram which shows the mechanism of power transmission. コネクタ部の構成を示す略線図である。It is a basic diagram which shows the structure of a connector part. 穿刺流路部の構成を示す略線図である。It is a basic diagram which shows the structure of a puncture flow path part. 穿刺流路部の構成を示す略線図である。It is a basic diagram which shows the structure of a puncture flow path part. カシメ及び押部の構成を示す略線図である。It is a basic diagram which shows the structure of a crimping and a press part. 穿刺の様子を示す略線図である。It is a basic diagram which shows the mode of puncture. 角度調整機構の構成を示す略線図である。It is a basic diagram which shows the structure of an angle adjustment mechanism. 角度調整機構におけるツマミ部の載置を示す略線図である。It is a basic diagram which shows mounting of the knob part in an angle adjustment mechanism. 角度調整機構における突出角度の変更を示す略線図である。It is a basic diagram which shows the change of the protrusion angle in an angle adjustment mechanism. 薬液投与システムの回路構成及び機能的構成を示す略線図である。It is a basic diagram which shows the circuit structure and functional structure of a chemical | medical solution administration system. 他の実施の形態における送出部の構成を示す略線図である。It is a basic diagram which shows the structure of the sending part in other embodiment.
 以下に、図面について、本発明の一実施の形態を詳述する。 Hereinafter, an embodiment of the present invention will be described in detail with reference to the drawings.
〔1.薬液投与システムの構成〕
 図1に示すように、薬液投与システム1は、使用者の皮膚に貼り付けられることにより保持されて使用される携帯型の薬液投与装置2と、使用者の入力指示に応じた信号を無線通信で薬液投与装置2に送信するコントローラ3と、薬液投与装置2の内部に設けられる充電池206(図11)を充電する充電器4(図21)とを含む構成とされる。
[1. Configuration of chemical solution administration system]
As shown in FIG. 1, a drug solution administration system 1 wirelessly communicates a signal corresponding to a user's input instruction with a portable drug solution administration device 2 that is held and used by being affixed to the user's skin. The controller 3 that transmits to the drug solution administration device 2 and the charger 4 (FIG. 21) that charges the rechargeable battery 206 (FIG. 11) provided inside the drug solution administration device 2 are configured.
〔2.薬液投与装置の構成〕
 薬液投与装置2は、内部に薬液(例えばインスリン)が貯蔵されており、コントローラ3から送信される制御信号に応じて薬液を使用者の体内に投与する。薬液投与装置2は、図2に示すように、互いに着脱可能な薬液貯蔵送出部10、駆動制御部20及び穿刺流路部30により構成される。
[2. Configuration of chemical administration device]
The chemical liquid administration device 2 stores therein a chemical liquid (for example, insulin), and administers the chemical liquid into the user's body in accordance with a control signal transmitted from the controller 3. As shown in FIG. 2, the drug solution administration device 2 includes a drug solution storage and delivery unit 10, a drive control unit 20, and a puncture channel unit 30 that are detachable from each other.
 薬液投与装置2は、薬液貯蔵送出部10と駆動制御部20が上下方向から係合された後、薬液貯蔵送出部10及び駆動制御部20に対して前方向から穿刺流路部30がスライドされて嵌合することにより一体となる。薬液投与装置2は、このような状態で使用者の皮膚に貼り付けられて使用される。 In the drug solution administration device 2, after the drug solution storage / delivery unit 10 and the drive control unit 20 are engaged from above and below, the puncture channel unit 30 is slid from the front with respect to the drug solution storage / delivery unit 10 and the drive control unit 20. To be integrated. The medicinal solution administration device 2 is used by being attached to the skin of the user in such a state.
 薬液投与装置2の大きさは、使用者の皮膚に貼り付けることができる程度にまで小型化されていればよいが、例えば横34mm、縦43mm、高さ12mmの略直方体形状とされる。 The size of the medicinal solution administration device 2 may be small enough to be attached to the user's skin, for example, a substantially rectangular parallelepiped shape having a width of 34 mm, a length of 43 mm, and a height of 12 mm.
〔2-1.薬液貯蔵送出部の構成〕
 薬液貯蔵送出部10は、図3及び図4に示すように、上側が開口し内部に空間が設けられた下筐体部101と該下筐体部101の開口に螺着される上筐体部102により扁平な略直方体形状に形成される。
[2-1. (Configuration of chemical storage and delivery unit)
As shown in FIG. 3 and FIG. 4, the chemical storage / delivery unit 10 includes a lower casing part 101 that is open on the upper side and has a space inside, and an upper casing that is screwed into the opening of the lower casing part 101. The portion 102 is formed into a flat and substantially rectangular parallelepiped shape.
 薬液貯蔵送出部10は、下筐体部101と上筐体部102とで形成される空間に薬液バッグ110、フィルタ部120、送出部130及び圧迫部150等が設けられる。 The chemical solution storage and delivery unit 10 is provided with a chemical solution bag 110, a filter unit 120, a delivery unit 130, a compression unit 150, and the like in a space formed by the lower casing unit 101 and the upper casing unit 102.
 下筐体部101には、底面101Aに両面テープ等でなる貼付部103が設けられる。薬液投与装置2は、貼付部103が使用者の皮膚に貼り付けられることにより該使用者に保持される。なお下筐体部101の底面101Aは透明な材質の部材で形成されており、薬液バッグ110に貯蔵される薬液の量が外から見えるようになされている。これにより、薬液投与装置2を該使用者の皮膚に貼り付けた後でも薬液残量を確認することが可能となる。 The lower housing part 101 is provided with a sticking part 103 made of double-sided tape or the like on the bottom face 101A. The medicinal solution administration device 2 is held by the user when the sticking portion 103 is stuck on the user's skin. The bottom surface 101 </ b> A of the lower housing 101 is formed of a transparent material so that the amount of the chemical stored in the chemical bag 110 can be seen from the outside. This makes it possible to check the remaining amount of the chemical solution even after the chemical solution administration device 2 is attached to the user's skin.
 下筐体部101の長手方向(以下、これを前後方向とも呼ぶ)に沿った側面には、駆動制御部20が配される方向に延設された突起でなる係合部101B~Eが設けられている。この係合部101B~Eは、後述する係合受部201A~D(図11)と係合することにより薬液貯蔵送出部10と駆動制御部20とを密着させる。 Engagement portions 101B to E, which are protrusions extending in the direction in which the drive control unit 20 is arranged, are provided on the side surfaces along the longitudinal direction (hereinafter also referred to as the front-rear direction) of the lower housing unit 101. It has been. The engaging portions 101B to E are brought into close contact with the chemical solution storage and delivery portion 10 and the drive control portion 20 by engaging with engagement receiving portions 201A to 201D (FIG. 11) described later.
 下筐体部101は、上筐体部102と密着する面に防水パッキン101Fが設けられており、下筐体部101が上筐体部102に防水パッキン101Fを介してネジ(図示せず)螺着されるか、超音波融着されるので、下筐体部101と上筐体部102との間から内部空間に液体が侵入することを防止することができる。 The lower casing unit 101 is provided with a waterproof packing 101F on a surface in close contact with the upper casing unit 102, and the lower casing unit 101 is screwed to the upper casing unit 102 via the waterproof packing 101F (not shown). Since it is screwed or ultrasonically fused, it is possible to prevent liquid from entering the internal space from between the lower casing portion 101 and the upper casing portion 102.
 下筐体部101の前後方向に沿った側面には、板バネリリースロッド154が挿入されるための孔101Gが設けられる。孔101Gにはダックビル様の弁パッキン(図示せず)が挿入されていて板バネリリースロッド154を抜いた場合に穴が閉じるようになっている。また下筐体部101の底面101Aには、薬液バッグ110に薬液を注入するため注入部104が嵌合する孔101Kが設けられる。 A hole 101G for inserting the leaf spring release rod 154 is provided on the side surface of the lower casing portion 101 along the front-rear direction. A duckbill-like valve packing (not shown) is inserted into the hole 101G, and the hole is closed when the leaf spring release rod 154 is removed. Further, a bottom 101 </ b> A of the lower housing part 101 is provided with a hole 101 </ b> K into which the injection part 104 is fitted to inject a chemical liquid into the chemical liquid bag 110.
 孔104Kの周辺部は薬液バッグ110に融着されている弾性部材である注入部104と下筐体部101のはめ合わせにて防水機能を実現している。 The peripheral part of the hole 104K realizes a waterproof function by fitting the injection part 104, which is an elastic member fused to the chemical solution bag 110, and the lower housing part 101.
 さらに下筐体部101は、薬液貯蔵送出部10に穿刺流路部30が係合される際に該穿刺流路部30の一部がはめ込まれる空間である凹部101Hが前方向側に設けられる。また下筐体部101は、穿刺流路部30が前方向から薬液貯蔵送出部10にスライドして係合されるように案内する、互いに向かい合う方向に突出された突起部101I及び101Jが前後方向に沿って設けられる。 Further, the lower casing portion 101 is provided with a concave portion 101H on the front side, which is a space into which a part of the puncture channel portion 30 is fitted when the puncture channel portion 30 is engaged with the drug solution storage and delivery unit 10. . Further, the lower casing portion 101 is provided with projections 101I and 101J protruding in opposite directions to guide the puncture flow path portion 30 so as to be slid and engaged with the medicinal solution storage / delivery portion 10 from the front direction. It is provided along.
 上筐体部102は、下筐体部101の突起部101I及び101Jと前後方向に連続するように互いに向かい合う方向に突出された突起部102A及び102Bが前後方向に沿って設けられる。なお上筐体部102は、突起部102A及び102Bを形成するため、該突起部102A及び102Bに挟まれる中央部102Cがその他の部分より一段低くなるように形成される。下筺体部101の突起部101I、101Jと、上筺体部の突起部102A、102B及び中央部102Cとの併せ部には防水用パッキンを挿入する。 The upper housing part 102 is provided with projecting parts 102A and 102B protruding in the front-rear direction so as to be continuous with the projecting parts 101I and 101J of the lower housing part 101 in the front-rear direction. The upper housing portion 102 is formed such that the central portion 102C sandwiched between the protrusion portions 102A and 102B is one step lower than the other portions in order to form the protrusion portions 102A and 102B. Waterproof gaskets are inserted into the joints of the protrusions 101I and 101J of the lower housing part 101 and the protrusions 102A and 102B and the central part 102C of the upper housing part.
 上筐体部102は、薬液貯蔵送出部10に穿刺流路部30が係合される際に穿刺流路部30の凸部301C(図15)がはまり込む凹部102Dが中央部102Cの所定位置に設けられる。 In the upper housing portion 102, a concave portion 102D into which a convex portion 301C (FIG. 15) of the puncture flow channel portion 30 is fitted when the puncture flow channel portion 30 is engaged with the drug solution storage and delivery portion 10 is a predetermined position of the central portion 102C. Provided.
 薬液貯蔵部としての薬液バッグ110は、図5に示すように、例えばポリウレタン、塩化ビニル、ポリエチレンでなる長方形のシート111から形成される。シート111は、図5(A)に示すように、長手方向における中央部分であって可撓性の熱可塑性樹脂である薬液バッグ110の底面となる部分(以下、これを中央部とも呼ぶ)112の両側に、少なくとも3以上の奇数個(本実施の形態では5個)の折り目113及び114が等間隔にそれぞれ設けられる。これによりシート111には、それぞれ隣接する折り目113及び114の間に所定幅の部分(以下、これを折畳部とも呼ぶ)115及び116が偶数個形成される。 As shown in FIG. 5, the chemical solution bag 110 as the chemical solution storage unit is formed from a rectangular sheet 111 made of, for example, polyurethane, vinyl chloride, or polyethylene. As shown in FIG. 5 (A), the sheet 111 is a central portion in the longitudinal direction and is a portion (hereinafter also referred to as a central portion) 112 that becomes the bottom surface of the chemical solution bag 110 that is a flexible thermoplastic resin. At least three odd or more (five in the present embodiment) fold lines 113 and 114 are provided at equal intervals on both sides of the sheet. As a result, an even number of portions (hereinafter also referred to as folding portions) 115 and 116 having a predetermined width are formed on the sheet 111 between the adjacent folds 113 and 114, respectively.
 またシート111は、長手方向における最も端よりの折り目113及び114よりさらに端側に、中央部112における長手方向の長さの半分より長い部分(以下、これを端部とも呼ぶ)117及び118が設けられる。 Further, the sheet 111 has portions (hereinafter also referred to as end portions) 117 and 118 that are longer than half of the length in the longitudinal direction in the central portion 112 on the further end side than the folds 113 and 114 from the most ends in the longitudinal direction. Provided.
 このシート111は、折畳部115及び116が中央部112と重なるように折り目113及び114が山折及び谷折に交互に折り畳まれ、図5(B)に示すように、端部117及び118の端側の一部が重なる。 In this sheet 111, the folds 113 and 114 are alternately folded into a mountain fold and a valley fold so that the fold portions 115 and 116 overlap the center portion 112, and as shown in FIG. Part of the end side overlaps.
 シート111は、端部117及び118のうちの互いに重なった部分が融着され、また幅方向の縁が融着される。シート111の幅方向の縁が融着される際、該シート111に囲まれた空間と外部空間とを連通させるノズル105を一方の縁に挟むようにして該縁が融着される。 In the sheet 111, the overlapping portions of the end portions 117 and 118 are fused, and the edges in the width direction are fused. When the edge in the width direction of the sheet 111 is fused, the edge is fused so that the nozzle 105 that connects the space surrounded by the sheet 111 and the external space is sandwiched between the edges.
 またシート111の中央部112の所定位置には、外部から薬液バッグ110に薬液を注入するために例えば合成ゴムなどで形成される逆止弁(不図示)を備えた注入部104が設けられる。このようにして図5(C)に示すような薬液バッグ110が形成される。 Also, at a predetermined position of the central portion 112 of the seat 111, an injection portion 104 having a check valve (not shown) formed of, for example, synthetic rubber or the like is provided to inject a chemical solution into the chemical solution bag 110 from the outside. In this way, a chemical solution bag 110 as shown in FIG. 5C is formed.
 このようにして形成された薬液バッグ110は、薬液が充填されていない状態では隣接する折畳部115及び116同士が接するようにして折畳まれており、中央部112と端部117及び118とが重なり合う。 The medical solution bag 110 formed in this way is folded so that the adjacent folding portions 115 and 116 are in contact with each other in a state where the medical solution is not filled, and the central portion 112 and the end portions 117 and 118 are Overlap.
 従って薬液バッグ110は、内部に充填された薬液をノズル105を介して外部に送出する際に、中央部112と端部117及び118とが接するように潰されることで薬液を内部に残すことなく外部に送出することができる。 Therefore, the chemical solution bag 110 is not crushed so that the central portion 112 and the end portions 117 and 118 are in contact with each other without leaving the chemical solution inside when the chemical solution filled therein is sent to the outside through the nozzle 105. Can be sent to the outside.
 ところで従来の薬液バッグは、2枚のフィルムの縁を融着されて形成されたものが一般的であり、2枚のフィルムにより形成される空間に薬液が注入されるが、その際には縁に近づくに連れて2枚のフィルムが離間する距離が短くなってしまう。 By the way, the conventional chemical solution bag is generally formed by fusing the edges of two films, and the chemical solution is injected into the space formed by the two films. As the distance approaches, the distance between the two films becomes shorter.
 従って従来の薬液バッグを使った薬液投与装置では、薬液バッグを格納される空間において、薬液バッグの縁に近い部分で薬液が注入された際に該薬液バッグが膨らまない部分に無駄な空間が形成されてしまう。かくして従来の薬液バッグでは薬液投与装置が大型化してしまうといった問題があった。 Therefore, in the conventional chemical solution administration device using the chemical solution bag, in the space where the chemical solution bag is stored, when the chemical solution is injected near the edge of the chemical solution bag, a useless space is formed in the portion where the chemical solution bag does not expand. It will be. Thus, the conventional drug solution bag has a problem in that the drug solution administration device is enlarged.
 一方、薬液バッグ110は、長手方向に折畳部115及び116を有しているので、薬液が注入される際には折畳部115及び116が、中央部112と端部117及び118を離間させる方向(上下方向)に広がる。 On the other hand, since the chemical solution bag 110 has the folding portions 115 and 116 in the longitudinal direction, the folding portions 115 and 116 separate the center portion 112 and the end portions 117 and 118 when the chemical solution is injected. It spreads in the direction (vertical direction).
 従って薬液バッグ110は、折畳部115及び116が広がることによって、薬液が注入される際に薬液バッグ110の縁付近であっても上下方向に広がることができるので、下筐体部101と上筐体部102とで形成される空間において、薬液が注入される際に薬液バッグ110の縁に近い部分でも無駄な空間が形成されてしまうことがなく、薬液投与装置2を小型化することができ、かくして使い勝手を向上することができる。 Therefore, the chemical solution bag 110 can expand in the vertical direction even when it is near the edge of the chemical solution bag 110 when the chemical solution is injected by expanding the folding parts 115 and 116. In the space formed with the casing 102, when the chemical solution is injected, a wasteful space is not formed even in a portion near the edge of the chemical solution bag 110, and the chemical solution administration device 2 can be downsized. Yes, thus improving usability.
 フィルタ部120は、図6に示すように、下側が開口し内部に空間が設けられた上蓋121の側面に、内部空間と薬液バッグ110とを連通するノズル105が接続されると共に、内部空間と送出部130とを連通する流路管106が接続される。 As shown in FIG. 6, the filter unit 120 is connected to a side surface of the upper lid 121 having an opening on the lower side and a space in the interior, and a nozzle 105 communicating the inner space and the chemical solution bag 110. A channel pipe 106 communicating with the delivery unit 130 is connected.
 フィルタ部120は、上蓋121の開口を塞ぐように、気体を通過させ液体を通過させないエアベントフィルタ122が設けられる。エアベントフィルタ122は、上蓋121と該上蓋121の開口を塞ぐ下蓋123との間に、周方向に沿って上下方向からOリング124及び125に挟まれるようにして固定される。なお、上蓋121と下蓋123とは例えば超音波融着などにより密着される。下蓋123は、上下方向に貫通した孔123Aが設けられる。 The filter unit 120 is provided with an air vent filter 122 that allows gas to pass but not liquid to close the opening of the upper lid 121. The air vent filter 122 is fixed between the upper lid 121 and the lower lid 123 that closes the opening of the upper lid 121 so as to be sandwiched between the O-rings 124 and 125 along the circumferential direction. The upper lid 121 and the lower lid 123 are in close contact with each other by, for example, ultrasonic fusion. The lower lid 123 is provided with a hole 123A penetrating in the vertical direction.
 これによりフィルタ部120は、上蓋121の内部空間から下蓋123に設けられる孔123Aを介して、薬液を排出することなく気体だけを外部に排出することができる。 Thus, the filter unit 120 can discharge only the gas from the inner space of the upper lid 121 through the hole 123A provided in the lower lid 123 without discharging the chemical solution.
 送出部130は、図7、図8(A)及び(B)に示すように、弁を有さないバルブレスポンプであり、筐体部131の内部に設けられた内部空間(これを筐体内部空間とも呼ぶ)131Aに、円筒状のシリンダ部132が周方向に回転可能に嵌入される。 As shown in FIGS. 7, 8 </ b> A, and 8 </ b> B, the delivery unit 130 is a valveless pump that does not have a valve, and is an internal space provided inside the housing unit 131 (this is the interior of the housing). A cylindrical cylinder part 132 is fitted into 131 </ b> A so as to be rotatable in the circumferential direction.
 シリンダ部132は、一端側が開口している円筒状であり、この一端側からシリンダ部132の内部空間(これをシリンダ内部空間とも呼ぶ)132A内に円柱状のピストン133が挿入される。 The cylinder part 132 has a cylindrical shape with one end opened, and a columnar piston 133 is inserted into the internal space 132A of the cylinder part 132 (also referred to as a cylinder internal space) from this one end side.
 尚、ここでは、シリンダ部132の一端側を下側、他端側を上側と定義して、送出部130の各部について説明することとする。 Here, each part of the delivery part 130 will be described by defining one end side of the cylinder part 132 as a lower side and the other end side as an upper side.
 シリンダ部132の内周面には、中央から下端に架けてメネジ132Bが形成される。このメネジ132Bは、ピストン133のピストン軸133Aに固定されたボス133Bの外周面に形成されるオネジ133Cと噛み合うようになっている。 A female thread 132B is formed on the inner peripheral surface of the cylinder part 132 from the center to the lower end. The female screw 132B is configured to mesh with a male screw 133C formed on the outer peripheral surface of a boss 133B fixed to the piston shaft 133A of the piston 133.
 またシリンダ部132の上端部を形成する円板状の蓋部132Cには、その上面に、蓋部132Cの中心軸(シリンダ部132の中心軸と同軸)に沿って上方に突する円柱状の突起部132Dが設けられる。この突起部132Dは、シリンダ部132が回転するときの軸となる。ゆえに、以下では、この突起部132Dを、軸部132Dと呼ぶ。 Further, the disc-shaped lid portion 132C that forms the upper end portion of the cylinder portion 132 has a cylindrical shape that projects upward on the upper surface along the central axis of the lid portion 132C (coaxial with the central axis of the cylinder portion 132). A protrusion 132D is provided. The protrusion 132D serves as an axis when the cylinder part 132 rotates. Therefore, hereinafter, the protrusion 132D is referred to as a shaft portion 132D.
 さらにこの蓋部132Cの外周面には、外方に突する直方体形状の突起部132Eが1個形成される。 Furthermore, one rectangular parallelepiped protrusion 132E protruding outward is formed on the outer peripheral surface of the lid 132C.
 さらにこの蓋部132Cには、1個のシリンダ口132Fがシリンダ内部空間132Aと連通して設けられる。このシリンダ口132Fは、図8(B)に示すように、蓋部132Cの中心軸(シリンダ部132の中心軸と同軸)と突起部132Eとを結ぶ線分(図示せず)上の、中心軸から所定量だけずれた位置に設けられる。 Furthermore, this lid portion 132C is provided with one cylinder port 132F communicating with the cylinder internal space 132A. As shown in FIG. 8B, the cylinder port 132F has a center on a line segment (not shown) connecting the center axis of the lid portion 132C (coaxial with the center axis of the cylinder portion 132) and the protrusion 132E. It is provided at a position displaced from the shaft by a predetermined amount.
 筐体部131は、薬液貯蔵送出部10の下筐体部101(図3)に固定されている。筐体部131には、シリンダ部132の外径とほぼ同径で且つシリンダ部132よりも若干長く形成された筐体内部空間131Aが設けられ、この筐体内部空間131Aにシリンダ部132が嵌入される。 The casing 131 is fixed to the lower casing 101 (FIG. 3) of the chemical storage / delivery unit 10. The housing part 131 is provided with a housing internal space 131A that is substantially the same diameter as the outer diameter of the cylinder part 132 and slightly longer than the cylinder part 132, and the cylinder part 132 is fitted into the housing internal space 131A. Is done.
 この筐体内部空間131Aを形成する内壁の上面(これを内壁上面とも呼ぶ)には、筐体内部空間131Aの中心軸に沿って凹部131Bが形成される。 A recess 131B is formed on the upper surface of the inner wall forming the housing inner space 131A (also referred to as the inner wall upper surface) along the central axis of the housing inner space 131A.
 また筐体内部空間131Aを形成する内壁の下面(これを内壁下面とも呼ぶ)の中央には、高さが基部137Bよりスベリ用のナイロンワッシャ143の厚み分短い筒状の出っ張り部142が形成され、出っ張り部142にはピストン軸133Aより大きい径の孔131Cが形成される。 In addition, a cylindrical protruding portion 142 whose height is shorter than the base portion 137B by the thickness of the sliding nylon washer 143 is formed at the center of the lower surface of the inner wall forming the housing internal space 131A (also referred to as the inner wall lower surface). The protruding portion 142 is formed with a hole 131C having a diameter larger than that of the piston shaft 133A.
 さらに筐体内部空間131Aを形成する出っ張り部142のある内壁下面と、筐体内部空間131Aに嵌入されたシリンダ部132の下端との間に、筐体内部空間131Aの周方向に沿う形状のコイルバネ134が配される。 Further, a coil spring having a shape along the circumferential direction of the housing internal space 131A between the lower surface of the inner wall having the protruding portion 142 forming the housing internal space 131A and the lower end of the cylinder part 132 fitted in the housing internal space 131A. 134 is arranged.
 このコイルバネ134は、ワッシャ135を介してシリンダ部132の下端を押し上げることで、シリンダ部132を上方(すなわちシリンダ口132F側)に付勢する。 This coil spring 134 pushes up the lower end of the cylinder part 132 via the washer 135, thereby urging the cylinder part 132 upward (that is, on the cylinder port 132F side).
 このように付勢されていることで、シリンダ部132は、常に、蓋部132Cの軸部132Dが筐体内部空間131Aを形成する内壁上面の凹部131Bに嵌合され、且つ蓋部132Cの上面が内壁上面に密接した状態となる。 By being biased in this way, the cylinder portion 132 is always fitted into the recess 131B on the upper surface of the inner wall forming the housing internal space 131A in the shaft portion 132D of the lid portion 132C, and the upper surface of the lid portion 132C. Is in close contact with the upper surface of the inner wall.
 さらに筐体内部空間131Aを形成する内壁の周面(これを内壁周面とも呼ぶ)には、シリンダ部132の蓋部132Cの外周面に対向する箇所、すなわち内壁周面の上端に、周方向(すなわちシリンダ部132の回転方向)に沿って半周分だけ延在する半円弧状の溝131Dが形成される。この溝131Dに、シリンダ部132の蓋部132Cの外周面に形成される突起部132Eが摺動自在に嵌合される。 Further, on the peripheral surface of the inner wall forming the housing internal space 131A (also referred to as the inner wall peripheral surface), the portion facing the outer peripheral surface of the lid portion 132C of the cylinder portion 132, that is, the upper end of the inner wall peripheral surface, A semicircular arc-shaped groove 131 </ b> D extending along a half circumference along the rotation direction of the cylinder portion 132 is formed. A protrusion 132E formed on the outer peripheral surface of the lid portion 132C of the cylinder portion 132 is slidably fitted into the groove 131D.
 この溝131Dと突起部132Eは、筐体部131に対するシリンダ部132の回転を半回転に制限するストッパとして機能する。 The groove 131D and the protruding portion 132E function as a stopper that restricts the rotation of the cylinder portion 132 relative to the housing portion 131 to a half rotation.
 すなわち、この溝131Dと突起部132Eによって、シリンダ部132の回転範囲は、突起部132Eが溝131Dの一端部131Eに当接する位置から、他端部131Fに当接する位置までの半回転に制限される。 That is, due to the groove 131D and the protrusion 132E, the rotation range of the cylinder part 132 is limited to a half rotation from the position where the protrusion 132E contacts the one end 131E of the groove 131D to the position where the other end 131F contacts. The
 また筐体部131の上端部には、シリンダ口132Fと同径でなる2個の流路131G及び131Hが筐体内部空間131Aと連通して設けられる。流路131Gは、外部からシリンダ部132に薬液を引き入れるときに使用する流路であり、以下、イン流路131Gと呼ぶ。一方、流路131Hは、シリンダ部132から外部に薬液を排出するときに使用する流路であり、以下、アウト流路131Hと呼ぶ。 Further, two flow paths 131G and 131H having the same diameter as the cylinder port 132F are provided at the upper end of the casing 131 so as to communicate with the casing internal space 131A. The channel 131G is a channel used when a chemical solution is drawn into the cylinder part 132 from the outside, and is hereinafter referred to as an in-channel 131G. On the other hand, the channel 131H is a channel used when the chemical liquid is discharged from the cylinder part 132 to the outside, and is hereinafter referred to as an out channel 131H.
 尚、イン流路131Gは、流路管106と接続され、アウト流路131Hは、流路管107と接続される。 The in-flow path 131G is connected to the flow path pipe 106, and the out flow path 131H is connected to the flow path pipe 107.
 イン流路131Gは、図8(B)に示すように、溝131Dの一端部131Eと他端部131Fとを結ぶ線分(図示せず)上の、筐体内部空間131Aの中心軸から溝131Dの一端部131E側に所定量ずれた位置に設けられる。一方、アウト流路131Hは、筐体内部空間131Aの中心軸を挟んでイン流路131Gとは反対側の位置に設けられる。 As shown in FIG. 8B, the in-flow channel 131G is a groove extending from the central axis of the housing internal space 131A on a line segment (not shown) connecting the one end 131E and the other end 131F of the groove 131D. It is provided at a position shifted by a predetermined amount on the one end 131E side of 131D. On the other hand, the out channel 131H is provided at a position opposite to the in channel 131G across the central axis of the housing internal space 131A.
 尚、イン流路131G及びアウト流路131Hの中心軸からのずれ量は、シリンダ部132の蓋部132Cに設けられるシリンダ口132Fの中心軸からのずれ量と等しい。 In addition, the deviation | shift amount from the center axis of the in-flow path 131G and the out-flow path 131H is equal to the deviation | shift amount from the center axis | shaft of the cylinder port 132F provided in the cover part 132C of the cylinder part 132. FIG.
 かくして、シリンダ部132は、突起部132Eが溝131Dの一端部131Eに当接する位置まで回転したとき(すなわち回転範囲の一端まで回転したとき)、シリンダ口132Fがイン流路131Gの真下に位置することになり、このときシリンダ口132Fとイン流路131Gとが接続する。 Thus, when the projection 132E rotates to a position where the projection 132E contacts the one end 131E of the groove 131D (that is, when it rotates to one end of the rotation range), the cylinder port 132F is positioned directly below the in-flow path 131G. In this case, the cylinder port 132F and the in-flow path 131G are connected.
 一方、突起部132Eが溝131Dの他端部131Fに当接する位置まで回転したとき(すなわち回転範囲の他端まで回転したとき)、シリンダ口132Fがアウト流路131Hの真下に位置することになり、このときシリンダ口132Fとアウト流路131Hとが接続する。 On the other hand, when the protrusion 132E rotates to a position where it comes into contact with the other end 131F of the groove 131D (that is, when it rotates to the other end of the rotation range), the cylinder port 132F is positioned directly below the out flow path 131H. At this time, the cylinder port 132F and the outflow passage 131H are connected.
 また、これら以外のときには、シリンダ口132Fが内壁上面により塞がれる。 In other cases, the cylinder port 132F is blocked by the upper surface of the inner wall.
 このように筐体内部空間131Aに嵌入されたシリンダ部132は、周方向への回転範囲が半回転に制限され、回転範囲の一端まで回転したときにシリンダ口132Fがイン流路131Gに接続され、回転範囲の他端まで回転したときにシリンダ口132Fがアウト流路131Hに接続される。 As described above, the cylinder portion 132 fitted in the housing internal space 131A has a rotation range in the circumferential direction limited to a half rotation, and the cylinder port 132F is connected to the in-flow path 131G when rotating to one end of the rotation range. When rotating to the other end of the rotation range, the cylinder port 132F is connected to the out flow path 131H.
 シリンダ内部空間132Aに挿入されるピストン133の外周面には、ピストン133とシリンダ内部空間132Aの内壁周面との間に隙間ができないように、周方向に沿って例えばXリング又はOリングのパッキン136が設けられている。 For example, X ring or O ring packing along the circumferential direction so that there is no gap between the piston 133 and the inner wall peripheral surface of the cylinder internal space 132A on the outer peripheral surface of the piston 133 inserted into the cylinder internal space 132A. 136 is provided.
 ピストン133に固定されるピストン軸133Aは、下端側から、筐体内部空間131Aの内壁下面に形成された出っ張り部142の孔131Cに挿通された駆動軸137の先端部137Aとはコイルバネ141を挟んで溶接され、駆動軸137と接続される。 The piston shaft 133A fixed to the piston 133 has a coil spring 141 sandwiched from the tip end portion 137A of the drive shaft 137 inserted through the hole 131C of the protruding portion 142 formed on the lower surface of the inner wall of the housing inner space 131A from the lower end side. And is connected to the drive shaft 137.
 駆動軸137は、ピストン軸133Aの外形とほぼ同径の内径を有する所定長さの先端部137Aと、ピストン軸133Aの外径とほぼ同径の外径を有する基部137Bとで構成される。 The drive shaft 137 includes a tip portion 137A having a predetermined length having an inner diameter substantially the same as the outer shape of the piston shaft 133A, and a base portion 137B having an outer diameter substantially the same as the outer diameter of the piston shaft 133A.
 駆動軸137は、先端部137Aとは反対側の端部にかさ歯車137Cが設けられ、筐体内部空間131Aの内壁下面に形成された出っ張り部142の先端部とスベリ用のナイロンワッシャ143を挟んで取り付けられたかさ歯車137Cが駆動用磁石138(図7)の回転軸139に設けられたかさ歯車139Aと噛み合うことで、回転軸139と接続される。 The drive shaft 137 is provided with a bevel gear 137C at the end opposite to the tip 137A, and sandwiches the tip of the protruding portion 142 formed on the lower surface of the inner wall of the housing internal space 131A and the nylon washer 143 for sliding. The bevel gear 137 </ b> C attached in (1) is engaged with the bevel gear 139 </ b> A provided on the rotation shaft 139 of the drive magnet 138 (FIG. 7), thereby being connected to the rotation shaft 139.
 駆動用磁石138の側面には、駆動軸137の回転を検出するための回転検出用磁石140が設けられる。 A rotation detection magnet 140 for detecting the rotation of the drive shaft 137 is provided on the side surface of the drive magnet 138.
 駆動用磁石138は、上筐体部102及び駆動制御部20の下筐体部202(図11)を挟んで動力伝達磁石209(図11、図12)と対向する位置に設けられ、後述するようにモータ207、ギヤヘッド208を介して回転する動力伝達磁石209に引き付けられて回転させられる。 The driving magnet 138 is provided at a position facing the power transmission magnet 209 (FIGS. 11 and 12) across the upper casing 102 and the lower casing 202 (FIG. 11) of the drive controller 20, and will be described later. In this manner, it is attracted to and rotated by the power transmission magnet 209 that rotates through the motor 207 and the gear head 208.
 駆動用磁石138が回転することで回転軸139が回転すると、この回転軸139の回転がかさ歯車139A及び137Cを介して駆動軸137に伝わり、駆動軸137が回転する。 When the rotating shaft 139 rotates due to the rotation of the driving magnet 138, the rotation of the rotating shaft 139 is transmitted to the driving shaft 137 via the bevel gears 139A and 137C, and the driving shaft 137 rotates.
 尚、ここでは、一例として、回転軸139が1回転したときに、駆動軸137も1回転するように、かさ歯車139Aと137Cの回転比が決められている。 Here, as an example, the rotation ratio of the bevel gears 139A and 137C is determined so that when the rotation shaft 139 makes one rotation, the drive shaft 137 also makes one rotation.
 駆動軸137は、その先端部137Aが、コイルバネ141を介してピストン軸133Aと接続されており、ピストン軸133Aに回転力を伝達でき、且つ駆動軸137に対して、コイルバネ141が伸びて、ピストン軸133Aが軸方向(上下方向)に摺動できる構造となっている。 The drive shaft 137 has a tip 137A connected to the piston shaft 133A via the coil spring 141, and can transmit a rotational force to the piston shaft 133A. The coil spring 141 extends to the drive shaft 137, and the piston The shaft 133A can slide in the axial direction (vertical direction).
 このコイルバネ141は、ピストン軸133Aが上方に押し上げられた分だけ伸びる。また、ピストン軸133Aのオネジ133Cとシリンダ部132のメネジ132Bの嵌合を付勢する。 The coil spring 141 extends as much as the piston shaft 133A is pushed upward. Further, the fitting of the male screw 133C of the piston shaft 133A and the female screw 132B of the cylinder part 132 is urged.
 ピストン軸133Aのオネジ133Cとシリンダ部132のメネジ132Bとの摩擦力は、シリンダ部132と筐体内部空間131Aを形成する内壁との摩擦力より大きくなるよう設定されている。 The frictional force between the male screw 133C of the piston shaft 133A and the female screw 132B of the cylinder part 132 is set to be larger than the frictional force between the cylinder part 132 and the inner wall forming the housing internal space 131A.
 これにより、駆動軸137が一方向に回転したときに、シリンダ部132の突起部132Eが溝131Dの一端部131E又は他端部131Fに当接するまでの間は、シリンダ部132とピストン133とが一体になって回転する。このとき、ピストン133は、シリンダ部132に対して摺動しない。 Thereby, when the drive shaft 137 rotates in one direction, the cylinder portion 132 and the piston 133 are not moved until the protrusion 132E of the cylinder portion 132 comes into contact with the one end portion 131E or the other end portion 131F of the groove 131D. Rotate together. At this time, the piston 133 does not slide with respect to the cylinder part 132.
 その後、シリンダ部132の突起部132Eが溝131Dの一端部131E又は他端部131Fに当接すると、このときシリンダ部132の回転は停止する。 Thereafter, when the protruding portion 132E of the cylinder portion 132 comes into contact with the one end portion 131E or the other end portion 131F of the groove 131D, the rotation of the cylinder portion 132 is stopped at this time.
 以降も駆動軸137が回転し続けると、今度は、停止しているシリンダ部132に対して、ピストン軸133Aが回転し始める。 Thereafter, when the drive shaft 137 continues to rotate, the piston shaft 133A starts to rotate with respect to the stopped cylinder portion 132.
 このとき、ピストン133は、シリンダ部132のメネジ132Bとピストン軸133Aのオネジ133Cとによって、シリンダ内部空間132A内を軸方向(上下方向)に摺動する。 At this time, the piston 133 slides in the cylinder internal space 132A in the axial direction (vertical direction) by the internal thread 132B of the cylinder portion 132 and the external thread 133C of the piston shaft 133A.
 このように、送出部130では、駆動軸137を介してピストン軸133Aが回転すると、シリンダ部132の突起部132Eが溝131Dの一端部131E又は他端部131Fに当接するまでの間は、シリンダ部132とピストン133とが一体になって回転し、シリンダ部132の突起部132Eが溝131Dの一端部131E又は他端部131Fに当接してシリンダ部132の回転が停止した以降は、コイルバネ141が延び縮みして、停止したシリンダ部132のシリンダ内部空間132A内をピストン133が摺動するようになっている。 Thus, in the delivery part 130, when the piston shaft 133A rotates via the drive shaft 137, until the projection 132E of the cylinder part 132 contacts the one end part 131E or the other end part 131F of the groove 131D, the cylinder After the part 132 and the piston 133 rotate together, the protrusion 132E of the cylinder part 132 contacts the one end part 131E or the other end part 131F of the groove 131D and the rotation of the cylinder part 132 stops, and then the coil spring 141 The piston 133 slides in the cylinder inner space 132A of the stopped cylinder part 132.
 実際、送出部130のシリンダ部132内に薬液を吸引する場合、まず初期状態として、図9(A)に示すように、シリンダ部132は、突起部132Eが溝131Dの他端部131Fに当接する位置で停止していて、ピストン133は、上死点に位置している。 Actually, when a chemical solution is sucked into the cylinder part 132 of the delivery part 130, first, as shown in FIG. 9 (A), the cylinder part 132 has a protruding part 132E that contacts the other end part 131F of the groove 131D. The piston 133 is stopped at the contact position, and the piston 133 is located at the top dead center.
 このとき、シリンダ口132Fは、アウト流路131Hの真下に位置することでアウト流路131Hと接続される。 At this time, the cylinder port 132F is connected to the outflow path 131H by being positioned directly below the outflow path 131H.
 この初期状態から、シリンダ部132の突起部132Eが溝131Dの一端部131E側に回転するように(すなわちシリンダ部132が、真上から見て反時計周りに回転するように)、駆動軸137を矢印Aに示す方向に回転させる。 From this initial state, the drive shaft 137 so that the protrusion 132E of the cylinder 132 rotates toward the one end 131E of the groove 131D (that is, the cylinder 132 rotates counterclockwise when viewed from directly above). Is rotated in the direction indicated by arrow A.
 すると、シリンダ部132の突起部132Eが溝131Dの他端部131Fから一端部131Eに当接するまでの間は、シリンダ部132とピストン133とが一体になって回転する。この間、ピストン133は、シリンダ部132に対して摺動しない。 Then, the cylinder part 132 and the piston 133 rotate together until the protrusion part 132E of the cylinder part 132 comes into contact with the one end part 131E from the other end part 131F of the groove 131D. During this time, the piston 133 does not slide with respect to the cylinder part 132.
 さらに駆動軸137を回転させ続け、図9(B)に示すように、シリンダ部132の突起部132Eが一端部131Eに当接すると(すなわちシリンダ部132が180度回転すると)、このときシリンダ部132の回転が停止する。 Further, when the drive shaft 137 continues to rotate and the projection 132E of the cylinder part 132 comes into contact with the one end part 131E (that is, when the cylinder part 132 rotates 180 degrees), as shown in FIG. The rotation of 132 stops.
 このとき、シリンダ口132Fは、イン流路131Gの真下に位置することでイン流路131Gと接続される。このようにして、送出部130では、まず流路をアウト流路131Hからイン流路131Gに切り替える。 At this time, the cylinder port 132F is connected to the in-flow path 131G by being positioned directly below the in-flow path 131G. Thus, in the delivery part 130, a flow path is switched from the out flow path 131H to the in flow path 131G first.
 このとき、シリンダ内部空間132Aは、シリンダ口132F、イン流路131G、流路管106を介して、フィルタ部120(図3)と接続される。 At this time, the cylinder internal space 132A is connected to the filter unit 120 (FIG. 3) via the cylinder port 132F, the in-flow path 131G, and the flow-path pipe 106.
 さらに図9(C)に示すように、駆動軸137を回転させ続け、停止しているシリンダ部132に対してピストン軸133Aを回転させることで、ピストン133を上死点から下死点へと摺動させる。 Further, as shown in FIG. 9C, the drive shaft 137 is continuously rotated, and the piston shaft 133A is rotated with respect to the stopped cylinder portion 132, whereby the piston 133 is moved from the top dead center to the bottom dead center. Slide.
 すると、薬液バッグ110(図3)に装填された薬液が、フィルタ部120、流路管106、イン流路131G、シリンダ口132Fを通って、シリンダ部132内の蓋部132Cとピストン133と間のシリンダ内部空間132Aに注入される。 Then, the chemical solution loaded in the chemical solution bag 110 (FIG. 3) passes through the filter unit 120, the flow channel pipe 106, the in-flow channel 131 </ b> G, and the cylinder port 132 </ b> F, and between the lid portion 132 </ b> C and the piston 133 in the cylinder unit 132. Is injected into the cylinder inner space 132A.
 その後、駆動軸137の回転回数がオネジのねじ山の数とメネジのねじ山の数で規定される規定の回転回数に達すると、図9(D)に示すように、駆動軸137の回転が停止する。尚、規定の回転回数は、シリンダ部132とピストン133が一体となって回転し始めてからピストン133が下死点に到達するまでに必要な駆動軸137の回転回数が設定されている。よって、駆動軸137の回転が停止したとき、ピストン133は下死点に位置する。 Thereafter, when the number of rotations of the drive shaft 137 reaches a predetermined number of rotations defined by the number of threads of the male screw and the number of threads of the female screw, as shown in FIG. Stop. The prescribed number of rotations is set to the number of rotations of the drive shaft 137 required until the piston 133 reaches the bottom dead center after the cylinder part 132 and the piston 133 start to rotate together. Therefore, when the rotation of the drive shaft 137 stops, the piston 133 is located at the bottom dead center.
 このようにして、送出部130では、シリンダ内部空間132A内に薬液を吸引する。 In this way, the delivery unit 130 sucks the chemical into the cylinder internal space 132A.
 つづけて、シリンダ部132内に吸引した薬液を排出する場合、図10(A)及び(B)に示すように、シリンダ部132の突起部132Eが溝131Dの他端部131F側に回転するように(すなわちシリンダ部132が吸入時とは逆方向に回転するように)、駆動軸137を矢印Aとは逆方向の矢印Bに示す方向に回転させる。 Subsequently, when the chemical solution sucked into the cylinder part 132 is discharged, as shown in FIGS. 10A and 10B, the protrusion 132E of the cylinder part 132 is rotated to the other end part 131F side of the groove 131D. (I.e., so that the cylinder portion 132 rotates in the direction opposite to that during suction), the drive shaft 137 is rotated in the direction indicated by the arrow B in the direction opposite to the arrow A.
 すると、シリンダ部132の突起部132Eが溝131Dの一端部131Eから他端部131Fに当接するまでの間は、シリンダ部132とピストン133とが一体になって回転する。この間、ピストン133は、シリンダ部132に対して摺動しない。 Then, until the protrusion 132E of the cylinder part 132 comes into contact with the other end part 131F from the one end part 131E of the groove 131D, the cylinder part 132 and the piston 133 rotate together. During this time, the piston 133 does not slide with respect to the cylinder part 132.
 さらに駆動軸137を回転させ続け、シリンダ部132の突起部132Eが他端部131Fに当接すると(すなわちシリンダ部132が吸入時とは逆方向に180度回転すると)、このときシリンダ部132の回転が停止する。 When the drive shaft 137 continues to rotate and the projection 132E of the cylinder part 132 comes into contact with the other end part 131F (that is, when the cylinder part 132 rotates 180 degrees in the direction opposite to that during suction), at this time, The rotation stops.
 このとき、シリンダ口132Fは、アウト流路131Hの真下に位置することでアウト流路131Hと接続される。このようにして、送出部130では、流路をイン流路131Gからアウト流路131Hに切り替える。 At this time, the cylinder port 132F is connected to the outflow path 131H by being positioned directly below the outflow path 131H. In this manner, the delivery unit 130 switches the flow path from the in-flow path 131G to the out-flow path 131H.
 このとき、シリンダ内部空間132Aは、シリンダ口132F、アウト流路131H、流路管107を介して、上筐体部102に設けられる弁体108(図3)と接続される。 At this time, the cylinder internal space 132A is connected to the valve body 108 (FIG. 3) provided in the upper housing portion 102 via the cylinder port 132F, the out flow path 131H, and the flow path pipe 107.
 尚、シリンダ部132は、コイルバネ134により上方に付勢されていることで、蓋部132Cの上面が常に筐体内部空間131Aの内壁上面と密接した状態で回転する。これにより、送出部130は、蓋部132Cと内壁上面との間に隙間ができてこの隙間に薬液が流れ出してしまうような状況を回避できる。 Note that the cylinder portion 132 is biased upward by the coil spring 134, so that the upper surface of the lid portion 132C always rotates in close contact with the upper surface of the inner wall of the housing internal space 131A. Thereby, the delivery unit 130 can avoid a situation in which a gap is formed between the lid 132C and the upper surface of the inner wall and the chemical liquid flows out into the gap.
 さらに駆動軸137を回転させ続け、停止しているシリンダ部132に対してピストン軸133Aを回転させることで、図10(C)に示すように、ピストン133を下死点から上死点へと摺動させる。 Further, by continuing to rotate the drive shaft 137 and rotating the piston shaft 133A with respect to the stopped cylinder part 132, the piston 133 is moved from the bottom dead center to the top dead center as shown in FIG. Slide.
 すると、シリンダ部132内の蓋部132Cとピストン133との間のシリンダ内部空間132Aに注入された薬液が、シリンダ口132F、アウト流路131H、流路管107を通って、弁体108へと排出される。尚、弁体108は、何も挿入されていない状態では流路を塞ぎ、穿刺流路部30に設けられるノズル302(図15)が挿入された状態では流路を開放して流路管107と該ノズル302とを連通させる。 Then, the chemical injected into the cylinder internal space 132A between the lid portion 132C in the cylinder portion 132 and the piston 133 passes through the cylinder port 132F, the out flow path 131H, and the flow path pipe 107 to the valve body 108. Discharged. The valve body 108 closes the flow path when nothing is inserted, and opens the flow path when the nozzle 302 (FIG. 15) provided in the puncture flow path section 30 is inserted to open the flow path tube 107. And the nozzle 302 are communicated with each other.
 その後、駆動軸137の回転回数がオネジのねじ山の数とメネジのねじ山の数で規定される規定の回転回数に達すると、図10(D)に示すように、駆動軸137の回転が停止する。尚、規定の回転回数は、吸入時の回転回数と同数であり、シリンダ部132とピストン133が一体となって回転し始めてからピストン133が上死点に到達するまでに必要な駆動軸137の回転回数が設定されている。よって、駆動軸137の回転が停止したとき、ピストン133は上死点に位置する。 Thereafter, when the number of rotations of the drive shaft 137 reaches a specified number of rotations defined by the number of threads of the male screw and the number of threads of the female screw, the drive shaft 137 is rotated as shown in FIG. Stop. The specified number of rotations is the same as the number of rotations at the time of suction, and the drive shaft 137 required until the piston 133 reaches the top dead center after the cylinder part 132 and the piston 133 start to rotate together. The number of rotations is set. Therefore, when the rotation of the drive shaft 137 stops, the piston 133 is located at the top dead center.
 このようにして、送出部130は、シリンダ部132から薬液を排出する。 In this manner, the delivery unit 130 discharges the chemical solution from the cylinder unit 132.
 かくして、送出部130は、薬液バッグ110に貯蔵された薬液を穿刺流路部30に設けられる流路を介して使用者の体内に送出する。 Thus, the delivery unit 130 delivers the drug solution stored in the drug solution bag 110 to the user's body through the flow channel provided in the puncture flow channel unit 30.
 上述したように、送出部130は、駆動軸137を介してピストン軸133Aが回転させられると、シリンダ部132の突起部132Eが溝131Dの一端部131E又は他端部131Fに到達するまでの間、シリンダ部132とピストン133とが一体になって回転することにより、シリンダ口132Fの接続先をイン流路131G又はアウト流路131Hに切り替わる。 As described above, when the piston shaft 133A is rotated via the drive shaft 137, the delivery unit 130 is until the protrusion 132E of the cylinder 132 reaches the one end 131E or the other end 131F of the groove 131D. When the cylinder part 132 and the piston 133 rotate together, the connection destination of the cylinder port 132F is switched to the in-flow path 131G or the out-flow path 131H.
 そのうえで、さらに駆動軸137を介してピストン軸133Aが回転させられると、このとき突起部132Eが溝131Dの一端部131E又は他端部131Fに当接していることで停止しているシリンダ部132に対してピストン軸133Aが回転することにより、シリンダ部132内をピストン133が軸方向に摺動する。 In addition, when the piston shaft 133A is further rotated via the drive shaft 137, at this time, the protrusion 132E is brought into contact with the one end 131E or the other end 131F of the groove 131D so that the cylinder portion 132 is stopped. On the other hand, when the piston shaft 133A rotates, the piston 133 slides in the axial direction in the cylinder portion 132.
 このように、送出部130は、ピストン軸133Aの回転制御(すなわち回転回数と回転方向の制御)のみで、ピストン133と共にシリンダ部132を回転させてシリンダ口132Fをイン流路131G又はアウト流路131Hに切り替えてからピストン133をシリンダ部132内で摺動させることができる。 Thus, the delivery unit 130 rotates the cylinder part 132 together with the piston 133 only by controlling the rotation of the piston shaft 133A (that is, controlling the number of rotations and the direction of rotation), so that the cylinder port 132F is connected to the in-flow path 131G or the out-flow path. The piston 133 can be slid in the cylinder part 132 after switching to 131H.
 こうすることで、逆止弁を設けることなく簡易な構成でありながら薬液の定量送出が可能となり、かくして、薬液の定量送出と小型化を同時に満たす送出部130を実現できる。 By doing so, it is possible to deliver a fixed amount of the chemical solution with a simple configuration without providing a check valve, and thus it is possible to realize a delivery unit 130 that satisfies the fixed amount of the chemical solution and miniaturization at the same time.
 またこのように送出部130は、ピストン軸133Aの回転制御のみで薬液の定量送出が可能であることから、例えば、シリンダ口132Fの接続先の切り替えと、ピストン133の摺動とを別々に制御しなくてはならないポンプと比較して、簡易な制御で定量送出が可能となる。 Further, in this way, since the delivery unit 130 can perform the quantitative delivery of the chemical liquid only by the rotation control of the piston shaft 133A, for example, the switching of the connection destination of the cylinder port 132F and the sliding of the piston 133 are separately controlled. Compared with a pump that must be, it is possible to deliver a fixed amount with simple control.
 圧迫部150は、図3に示すように、押え板151、支持部152、板バネ153を含む構成とされる。押え板151は、薬液バッグ110の中央部112より大きな面積を有する板材でなり、薬液バッグ110の上側に設けられる。押え板151は、下筐体部101に固定された支持部152に、例えばヒンジ機構でなる連結部151A及び152Aを中心として薬液バッグ110に離間する方向及び接近する方向に回動可能に支持される。 As shown in FIG. 3, the compression unit 150 includes a press plate 151, a support unit 152, and a plate spring 153. The holding plate 151 is a plate material having an area larger than the central portion 112 of the chemical solution bag 110 and is provided on the upper side of the chemical solution bag 110. The holding plate 151 is supported by a support portion 152 fixed to the lower casing portion 101 so as to be rotatable in a direction away from and approaching the chemical solution bag 110 around the connecting portions 151A and 152A formed of, for example, a hinge mechanism. The
 板バネ153は、押え板151と上筐体部102との間に略V字状に折り曲げられた状態で設けられる板材であり、略V字状に曲げられて対向する板部同士が互いに離間する方向(開こうとする方向)に力が働く。従って板バネ153は、押え板151と上筐体部102との間に配された場合、押え板151を薬液バッグ110側へ常に一定の力で押え付ける。 The plate spring 153 is a plate material provided in a state of being bent in a substantially V shape between the holding plate 151 and the upper housing portion 102, and the plate portions that are bent in a substantially V shape and are opposed to each other are separated from each other. The force works in the direction to open (the direction to open). Therefore, when the leaf spring 153 is disposed between the holding plate 151 and the upper housing portion 102, the holding plate 151 is always pressed against the chemical solution bag 110 side with a constant force.
 ところで圧迫部150は、薬液バッグ110に薬液が注入される前(図4(A))において、下筐体部101の孔101Gから、押え板151と板バネ153との間に板バネリリースロッド154が挿入される。このとき圧迫部150では、板バネ153が押え板151を押え付けることなく、押え板151が自由に回動可能な状態である。 By the way, the compression portion 150 is a plate spring release rod between the holding plate 151 and the plate spring 153 through the hole 101G of the lower housing portion 101 before the chemical solution is injected into the chemical solution bag 110 (FIG. 4A). 154 is inserted. At this time, in the compression unit 150, the presser plate 151 can freely rotate without the plate spring 153 pressing the presser plate 151.
 そして圧迫部150は、薬液バッグ110に薬液が注入された後に板バネリリースロッド154が取り外されると、板バネ153が押え板151を薬液バッグ110側に押え付ける。これにより圧迫部150は、押え板151が薬液バッグ110を下筐体部101との間で挟み込み、該薬液バッグ110に一定の陽圧を与える(図4(B))。 When the leaf spring release rod 154 is removed after the chemical solution is injected into the chemical solution bag 110, the compression portion 150 presses the holding plate 151 against the chemical solution bag 110 side. As a result, the pressing plate 151 sandwiches the chemical solution bag 110 with the lower housing 101 and the presser plate 151 applies a constant positive pressure to the chemical solution bag 110 (FIG. 4B).
 これにより圧迫部150は、薬液バッグ110に溶存気体が存在している場合には、フィルタ部120を介して外部に溶存気体を排出することができる。 Thus, when the dissolved gas is present in the chemical solution bag 110, the compression unit 150 can discharge the dissolved gas to the outside through the filter unit 120.
 また圧迫部150は、送出部130により薬液バッグ110に貯蔵された薬液を送出する際に、該薬液バッグ110を潰れる方向に押し付けるので、薬液バッグ110に貯蔵された薬液を内部に残すことなく押し出すようにして送出させることができる。 In addition, when sending out the chemical solution stored in the chemical solution bag 110 by the delivery unit 130, the compression unit 150 presses the chemical solution bag 110 in a direction to be crushed, so that the chemical solution stored in the chemical solution bag 110 is pushed out without leaving inside. Thus, it can be sent out.
〔2-2.駆動制御部の構成〕
 駆動制御部20は、図11に示すように、穿刺流路部30が前方向から挿入されるよう、該穿刺流路部30の形状に合わせた凹部20Aを有する略コの字型形状に形成される。
[2-2. Configuration of drive control unit]
As shown in FIG. 11, the drive control unit 20 is formed in a substantially U-shape having a recess 20 </ b> A that matches the shape of the puncture flow channel portion 30 so that the puncture flow channel portion 30 is inserted from the front direction. Is done.
 駆動制御部20は、下側が開口し内部に空間が設けられた上筐体部201と、該上筐体部201の開口に螺着される下筐体部202との間で形成される空間に充電アンテナ203、基板部204、通信アンテナ205、充電池206、モータ207、ギヤヘッド208、動力伝達磁石209、磁気センサ210及び211等が設けられる。 The drive control unit 20 is a space formed between an upper housing part 201 that is open on the lower side and has a space inside, and a lower housing part 202 that is screwed into the opening of the upper housing part 201. Are provided with a charging antenna 203, a substrate 204, a communication antenna 205, a rechargeable battery 206, a motor 207, a gear head 208, a power transmission magnet 209, magnetic sensors 210 and 211, and the like.
 上筐体部201の前後方向に沿った外側面は、薬液貯蔵送出部10に設けられる係合部101B~Eとそれぞれ係合するための溝である係合受部201A~Dが設けられる。 The outer surface along the front-rear direction of the upper housing part 201 is provided with engagement receiving parts 201A to 201D that are grooves for engaging with the engagement parts 101B to E provided in the chemical solution storage and delivery part 10, respectively.
 また上筐体部201の上面には、薬液を一時的に一定量だけ投与する(ボーラス投与)際に使用者に押下操作されるボーラススイッチ201Eが設けられる。このボーラススイッチ201Eは、上筐体部201の上面より窪んだ位置に設けられ、例えば寝返り等により誤って使用者に押下されることを防止することができる。 Also, on the upper surface of the upper housing part 201, a bolus switch 201E that is pressed down by the user when a certain amount of chemical solution is temporarily administered (bolus administration) is provided. The bolus switch 201E is provided at a position recessed from the upper surface of the upper housing portion 201, and can be prevented from being accidentally pressed by the user, for example, by turning over.
 下筐体部202は、上筐体部201と密着する面に防水パッキン202Aが設けられており、上筐体部201が下筐体部202に防水パッキン202Aを介してネジ(図示せず)螺着されるか、超音波融着されるので、上筐体部201と下筐体部202との間から内部空間に液体が侵入することを防止することができる。 The lower casing 202 is provided with a waterproof packing 202A on the surface that is in close contact with the upper casing 201, and the upper casing 201 is screwed to the lower casing 202 via the waterproof packing 202A (not shown). Since it is screwed or ultrasonically fused, it is possible to prevent liquid from entering the internal space from between the upper casing portion 201 and the lower casing portion 202.
 下筐体部202の上面には、充電アンテナ203が貼り付けられており、後述する充電器4(図21)から供給される電気を受信する。 The charging antenna 203 is affixed on the upper surface of the lower housing | casing part 202, and the electricity supplied from the charger 4 (FIG. 21) mentioned later is received.
 また下筐体部202の上面には、CPU(Central
Processing Unit)、RAM(Random Access Memory)、ROM(Read Only Memory)等の電気回路及びコントローラ3との間で信号を送受信するための通信アンテナ205が配置された基板部204が充電アンテナ203の上側に重ねて設けられる。
Further, on the upper surface of the lower housing section 202, a CPU (Central
A board unit 204 on which a communication antenna 205 for transmitting and receiving signals to and from an electrical circuit such as a processing unit (RAM), a random access memory (RAM), and a read only memory (ROM) and the controller 3 is disposed above the charging antenna 203. It is provided to overlap.
 さらに下筐体部202の上面には、充電アンテナ203から供給される電気により充電して駆動時に各部に電気を供給する充電池206が設けられる。 Furthermore, a rechargeable battery 206 is provided on the upper surface of the lower casing unit 202, which is charged by electricity supplied from the charging antenna 203 and supplies electricity to each unit during driving.
 さらに下筐体部202の上面には、薬液貯蔵送出部10の駆動用磁石138と対向する位置にモータ207、ギヤヘッド208及び動力伝達磁石209が上から順に重なるようにして設けられる。また下筐体部202の上面には、磁気センサ210が設けられる。 Further, on the upper surface of the lower casing unit 202, a motor 207, a gear head 208, and a power transmission magnet 209 are provided so as to overlap in order from the top at a position facing the driving magnet 138 of the drug solution storage and delivery unit 10. A magnetic sensor 210 is provided on the upper surface of the lower housing unit 202.
 モータ207は、ギヤヘッド208を介して動力伝達磁石209を回転させる。動力伝達磁石209は、図12に示すように、薬液貯蔵送出部10と駆動制御部20とが密着された状態で駆動用磁石138と互いに引き付け合う極性となるように該駆動用磁石138と対向する配置される。 The motor 207 rotates the power transmission magnet 209 via the gear head 208. As shown in FIG. 12, the power transmission magnet 209 is opposed to the driving magnet 138 so as to have a polarity attracting the driving magnet 138 in a state where the chemical storage / delivery unit 10 and the drive control unit 20 are in close contact with each other. To be placed.
 動力伝達磁石209は、ギヤヘッド208を介してモータ207に回転されると、駆動用磁石138を磁力により引き付けながら自身の回転とともに回転させる。 When the power transmission magnet 209 is rotated by the motor 207 via the gear head 208, the power transmission magnet 209 rotates with its own rotation while attracting the driving magnet 138 by magnetic force.
 従ってモータ207は、ギヤヘッド208、動力伝達磁石209及び駆動用磁石138を介して非接触により回転軸139を回転させてピストン軸133Aと接続される駆動軸137を回転させることで、シリンダ部132とピストン133を回転させ、またピストン133を摺動させる。 Accordingly, the motor 207 rotates the rotating shaft 139 in a non-contact manner via the gear head 208, the power transmission magnet 209, and the driving magnet 138 to rotate the driving shaft 137 connected to the piston shaft 133A, thereby The piston 133 is rotated and the piston 133 is slid.
 ところでモータ207は回転軸139及び駆動軸137を動力伝達磁石209及び駆動用磁石138の磁力を介して非接触で回転させるため、モータ207の回転に追従して回転軸139及び駆動軸137が回転しているか否かを検出する必要がある。そこで回転軸139及び駆動軸137が回転していることを検出する磁気センサ210が、回転検出用磁石140が移動する円周上に対向して配される。 By the way, since the motor 207 rotates the rotating shaft 139 and the driving shaft 137 in a non-contact manner through the magnetic force of the power transmission magnet 209 and the driving magnet 138, the rotating shaft 139 and the driving shaft 137 rotate following the rotation of the motor 207. It is necessary to detect whether or not Therefore, the magnetic sensor 210 that detects that the rotation shaft 139 and the drive shaft 137 are rotating is disposed on the circumference on which the rotation detection magnet 140 moves.
 より具体的には、磁気センサ210が回転検出用磁石140の磁力を検出した後、再度、磁力を検出することにより回転軸139及び駆動軸137が1回転したことを検出する。 More specifically, after the magnetic sensor 210 detects the magnetic force of the rotation detecting magnet 140, it detects that the rotating shaft 139 and the drive shaft 137 have made one rotation by detecting the magnetic force again.
 このようにして磁気センサ210は、回転軸139及び駆動軸137が回転していることを検出することにより、シリンダ部132とピストン133の回転、及びピストン133の摺動を検出することができる。尚、ここでは、一例として、回転回数を1回転単位で検出するようになっているが、磁気センサ210の数を増やして回転回数をより細かく検出するようにしてもよい。 Thus, the magnetic sensor 210 can detect the rotation of the cylinder part 132 and the piston 133 and the sliding of the piston 133 by detecting that the rotation shaft 139 and the drive shaft 137 are rotating. Here, as an example, the number of rotations is detected in units of one rotation, but the number of rotations may be detected more finely by increasing the number of magnetic sensors 210.
 かくして詳しくは後述するように、マイクロコンピュータ220(図21)は、自身と同じ上筐体部201と下筐体部202で形成される空間内に設けられた磁気センサ210で、異なる空間である下筐体部101と上筐体部102で形成される空間内に設けられる送出部130の駆動を非接触で確認することができる。 Thus, as will be described in detail later, the microcomputer 220 (FIG. 21) is a magnetic sensor 210 provided in the same space formed by the upper housing portion 201 and the lower housing portion 202 and is a different space. It is possible to check the drive of the sending unit 130 provided in the space formed by the lower housing unit 101 and the upper housing unit 102 without contact.
 上筐体部201には、穿刺流路部30が密着する際に接触する凹部20Aの前面に、充電池206から穿刺流路部30に電気を供給し、また穿刺流路部30との間で各種信号を送受信するためのコネクタ部212が設けられる。コネクタ部212は、図13(A)及び(B)に示すように、電気及び各種信号を送受信するためのスプリングコネクタ212Cが複数本集められた電気コネクタ部212Aの外側を防水ゴム212Bで覆う構造でなる。 Electricity is supplied from the rechargeable battery 206 to the puncture channel unit 30 on the front surface of the recess 20A that comes into contact with the upper casing unit 201 when the puncture channel unit 30 is in close contact therewith. A connector unit 212 for transmitting and receiving various signals is provided. As shown in FIGS. 13A and 13B, the connector portion 212 has a structure in which a waterproof rubber 212B covers the outside of the electrical connector portion 212A in which a plurality of spring connectors 212C for transmitting and receiving electricity and various signals are collected. It becomes.
 またコネクタ部212と接続する穿刺流路部30のコネクタ部350(図15)も同様に電気及び各種信号を送受信するためのコネクタ部350Cが複数本集められた電気コネクタ部350Aの外側を防水ゴム350Bで覆う構造でなる。 Similarly, the connector part 350 (FIG. 15) of the puncture flow path part 30 connected to the connector part 212 also has a waterproof rubber outside the electric connector part 350A in which a plurality of connector parts 350C for transmitting and receiving electricity and various signals are collected. The structure is covered with 350B.
 これにより駆動制御部20では、コネクタ部212がコネクタ部350と接続される際に、防水ゴム212B及び350Bにより電気コネクタ部212A及び350Bに液体が触れることを防止することができる。また、コネクタの1ピンを利用して、穿刺流路部30を薬液貯蔵送出部10に挿入する場合に、挿入が許される限界(十分な挿入がされていない場合)にては接触されない長さのピンを設け、穿刺流路部30側でアースで電位に接続しておき、駆動制御部20側にてこのピンの電位がアース電位であるか無いかをチェックして、ア-ス電位でない場合には穿刺流路部30の挿入不足を警報表示して穿刺流路部の挿入状態を監視する。 Thereby, in the drive control unit 20, when the connector unit 212 is connected to the connector unit 350, the waterproof rubber 212B and 350B can prevent the liquid from touching the electrical connector units 212A and 350B. In addition, when inserting the puncture flow path section 30 into the drug solution storage / delivery section 10 using one pin of the connector, the length is not contacted at the limit where insertion is permitted (when sufficient insertion is not performed). This pin is provided and connected to the ground potential on the puncture flow path section 30 side, and it is checked whether the potential of this pin is the ground potential or not on the drive control section 20 side. In this case, the insertion of the puncture channel 30 is monitored by displaying an alarm indicating that the puncture channel 30 is insufficiently inserted.
〔2-3.穿刺流路部の構成〕
 穿刺流路部30は、図14及び図15に示すように、薬液貯蔵送出部10及び駆動制御部20が係合された状態で形成される凹部101H及び凹部20Aの空間に嵌合する前後方向に細長い形状でなる。穿刺流路部30は、外殻を形成する筐体部301の内部空間に各部が設けられる。なお図14(A)では外観構成を示し、図14(B)では内部構成を示す。また図15では、説明の便宜上、一部を断面で示す。
[2-3. (Configuration of puncture channel)
As shown in FIGS. 14 and 15, the puncture channel portion 30 is fitted in the space between the recess 101H and the recess 20A formed in a state where the drug solution storage / delivery unit 10 and the drive control unit 20 are engaged. It has an elongated shape. The puncture flow path part 30 is provided with each part in the internal space of the housing part 301 that forms the outer shell. 14A shows an external configuration, and FIG. 14B shows an internal configuration. Further, in FIG. 15, for convenience of explanation, a part is shown in cross section.
 筐体部301は、穿刺流路部30が薬液貯蔵送出部10に嵌合した際に、下筐体部101の底面101Aと同一平面上に位置する底面301Aと、上筐体部102の中央部102Cに隣接して対向する高さに位置する底面301Bとを有する。 When the puncture flow path unit 30 is fitted to the drug solution storage and delivery unit 10, the housing unit 301 includes a bottom surface 301 </ b> A located on the same plane as the bottom surface 101 </ b> A of the lower housing unit 101 and the center of the upper housing unit 102. A bottom surface 301B located at a height facing and adjacent to the portion 102C.
 筐体部301は、穿刺流路部30が薬液貯蔵送出部10に嵌合した際に上筐体部102の凹部102Dに嵌り込む凸部301Cが底面301Bにおける凹部102Dと対向する位置に設けられる。 The housing portion 301 is provided at a position where a convex portion 301C that fits into the concave portion 102D of the upper housing portion 102 when the puncture flow path portion 30 is fitted to the drug solution storage and delivery portion 10 faces the concave portion 102D in the bottom surface 301B. .
 また筐体部301は、薬液貯蔵送出部10の下筐体部101の突起部101I及び上筐体部102の突起部102A、下筐体部101の突起部101J及び上筐体部102の突起部102Bにそれぞれ係合する案内溝301D及び301Eが前後方向に沿って側面に形成される。 Further, the casing 301 includes a protrusion 101I of the lower casing 101 and a protrusion 102A of the upper casing 102, a protrusion 101J of the lower casing 101, and a protrusion of the upper casing 102. Guide grooves 301D and 301E that respectively engage with the portion 102B are formed on the side surfaces along the front-rear direction.
 筐体部301は、嵌合された薬液貯蔵送出部10及び駆動制御部20から穿刺流路部30を外す際に使用者の指を引っ掛けるための凹部301Qが上面301Fに設けられる。 The casing 301 is provided with a recess 301Q on the upper surface 301F for hooking a user's finger when removing the puncture channel 30 from the drug solution storage / delivery unit 10 and the drive controller 20 that are fitted.
 また筐体部301は、上面301Fから前面301Gにかけて湾曲されており、湾曲された湾曲面301Hに、詳しくは後述する角度調整機構340が設けられる。 The casing 301 is curved from the upper surface 301F to the front surface 301G, and an angle adjustment mechanism 340, which will be described in detail later, is provided on the curved surface 301H.
 また筐体部301は、穿刺流路部30が薬液貯蔵送出部10に嵌合された状態で、薬液貯蔵送出部10の弁体108と対向する位置に孔301Iが設けられ、弁体108に挿入されるノズル302が該孔301Iを貫通するようにして固着される。ノズル302は、孔301Iとの間で隙間が設けられることなく固着される。 In addition, the casing 301 is provided with a hole 301I at a position facing the valve body 108 of the chemical liquid storage / delivery section 10 in a state where the puncture flow path section 30 is fitted to the chemical liquid storage / delivery section 10. The nozzle 302 to be inserted is fixed so as to penetrate the hole 301I. The nozzle 302 is fixed without providing a gap with the hole 301I.
 ノズル302は、穿刺流路部30が薬液貯蔵送出部10に嵌合された状態で一端が弁体108に挿入されて流路管107と連通される。ノズル302は、他端に流水センサ303が接続される。 One end of the nozzle 302 is inserted into the valve body 108 in a state where the puncture flow path section 30 is fitted to the drug solution storage and delivery section 10 and communicates with the flow path pipe 107. The nozzle 302 is connected to a running water sensor 303 at the other end.
 流水センサ303は、通過する薬液が流れているか否かを検出するものであり、例えばサーミスタ単体を加熱源と温度センサに用いる方式のほか、加熱源と温度センサを分離して用いる方式として、加熱源に抵抗器、ヒ-タ線、半導体、温度センサはサーモファイル、白金抵抗体、半導体などを組み合わせたものが適応可能である。 The flowing water sensor 303 detects whether or not the passing chemical solution is flowing. For example, in addition to a method in which the thermistor alone is used as a heating source and a temperature sensor, a heating source and a temperature sensor are used separately. A combination of a resistor, a heater wire, a semiconductor, and a temperature sensor as a source, a thermo file, a platinum resistor, a semiconductor, and the like can be applied.
 流水センサ303は、ノズル302が接続された端とは反対側の端に穿刺流路針304が接続され、ノズル302と穿刺流路針304とを連通させる。穿刺流路針304は、流水センサ303に接続された一端側がS字上に折り返され、そこから前後方向に沿って配され、他端側で底面301Aに到達するように曲げられる。なお穿刺流路針304は、金属製の部材でなるが、例えば28ゲージの中空管であり、容易に曲げられるようになされている。 The flowing water sensor 303 has a puncture channel needle 304 connected to the end opposite to the end to which the nozzle 302 is connected, and allows the nozzle 302 and the puncture channel needle 304 to communicate with each other. The puncture flow path needle 304 is bent so that one end side connected to the running water sensor 303 is folded back on the S-shape, is arranged along the front-rear direction therefrom, and reaches the bottom surface 301A on the other end side. The puncture channel needle 304 is made of a metal member, but is a 28 gauge hollow tube, for example, which can be easily bent.
 穿刺流路針304は、S字上に折り返された直後の位置で、筐体部301から内部に向かって突設される固定部305によって固定される。 The puncture channel needle 304 is fixed by a fixing portion 305 that protrudes inward from the housing portion 301 at a position immediately after being folded back on the S-shape.
 穿刺流路針304は、固定部305に固定された位置より前方側の一部(以下、これを弾性部とも呼ぶ)304Aが螺旋状に巻かれている。弾性部304Aは前後方向に伸縮自在である。 The puncture flow path needle 304 is spirally wound with a part (hereinafter also referred to as an elastic portion) 304A on the front side from the position fixed to the fixing portion 305. The elastic portion 304A is extendable in the front-rear direction.
 穿刺流路針304は、底面301Aに到達するように曲げられた他端側の先端の部分(以下、これを先端部とも呼ぶ)304Bが鋭く尖った形状でなる。 The puncture channel needle 304 has a sharply sharp shape at a tip portion (hereinafter also referred to as a tip portion) 304B that is bent so as to reach the bottom surface 301A.
 このような形状でなる穿刺流路針304は、流水センサ303から流れてきた薬液を内空を通して先端部304Bから外部に送出する。 The puncture flow path needle 304 having such a shape sends the drug solution flowing from the flowing water sensor 303 to the outside through the inner space from the distal end portion 304B.
 穿刺流路針304は、先端部304Bから弾性部304Aにかけて例えばシース部310に覆われる。 The puncture channel needle 304 is covered with, for example, the sheath portion 310 from the distal end portion 304B to the elastic portion 304A.
 シース部310は、例えばテフロン(登録商標)やポリエチレンでなり、柔軟性を有するシース311と、例えばテフロン(登録商標)やポリオレフィン、ポリウレタンでなり柔らかく、一端変形するとそのままの形状を維持して元の形状には戻ることがない特性(永久変形、塑性変形)を有している伸長部312とによって構成される。伸長部312として、柔らかくて変形しやすくて、元に戻らない特性を有する材料としては、熱収縮チューブなど高温化で紫外線により架橋されている材料が挙げられ、ポリオレフィン、テフロン(登録商標)、シリコン、ポリ塩化ビニルポリフッ化ビニルデンなどを用いることができる。 The sheath part 310 is made of, for example, Teflon (registered trademark) or polyethylene, and the sheath 311 has flexibility, and is soft, for example, made of Teflon (registered trademark), polyolefin, or polyurethane. It is comprised by the expansion | extension part 312 which has the characteristic (permanent deformation, plastic deformation) which does not return to a shape. Examples of the material that is soft and easily deformed and has the property of not returning to the extension 312 include a material that is crosslinked by ultraviolet rays at a high temperature, such as a heat-shrinkable tube, such as polyolefin, Teflon (registered trademark), silicon. Polyvinyl chloride, polyvinyl fluoride fluoride, etc. can be used.
 シース311は、穿刺流路針304の先端部304Bから弾性部304Aの前方までの大部分を覆っており、かつ穿刺流路針304に対して固定はされていない。 The sheath 311 covers most of the puncture channel needle 304 from the distal end 304B to the front of the elastic portion 304A, and is not fixed to the puncture channel needle 304.
 また伸長部312は、シース311の弾性部304A側の一端側の一部と重なる位置から弾性部304Aの直前まで穿刺流路針304を覆っており、固定部305側の一端が穿刺流路針304に固定され、他端がシース311に固定される。なお伸長部312は、固定された両端では隙間から液体を漏らすことがないように周方向に沿って穿刺流路針304及びシース311との隙間を密閉するようにして固定される。 The extending portion 312 covers the puncture channel needle 304 from a position overlapping one end side of the elastic portion 304A side of the sheath 311 to just before the elastic portion 304A, and one end on the fixed portion 305 side is the puncture channel needle. The other end is fixed to the sheath 311. The extending portion 312 is fixed so as to seal the gap between the puncture flow path needle 304 and the sheath 311 along the circumferential direction so that the liquid does not leak from the gap at both fixed ends.
 穿刺流路針304の弾性部304Aよりも先端部304B側の所定の位置に、該穿刺流路針304とシース311とをまとめて固定するカシメ306が設けられる。カシメ306は、例えばアルミニウムや銅のような一定の力が加えられると変形する材質でなる。 A caulking 306 that fixes the puncture flow path needle 304 and the sheath 311 together is provided at a predetermined position closer to the distal end portion 304B than the elastic portion 304A of the puncture flow path needle 304. The caulking 306 is made of a material that deforms when a certain force is applied, such as aluminum or copper.
 カシメ306は、リング形状である状態から、穿刺流路針304及びシース311がリング孔に挿通された後に左右方向から潰されて上下方向の一部が重なり合い、穿刺流路針304及びシース311を締め付けて固定する。これによりシース311は穿刺流路針304に対して滑らないように固定される。カシメ306は、シース311に対して接着されており、カシメ306の締め付けが緩んだ場合でもシース311とは離れることがない。 The caulking 306 is crushed from the left and right direction after the puncture flow path needle 304 and the sheath 311 are inserted into the ring hole from the ring shape, and a part of the vertical direction overlaps, and the puncture flow path needle 304 and the sheath 311 are overlapped. Tighten and fix. Thereby, the sheath 311 is fixed so as not to slip with respect to the puncture flow path needle 304. The caulking 306 is bonded to the sheath 311 and does not leave the sheath 311 even when the caulking 306 is loosened.
 穿刺流路部30は、カシメ306の前方であって、該カシメ306から所定距離だけ離れた位置に移動制限部307が設けられる。この所定距離は、詳しくは後述するように、穿刺流路針304及びシース311が筐体部301の底面301Aから突出する距離、すなわち穿刺流路針304及びシース311を使用者に穿刺する深さ距離と同じ距離であり、本実施の形態では10mmに設定される。移動制限部307は、筐体部301に固定されており、中央に設けられた孔に穿刺流路針304とシース部310が接触することなく挿通するように配される。 The puncture flow path part 30 is provided in front of the caulking 306 and a movement restricting part 307 at a position away from the caulking 306 by a predetermined distance. As will be described later in detail, the predetermined distance is a distance at which the puncture flow path needle 304 and the sheath 311 protrude from the bottom surface 301A of the housing 301, that is, a depth at which the puncture flow path needle 304 and the sheath 311 are punctured to the user. It is the same distance as the distance, and is set to 10 mm in the present embodiment. The movement restricting portion 307 is fixed to the housing portion 301 and is arranged so that the puncture flow path needle 304 and the sheath portion 310 can be inserted into a hole provided in the center without contacting.
 穿刺流路部30は、カシメ306の後方であって伸長部312よりも前方の位置に穿刺機構320が設けられる。穿刺機構320は、固定板321、バネ322、支持板323及び押部324により構成される。 The puncture flow path section 30 is provided with a puncture mechanism 320 at a position behind the caulking 306 and ahead of the extension section 312. The puncture mechanism 320 includes a fixed plate 321, a spring 322, a support plate 323, and a pressing portion 324.
 固定板321は、筐体部301に固定されており、中央に設けられた孔に穿刺流路針304とシース部310が接触することなく挿通するように配される。 The fixing plate 321 is fixed to the housing part 301 and is arranged so that the puncture flow path needle 304 and the sheath part 310 can be inserted into a hole provided in the center without contact.
 固定板321の前方にはバネ322が配される。バネ322は、穿刺流路針304とシース部310が接触することなく内空を挿通するよう配されており、固定板321と支持板323に挟まれて自然長よりも圧縮された状態で配される。 A spring 322 is disposed in front of the fixed plate 321. The spring 322 is arranged so as to pass through the inner space without contact between the puncture flow path needle 304 and the sheath portion 310, and is arranged in a state where it is sandwiched between the fixed plate 321 and the support plate 323 and compressed more than the natural length. Is done.
 支持板323は、穿刺流路針304とシース部310が接触することなく挿通するように配されており、バネ322が接する面とは反対側の面であって穿刺流路針304とシース部310より下側で押部324を支持する。また支持板323は、押部324を支持する面と同一面で押部324を支持する位置よりも下側の位置で穿刺リリース機構330により前方向に移動しないように保持される。 The support plate 323 is arranged so that the puncture flow path needle 304 and the sheath portion 310 are inserted without contacting each other, and is a surface on the opposite side to the surface where the spring 322 is in contact with the puncture flow path needle 304 and the sheath portion. The push portion 324 is supported below 310. The support plate 323 is held so as not to move forward by the puncture release mechanism 330 at a position lower than a position where the pressing portion 324 is supported on the same surface as the surface supporting the pressing portion 324.
 押部324は、図16に示すように、略円柱形状でなり、その先端が上下方向に長く左右方向に短いマイナス型(一文字型)となる形状でなる。押部324は、カシメ306の上下方向に延びた部分のうちの下側で重なり合っている部材同士の間に先端が位置するように支持板323に支持される。 As shown in FIG. 16, the pressing portion 324 has a substantially cylindrical shape, and has a negative shape (one character type) whose tip is long in the vertical direction and short in the horizontal direction. The pressing portion 324 is supported by the support plate 323 so that the tip is located between members overlapping on the lower side of the portion of the caulking 306 extending in the vertical direction.
 穿刺リリース機構330は、制限部331、バネ332及びアクチュエータ333により構成される。 The puncture release mechanism 330 includes a limiting portion 331, a spring 332, and an actuator 333.
 制限部331は、断面が略L字型となる形状となるように前後方向に延びた部分と上下方向に延びた部分とを有しており、前後方向に延びた部分の中央付近に設けられた回転軸331Aを中心に回動自在に保持される。制限部331は、上下方向に延びた部分の回転軸331A側の面で支持板323を支持するように配され、支持板323が前方向に移動しないように制限する。 The restricting portion 331 has a portion extending in the front-rear direction and a portion extending in the up-down direction so that the cross section has a substantially L shape, and is provided near the center of the portion extending in the front-rear direction. The rotary shaft 331A is held rotatably. The restricting portion 331 is disposed so as to support the support plate 323 with the surface on the rotating shaft 331A side of the portion extending in the vertical direction, and restricts the support plate 323 from moving in the forward direction.
 制限部331は、前後方向に延びた部分の回転軸331Aよりも前方向側の下面にバネ332が接続され、回転軸331Aより後側の上面にアクチュエータ333の突起部333Aが接する。 The restriction portion 331 has a spring 332 connected to the lower surface on the front side of the rotation shaft 331A of the portion extending in the front-rear direction, and the protrusion 333A of the actuator 333 is in contact with the upper surface on the rear side of the rotation shaft 331A.
 バネ332は、一端が制限部331に接続され、他端が筐体部301の底面301B側に接続されており、縮もうとする方向に常に力が加えられた状態で配される。 The spring 332 has one end connected to the restricting portion 331 and the other end connected to the bottom surface 301B side of the housing portion 301, and is arranged in a state in which a force is always applied in the direction of contraction.
 アクチュエータ333は、電力が供給されることにより突起部333Aを前後方向に移動させるようになされており、突起部333Aが制限部331に接する状態で配される。 The actuator 333 is configured to move the protruding portion 333A in the front-rear direction when electric power is supplied, and is disposed in a state where the protruding portion 333A is in contact with the limiting portion 331.
 なお、バネ322が固定板321と支持板323に挟まれて自然長よりも圧縮され、制限部331が支持板323と接し、アクチュエータ333の突起部333Aが制限部331に接する状態で配された状態を初期状態(図15、図17(A))とも呼ぶ。なお図17では説明の便宜上、穿刺流路針304及びシース311が曲げられていない真っ直ぐな状態で図示されているが、実際には上述したように、その一部が曲げられている。 The spring 322 is sandwiched between the fixed plate 321 and the support plate 323 and compressed more than the natural length, the limiting portion 331 is in contact with the support plate 323, and the projection 333A of the actuator 333 is disposed in contact with the limiting portion 331. The state is also referred to as an initial state (FIGS. 15 and 17A). In FIG. 17, for convenience of explanation, the puncture flow path needle 304 and the sheath 311 are illustrated in a straight state that is not bent, but in reality, a part thereof is bent as described above.
 初期状態において、アクチュエータ333が駆動して突起部333Aが後方向に移動されて該突起部333Aから制限部331が開放されると、制限部331がバネ332の自然長に戻ろうとする力により回転軸331Aを中心に反時計回りに回転されて支持板323から離れる。 In the initial state, when the actuator 333 is driven and the protrusion 333A is moved backward to release the restricting part 331 from the protrusion 333A, the restricting part 331 is rotated by the force of returning to the natural length of the spring 332 It is rotated counterclockwise around the shaft 331 </ b> A and moves away from the support plate 323.
 穿刺機構320では、制限部331が支持板323から離れると、縮んでいたバネ322が自然長に戻ろうとして伸びて支持板323及び押部324を前方向に押す。前方向に押された押部324は、カシメ306が移動制限部307に接するまで穿刺流路針304及びシース311と共にカシメ306を前方向に押す。 In the puncture mechanism 320, when the restricting portion 331 is separated from the support plate 323, the contracted spring 322 extends to return to the natural length and pushes the support plate 323 and the pressing portion 324 in the forward direction. The pushing portion 324 pushed in the forward direction pushes the caulking 306 forward together with the puncture channel needle 304 and the sheath 311 until the caulking 306 comes into contact with the movement restricting portion 307.
 このときカシメ306は、上下方向に延びた部分のうちの上側で重なり合っている部分が前後方向に延びるカシメガイド308に沿って穿刺流路針304及びシース311を挟んだまま前方向に移動する。 At this time, the caulking 306 moves in the forward direction while sandwiching the puncture channel needle 304 and the sheath 311 along the caulking guide 308 in which the upper portion of the portions extending in the vertical direction overlaps on the upper side.
 因みに、カシメガイド308の断面は下方が開口したコの字型でなり、カシメ306は、上下方向に延びた部分のうちの上側で重なり合っている部分がカシメガイド308の開口された方向から嵌るようにして保持される。 By the way, the cross section of the caulking guide 308 has a U-shape with an opening at the bottom, and the caulking 306 fits from the direction in which the caulking guide 308 is opened in the overlapping portion on the upper side. Is retained.
 カシメ306が前方向に移動する際、穿刺流路針304は弾性部304Aが伸びる(図17(B))。そして穿刺流路針304及びシース311は、筐体部301の底面301Aから突出し、先端部304Bが使用者を穿刺してシース311と共に使用者の体内に入り込む。 When the caulking 306 moves in the forward direction, the elastic portion 304A of the puncture channel needle 304 is extended (FIG. 17B). The puncture flow path needle 304 and the sheath 311 protrude from the bottom surface 301A of the housing 301, and the distal end 304B punctures the user and enters the user's body together with the sheath 311.
 穿刺機構320は、カシメ306が移動制限部307に接した後もバネ322が伸び続け、カシメ306の下方で重なり合っている部材同士の間に押部324の先端が入り込む。このとき押部324は、カシメ306の下方で重なり合っている部材を両側に開き、穿刺流路針304及びシース311に対するカシメ306の締め付けを緩める。 In the puncture mechanism 320, the spring 322 continues to extend even after the caulking 306 comes into contact with the movement restricting portion 307, and the tip of the pressing portion 324 enters between the members overlapping below the caulking 306. At this time, the pusher 324 opens the overlapping members below the caulking 306 on both sides, and loosens the tightening of the caulking 306 with respect to the puncture channel needle 304 and the sheath 311.
 カシメ306による締め付けが緩むことによって穿刺流路針304に対するカシメ306による固定が解除される。そうすると、穿刺流路針304は、弾性部304Aが自然長まで縮まり、先端部304Bが底面301Aの内側の初期位置まで戻る。 When the tightening by the caulking 306 is loosened, the fixation by the caulking 306 to the puncture channel needle 304 is released. Then, in the puncture channel needle 304, the elastic portion 304A contracts to the natural length, and the distal end portion 304B returns to the initial position inside the bottom surface 301A.
 このときシース部310では、シース311がカシメ306に固定されて移動できないので、弾性部304Aが縮むに連れて一端が穿刺流路針304に固定された伸長部312が伸びる。 At this time, in the sheath portion 310, the sheath 311 is fixed to the caulking 306 and cannot move, so the extension portion 312 having one end fixed to the puncture channel needle 304 extends as the elastic portion 304A contracts.
 そしてシース部310は、一端伸びた伸長部312が元の形状に戻ることがないことから、シース311の先端部が底面301Aから突出した状態に維持される(図17(C))。 The sheath portion 310 is maintained in a state in which the distal end portion of the sheath 311 protrudes from the bottom surface 301A because the elongated portion 312 that extends at one end does not return to the original shape (FIG. 17C).
 このように穿刺流路部30は、使用者を穿刺する際には先端部304Bが鋭利な金属製の穿刺流路針304で穿刺し、その後、柔軟性のあるシース311だけを体内に挿入し続け、金属製でなる穿刺流路針304を体外に戻すことができる。 In this way, when puncturing the user, the puncture channel section 30 punctures with the metal puncture channel needle 304 having a sharp tip 304B, and then inserts only the flexible sheath 311 into the body. Subsequently, the puncture channel needle 304 made of metal can be returned to the outside of the body.
 よって薬液投与装置2は、使用者が使用している最中は金属製の穿刺流路針304を体内に残しておくことがなく、柔軟性を有するシース311だけを体内に挿入し続けることができ、使用者に痛みや不快感を与えることを軽減でき、かくして使い勝手を向上することができる。 Therefore, the medicinal solution administration device 2 does not leave the metal puncture channel needle 304 in the body while the user is using it, and can continue to insert only the flexible sheath 311 into the body. It is possible to reduce pain and discomfort to the user, thus improving usability.
 これに対して従来の薬液投与装置では、シースの一端が針に対してパッキンを介して接続されており、針及びシースを皮膚に穿刺した後、針を体外に引き抜く際にシースをパッキン部分で滑らせてその位置に留まるようになされていた。 On the other hand, in the conventional drug solution administration device, one end of the sheath is connected to the needle through a packing, and after the needle and the sheath are punctured into the skin, the sheath is inserted into the packing portion when the needle is pulled out of the body. It was made to slide and stay in that position.
 従って従来の薬液投与装置では、針とシースの隙間をパッキンで塞いでいるので薬液が漏れてしまうか、また、シ-ルを強固にすると針とパッキンの摩擦が大きくなり針が十分にもどらない可能性があった。 Therefore, in the conventional liquid medicine administration device, the gap between the needle and the sheath is closed with the packing, so that the liquid medicine leaks, or when the seal is strengthened, the friction between the needle and the packing increases and the needle does not return sufficiently. There was a possibility.
 一方、薬液投与装置2は、伸長部312の一端で穿刺流路針304との隙間を設けることなく固定されているので、薬液が漏れてしまうことがない。また、パッキンと針との摩擦による穿刺動作への支障が発生しない。 On the other hand, since the medicinal solution administration device 2 is fixed without providing a gap with the puncture channel needle 304 at one end of the extending portion 312, the medicinal solution does not leak. In addition, there is no hindrance to the puncturing operation due to the friction between the packing and the needle.
 ところで穿刺流路部30(図14及び図15)は、移動制限部307より前方であって筐体部301の湾曲面301Hに、底面301Aに対する穿刺流路針304及びシース311の突出する角度(以下、これを突出角度とも呼ぶ)を調整する角度調整機構340が設けられる。この突出角度は、底面301Aが使用者の皮膚に当接されるので、穿刺流路針304及びシース311の使用者の皮膚に対する角度(以下、これを穿刺角度とも呼ぶ)と同じ角度となる。 By the way, the puncture flow path section 30 (FIGS. 14 and 15) is forward of the movement restricting section 307 and on the curved surface 301H of the housing section 301, the angle at which the puncture flow path needle 304 and the sheath 311 project with respect to the bottom surface 301A ( Hereinafter, an angle adjustment mechanism 340 for adjusting the projection angle is also provided. Since the bottom surface 301A is in contact with the user's skin, the protruding angle is the same as the angle of the puncture flow path needle 304 and the sheath 311 with respect to the user's skin (hereinafter also referred to as the puncture angle).
 角度調整機構340は、図18に示すように、筐体部301に一端が固定されたL字型の円柱でなる支持部341に支持される。支持部341は、筐体部301に固定された一端とは反対側で左右方向に直交するように配される端面における同心円状で所定角度ごとに複数個(本実施例では4個)の凹部341Aが設けられる。なお、凹部341Aは、詳しくは後述するように、穿刺流路針304及びシース311の穿刺角度が20°~90°になるような位置に設けられる。 As shown in FIG. 18, the angle adjustment mechanism 340 is supported by a support portion 341 made of an L-shaped column whose one end is fixed to the housing portion 301. The support portion 341 is a concentric circular shape at the end surface arranged to be orthogonal to the left-right direction on the side opposite to the one end fixed to the housing portion 301, and a plurality of (four in this embodiment) concave portions at a predetermined angle. 341A is provided. The concave portion 341A is provided at a position where the puncture angle of the puncture channel needle 304 and the sheath 311 is 20 ° to 90 °, as will be described in detail later.
 角度調整機構340は、支持部341の端面と対向する位置に凹部341Aと同心円状で該凹部341Aに嵌るように凸部342Aが突設された中心部342が設けられる。中心部342は、バネ343及びバネ押板344を介してネジ345により支持部341に向かって押し付けられながら、突設された凸部342Aが凹部341Aに嵌る位置で支持部341に支持される。 The angle adjusting mechanism 340 is provided with a central portion 342 having a convex portion 342A projecting so as to be concentric with the concave portion 341A and fitted into the concave portion 341A at a position facing the end surface of the support portion 341. The central portion 342 is supported by the support portion 341 at a position where the protruding convex portion 342A fits into the concave portion 341A while being pressed toward the support portion 341 by the screw 345 through the spring 343 and the spring pressing plate 344.
 中心部342は、自身が回転する際の回転軸と直交する方向に、軸部346が設けられる。軸部346は、円柱形状でなり、一端が穿刺流路針304及びシース311を保持する保持部347と接続され、他端が使用者に角度を調整される際に持たれるツマミ部348に接続される。 The central portion 342 is provided with a shaft portion 346 in a direction orthogonal to the rotation axis when the center portion 342 rotates. The shaft portion 346 has a cylindrical shape, one end is connected to the holding portion 347 that holds the puncture channel needle 304 and the sheath 311, and the other end is connected to the knob portion 348 that is held when the angle is adjusted by the user. Is done.
 保持部347は、シース311の外形よりも太い内径を有する管であり、穿刺流路針304及びシース311が挿通され、穿刺流路針304及びシース311を固定することなく保持する。 The holding portion 347 is a tube having an inner diameter that is thicker than the outer shape of the sheath 311, and the puncture flow path needle 304 and the sheath 311 are inserted therethrough, and the puncture flow path needle 304 and the sheath 311 are held without being fixed.
 ツマミ部348は、図19に示すように、使用者に持たれるツマミ348Aと、該ツマミ348Aを支えるツマミ支持部348Bとからなる。ツマミ部348は、筐体部301の湾曲面301Hに設けられた開口301Jの左右両側が断面L字型となるレール部301K及び301Mに、ツマミ支持部348Bの両端が引っかかるようにして載置される。 As shown in FIG. 19, the knob portion 348 includes a knob 348A held by the user and a knob support portion 348B that supports the knob 348A. The knob portion 348 is placed so that both ends of the knob support portion 348B are hooked on rail portions 301K and 301M whose left and right sides of the opening 301J provided on the curved surface 301H of the housing portion 301 are L-shaped in cross section. The
 ツマミ支持部348Bは、筐体部301と該筐体部301の湾曲面301H上に設けられるパネル部349に挟まれるようにして載置される。パネル部349は、ツマミ348Aが湾曲面301Hに沿った方向(以下、これを湾曲方向とも呼ぶ)に移動し得るように開口し、かつレール部301K及び301Mよりも湾曲方向に沿って長い形状をしている。 The knob support portion 348B is placed so as to be sandwiched between the housing portion 301 and the panel portion 349 provided on the curved surface 301H of the housing portion 301. The panel portion 349 opens so that the knob 348A can move in a direction along the curved surface 301H (hereinafter also referred to as a curved direction), and has a shape that is longer in the curved direction than the rail portions 301K and 301M. is doing.
 なお、ツマミ支持部348Bの上面の縁には防水パッキン348Cが設けられており、該ツマミ支持部348Bとパネル部349との間から液体が筐体部301内に進入することを防止する。 A waterproof packing 348C is provided on the edge of the upper surface of the knob support portion 348B, and prevents liquid from entering the housing portion 301 from between the knob support portion 348B and the panel portion 349.
 このような構成でなる角度調整機構340は、ツマミ部348が使用者によって湾曲方向に移動されることにより、中心部342を中心とした軸部346の回転に応じて保持部347が回転される。 In the angle adjusting mechanism 340 having such a configuration, the holding portion 347 is rotated according to the rotation of the shaft portion 346 around the center portion 342 when the knob portion 348 is moved in the bending direction by the user. .
 これにより、角度調整機構340は、図20(A)及び(B)に示すように、保持部347で保持した穿刺流路針304及びシース311の底面301Aに対する突出角度を20°~90°の範囲で変更する。なお図20(A)は突出角度が90°の場合を示しており、図20(B)は突出角度が20°の場合を示している。 Accordingly, as shown in FIGS. 20 (A) and 20 (B), the angle adjusting mechanism 340 sets the protrusion angle of the puncture flow path needle 304 held by the holding portion 347 and the bottom surface 301A of the sheath 311 to 20 ° to 90 °. Change in range. 20A shows a case where the protrusion angle is 90 °, and FIG. 20B shows a case where the protrusion angle is 20 °.
 すなわち、角度調整機構340は、底面301Aと平行に配される使用者の表皮に対する穿刺流路針304及びシース311の穿刺角度を20°~90°の範囲で変更することができる。なお、穿刺角度によって先端部304Bと底面301Aとの距離が変化する穿刺角度にて先端部304Bが底面301Aより外に出ないように穿刺流路針304及びシース311を設定する。 That is, the angle adjusting mechanism 340 can change the puncture angle of the puncture flow path needle 304 and the sheath 311 with respect to the user's epidermis arranged in parallel with the bottom surface 301A in the range of 20 ° to 90 °. The puncture channel needle 304 and the sheath 311 are set so that the tip 304B does not come out of the bottom 301A at a puncture angle at which the distance between the tip 304B and the bottom surface 301A varies depending on the puncture angle.
 なお、穿刺流路針304の先端部304B及びシース311の先端は、底面301Aに設けられた開口301Nを塞ぎかつシース311の外周に接するように配される例えばエラストマーでなる柔軟性を有する先端保持部309に保持される。 Note that the distal end portion 304B of the puncture channel needle 304 and the distal end of the sheath 311 are arranged so as to close the opening 301N provided in the bottom surface 301A and come into contact with the outer periphery of the sheath 311. Held by the unit 309.
 先端保持部309は、底面301Aの内側に設けたL字のリブにはめられており、両側が301の前面301G、背面301Vの内側に沿って前後方向にずれるようになっている。その柔軟性により、穿刺流路針304の先端部304B及びシース311の先端が角度調整機構340に移動されてもそれに追従でき、かつ開口301Nを塞ぎ続ける。よって筐体部301内に液体が進入することを防止することができる。 The tip holding portion 309 is fitted to an L-shaped rib provided inside the bottom surface 301A, and both sides are shifted in the front-rear direction along the inside of the front surface 301G and the back surface 301V of the 301. Due to the flexibility, even if the distal end portion 304B of the puncture flow path needle 304 and the distal end of the sheath 311 are moved to the angle adjusting mechanism 340, they can follow it and continue to close the opening 301N. Accordingly, liquid can be prevented from entering the housing portion 301.
 また、先端保持部309には、穿刺流路針304の先端部304Bのさらに先の位置で、穿刺流路針304の先端部304B及びシース311の先端に蓋をする形で、エアベントフィルタ309Aが設けられる。 The tip holding portion 309 includes an air vent filter 309A that covers the tip portion 304B of the puncture channel needle 304 and the tip of the sheath 311 at a position further ahead of the tip portion 304B of the puncture channel needle 304. Provided.
 従ってエアベントフィルタ309Aは、使用者が使用する前において穿刺流路針304を流れてきた薬液を外部に漏らすことなく、穿刺流路針304に始めから存在する空気だけを外部に排出することができる。 Therefore, the air vent filter 309A can discharge only the air present in the puncture channel needle 304 to the outside without leaking the drug solution flowing through the puncture channel needle 304 before use by the user. .
 このように薬液投与装置2では、角度調整機構340が使用者の操作に応じて穿刺流路針304及びシース311の底面301Aに対する突出角度を20°~90°の範囲で変更することができる。 Thus, in the drug solution administration device 2, the angle adjustment mechanism 340 can change the protrusion angle of the puncture flow path needle 304 and the bottom surface 301A of the sheath 311 with respect to the bottom surface 301A within a range of 20 ° to 90 ° according to the operation of the user.
 ところで人の体は、体表から1.5mm~4mm程度までに表皮及び真皮等の皮膚があり、その内部で体表から4mm~9mm程度までの深さの位置に皮下組織があり、さらに内側に筋肉などがある。 By the way, the human body has skins such as epidermis and dermis from about 1.5 mm to 4 mm from the body surface, and there is subcutaneous tissue at a depth of about 4 mm to 9 mm from the body surface inside, and further inside Have muscles.
 例えばインスリンを外部から投与する場合、使用者に対する負担や痛み、インスリンの吸収速度などが考慮され、表面から4mm~9mm程度の深さにある皮下組織に投与されることが一般的である。 For example, when insulin is administered from the outside, it is generally administered to a subcutaneous tissue at a depth of about 4 mm to 9 mm from the surface in consideration of burden on the user, pain, absorption rate of insulin, and the like.
 しかしながら皮下組織の深さはその位置及び年齢、体格、性別等の個人差により異なるものの、従来の薬液投与装置では決まった穿刺角度で決まった距離だけ穿刺されるため、一部の使用者にとっては皮下組織に対してインスリンを投与できなくなる可能性があった。 However, although the depth of the subcutaneous tissue varies depending on individual differences such as its position and age, physique, gender, etc., since conventional drug solution administration devices puncture a fixed distance at a fixed puncture angle, for some users Insulin could not be administered to the subcutaneous tissue.
 これに対して薬液投与装置2は、角度調整機構340により使用者の表皮に対する穿刺流路針304及びシース311の穿刺角度を20°~90°の範囲で変更することができるので、突出角度を調節させることにより任意の深さに穿刺することができ、全ての使用者にとって最適とされる皮下組織に確実に穿刺することができる。また、近年、真皮層に薬液を投与することにより、皮下に投与していたときに比べて少量の薬液で同等の薬効を得られることから、穿刺距離を真皮に設定することも可能である。かくして薬液投与装置2は、使い勝手を向上させることができる。 In contrast, the medicinal-solution administration device 2 can change the puncture angle of the puncture flow path needle 304 and the sheath 311 with respect to the user's epidermis within the range of 20 ° to 90 ° by the angle adjusting mechanism 340. By adjusting, it is possible to puncture to an arbitrary depth, and it is possible to reliably puncture the subcutaneous tissue that is optimal for all users. In recent years, by administering a drug solution to the dermis layer, it is possible to obtain the same medicinal effect with a small amount of drug solution compared to when administered subcutaneously, and therefore it is possible to set the puncture distance to the dermis. Thus, the medicinal solution administration device 2 can improve usability.
 ところで、筐体部301には、駆動制御部20が密着する際に該駆動制御部20のコネクタ部212と対向する位置に設けられた孔301Pに隙間なくコネクタ部350が接着される。コネクタ部350は、図13(A)及び(B)に示したように、電気及び各種信号を送受信するためのコネクタ部350Cが複数本集められた電気コネクタ部350Aの外側を防水ゴム350Bで覆う構造でなる。 By the way, when the drive control unit 20 is in close contact with the housing unit 301, the connector unit 350 is adhered to the hole 301P provided at a position facing the connector unit 212 of the drive control unit 20 without a gap. As shown in FIGS. 13A and 13B, the connector portion 350 covers the outside of the electrical connector portion 350A in which a plurality of connector portions 350C for transmitting and receiving electricity and various signals are collected with a waterproof rubber 350B. Constructed.
 このように薬液投与装置2は、使用者の皮膚を穿刺する穿刺流路針304が設けられる穿刺流路部30が、薬液が貯蔵される薬液バッグ110が設けられた薬液貯蔵送出部10及び送出部130を動作させるモータ207や基板部204が設けられた駆動制御部20に対して別体に設けられる。 Thus, the medicinal solution administration device 2 includes the puncture channel unit 30 provided with the puncture channel needle 304 for puncturing the user's skin, the medicinal solution storage and delivery unit 10 provided with the medicinal solution bag 110 for storing the medicinal solution, and the delivery. The drive control unit 20 provided with the motor 207 for operating the unit 130 and the substrate unit 204 is provided separately.
 従って薬液投与装置2では、例えば穿刺に失敗した場合、かゆみ、炎症が発生した場合であっても、穿刺流路部30だけを取り替えさせるだけでよく、使い勝手がよい。 Therefore, in the drug administration device 2, for example, even when puncture fails, itching or inflammation occurs, it is only necessary to replace the puncture flow path section 30 and it is easy to use.
 これに対して従来の薬液投与装置では、使用者の皮膚を穿刺する針、薬液が貯蔵される薬液バッグ、モータ等が全て同一の筐体内に設けられているため、例えば穿刺に失敗した場合、かゆみ、炎症が発生した場合には装置全体を取り替えなくてはならず、使い勝手が悪いばかりか、経済的な負担も増えるという問題があった。 On the other hand, in the conventional medicinal solution administration device, since the needle for puncturing the user's skin, the medicinal solution bag for storing the medicinal solution, the motor, etc. are all provided in the same housing, for example, when puncture fails, When itching and inflammation occur, the entire device must be replaced, which is not only convenient but also increases the economic burden.
〔3.薬液投与システムの回路構成等〕
 次に、薬液投与システム1の回路構成及び機能的構成を図21を用いて説明する。
[3. (Circuit configuration of chemical solution administration system etc.)
Next, the circuit configuration and functional configuration of the drug solution administration system 1 will be described with reference to FIG.
 コントローラ3は、マイクロコンピュータ361、電池362、電池監視部363、モードスイッチ364、数値設定スイッチ365、表示部366、送信部367、受信部368及び通信アンテナ369により構成される。 The controller 3 includes a microcomputer 361, a battery 362, a battery monitoring unit 363, a mode switch 364, a numerical value setting switch 365, a display unit 366, a transmission unit 367, a reception unit 368, and a communication antenna 369.
 マイクロコンピュータ361は、CPU、RAM、ROM等でなるコンピュータであり、CPUがROMに格納される基本プログラムをRAMに読みだして実行することにより全体を統括制御するとともに、CPUがROMに格納される各種プログラムをRAMに読みだして実行することにより各種処理を実行する。 The microcomputer 361 is a computer including a CPU, a RAM, a ROM, and the like. The CPU reads and executes a basic program stored in the ROM and executes the overall control, and the CPU is stored in the ROM. Various processes are executed by reading various programs into the RAM and executing them.
 電池362は、各部に電源電力を供給する。電池監視部363は、電池362の有無や残量等を監視し、マイクロコンピュータ361に通知する。 The battery 362 supplies power to each unit. The battery monitoring unit 363 monitors the presence / absence and remaining amount of the battery 362 and notifies the microcomputer 361 of it.
 モードスイッチ364は、薬液を連続的に長時間投与するベーサルモードや薬液を一時的に投与するボーラスモードを設定するためのスイッチである。数値設定スイッチ365は、薬液の1時間当たりの投与量や投与時間などを設定するためのスイッチである。 The mode switch 364 is a switch for setting a basal mode in which a chemical solution is continuously administered for a long time and a bolus mode in which a chemical solution is temporarily administered. The numerical value setting switch 365 is a switch for setting the dose per hour and the administration time of the drug solution.
 マイクロコンピュータ361は、モードスイッチ364や数値設定スイッチ365に対する操作に応じた内容を表示部366に表示するとともに、その内容を示す信号を送信部367及び通信アンテナ369を介して薬液投与装置2に送信する。 The microcomputer 361 displays the contents corresponding to the operation on the mode switch 364 and the numerical value setting switch 365 on the display unit 366 and transmits a signal indicating the contents to the drug solution administration device 2 via the transmission unit 367 and the communication antenna 369. To do.
 また、マイクロコンピュータ361は、薬液投与装置2から送信された信号を通信アンテナ369で受信すると受信部368を介して取得し、該信号に応じた内容を表示部366に表示することにより使用者に通知するとともに、その内容に応じた処理を実行する。 Further, when the microcomputer 361 receives the signal transmitted from the drug solution administration device 2 by the communication antenna 369, the microcomputer 361 acquires the signal via the receiving unit 368, and displays the contents corresponding to the signal on the display unit 366 to the user. Notification is performed and processing corresponding to the content is executed.
 一方、薬液投与装置2は、充電池206から供給される電源電力により電気回路が動作し、駆動制御部20に設けられるマイクロコンピュータ220が全体を統括制御する。 On the other hand, in the drug solution administration device 2, the electric circuit is operated by the power supply supplied from the rechargeable battery 206, and the microcomputer 220 provided in the drive control unit 20 performs overall control.
 マイクロコンピュータ220は、CPU、RAM、ROM等でなるコンピュータであり、CPUがROMに格納される基本プログラムをRAMに読みだして実行することにより全体を統括制御するとともに、CPUがROMに格納される各種プログラムをRAMに読みだして実行することにより各種処理を実行する。 The microcomputer 220 is a computer including a CPU, a RAM, a ROM, and the like. The CPU reads and executes a basic program stored in the ROM and executes the overall control, and the CPU is stored in the ROM. Various processes are executed by reading various programs into the RAM and executing them.
 マイクロコンピュータ220は、通信アンテナ205で受信したコントローラ3から送信された信号を受信部222を介して受信すると、該信号の内容に応じて各部を動作させる。 When the microcomputer 220 receives the signal transmitted from the controller 3 received by the communication antenna 205 via the receiving unit 222, the microcomputer 220 operates each unit according to the content of the signal.
 具体的には、薬液バッグにインシュリンを必要量充填し、角度調整機構340を操作させることにより穿刺角度が調整され、コントローラ3により、ベーサルモードとボーラスモードの投与量、投与時間を設定し、薬液投与装置2に送り、薬液投与装置内のRAMに記憶させた後、薬液投与装置2が使用者に貼付部103を介して貼り付けられた状態で、マイクロコンピュータ220は、薬液を投与開始する信号がコントローラ3から供給されると、穿刺流路部30が駆動制御部20と接続されているか否かをコネクタ部212及び350の接続により確認する。そして、マイクロコンピュータ220は、穿刺リリース機構330を駆動して使用者に穿刺流路針304及びシース311を穿刺する。そして、生体に挿入されたシース部分の空間をインシュリンで埋めるよう(プライミング)規定量のインシュリンをモータ207を回転させて送出部130を駆動して送液する。 Specifically, the puncture angle is adjusted by filling the drug solution bag with a necessary amount of insulin and operating the angle adjustment mechanism 340, and the controller 3 sets the dose and administration time of the basal mode and the bolus mode. After being sent to the administration device 2 and stored in the RAM of the drug solution administration device, the microcomputer 220 signals that the administration of the drug solution is started with the drug solution administration device 2 attached to the user via the application unit 103. Is supplied from the controller 3, it is confirmed by connection of the connector parts 212 and 350 whether or not the puncture flow path part 30 is connected to the drive control part 20. The microcomputer 220 drives the puncture release mechanism 330 to puncture the user with the puncture channel needle 304 and the sheath 311. Then, a prescribed amount of insulin is rotated so as to fill the space of the sheath portion inserted into the living body with priming (priming), the motor 207 is rotated, and the delivery unit 130 is driven to send the solution.
 そして、マイクロコンピュータ220は、コントローラ3から設定記憶された投与時間になると、記憶された薬液投与量を、または、ボーラスの任意投与がコントローラ3から送信されると、コントローラ3により設定された薬液投与量を投与するために、モータ207を回転させて送出部130を駆動して使用者の体内に薬液を投与する。 Then, when the administration time set and stored from the controller 3 is reached, the microcomputer 220 sends the stored medicinal solution dosage or the medicinal solution administration set by the controller 3 when the arbitrary administration of the bolus is transmitted from the controller 3. In order to administer the amount, the motor 207 is rotated to drive the delivery unit 130 to administer the drug solution into the user's body.
 このとき薬液投与装置2では、注入部104を介して薬液バッグ110に予め貯蔵された薬液が、フィルタ部120、送出部130、流水センサ303、穿刺流路針304及びシース311などを介して使用者の体内に投与される。 At this time, in the drug solution administration device 2, the drug solution stored in advance in the drug solution bag 110 via the injection unit 104 is used via the filter unit 120, the delivery unit 130, the running water sensor 303, the puncture channel needle 304, the sheath 311, and the like. It is administered to the body of a person.
 薬液を投与している間、マイクロコンピュータ220は、モータ207の回転回数をエンコーダ223を介して監視するとともに、流れ検出制御部224を介して薬液が流れているか否かを検出する。なお流れ検出制御部224は、流水センサ303のサーミスタを加熱するとともに、該サーミスタの温度変化を監視する。 During the administration of the chemical solution, the microcomputer 220 monitors the number of rotations of the motor 207 via the encoder 223 and detects whether or not the chemical solution is flowing via the flow detection control unit 224. The flow detection control unit 224 heats the thermistor of the flowing water sensor 303 and monitors the temperature change of the thermistor.
 またマイクロコンピュータ220は、磁気センサ210が検出する磁力に基づいて送出部130が駆動しているか否かを検出する。 Further, the microcomputer 220 detects whether or not the sending unit 130 is driven based on the magnetic force detected by the magnetic sensor 210.
 そしてマイクロコンピュータ220は、モータ207が正常に回転していない場合や、送出部130が正常に駆動していない場合、又は薬液が流れていない場合には、再び実施し、状態が変わらない場合、各部を停止させ、その旨を送信部221及び通信アンテナ205を介してコントローラ3に送信する。 The microcomputer 220 performs again when the motor 207 is not rotating normally, when the delivery unit 130 is not normally driven, or when no chemical is flowing, and when the state does not change, Each unit is stopped, and a message to that effect is transmitted to the controller 3 via the transmission unit 221 and the communication antenna 205.
 マイクロコンピュータ220は、充電池206を充電する際、受信・充電回路225を制御して充電器4から供給される電磁波を充電アンテナ203を介して受信して充電池206を充電する。なお充電池206には電池安全回路部226が設けられ、電池安全回路部226が充電中の過充電、過放電及び電池温度を監視し熱暴走を防止する。 When charging the rechargeable battery 206, the microcomputer 220 controls the receiving / charging circuit 225 to receive the electromagnetic wave supplied from the charger 4 via the charging antenna 203 to charge the rechargeable battery 206. The rechargeable battery 206 is provided with a battery safety circuit unit 226. The battery safety circuit unit 226 monitors overcharge, overdischarge and battery temperature during charging to prevent thermal runaway.
 充電器4は、コンセント401、AC/DC変換器402、高周波変換部403及び送信アンテナ404を含む構成とされる。充電器4は、コンセント401から送られてくる交流をAC/DC変換器402で直流に変換し、送信アンテナ404で送信するために高周波変換部403で高周波に変換した後、送信アンテナ404を介して薬液投与装置2に電磁波を送信する。 The charger 4 includes an outlet 401, an AC / DC converter 402, a high frequency converter 403, and a transmission antenna 404. The charger 4 converts alternating current sent from the outlet 401 into direct current by the AC / DC converter 402, converts it to high frequency by the high frequency conversion unit 403 for transmission by the transmission antenna 404, and then passes through the transmission antenna 404. Then, electromagnetic waves are transmitted to the drug solution administration device 2.
 従って薬液投与装置2では、薬液バッグ110を含む薬液貯蔵送出部10と、穿刺流路針304及びシース311を含む穿刺流路部30とが薬液を用いるという衛生上の観点から一度のみの使用であるのに対して、薬液を用いていない駆動制御部20は薬液貯蔵送出部10及び穿刺流路部30を着脱させることにより何度も使用することができる。このとき駆動制御部20の充電池206は充電器により充電されるので複数回の使用も行える。 Therefore, in the drug solution administration device 2, the drug solution storage and delivery unit 10 including the drug solution bag 110 and the puncture channel unit 30 including the puncture channel needle 304 and the sheath 311 are used only once from the hygiene viewpoint that the drug solution is used. On the other hand, the drive control unit 20 that does not use the chemical solution can be used many times by attaching and detaching the chemical solution storage and delivery unit 10 and the puncture flow path unit 30. At this time, since the rechargeable battery 206 of the drive control unit 20 is charged by the charger, it can be used multiple times.
〔4.他の実施の形態〕
〔4-1.他の実施の形態1〕
 尚、上述した実施の形態では、送出部130において、駆動軸137を回転させることでシリンダ部132とピストン133とを一体に回転させてシリンダ口132Fの接続先をイン流路131G又はアウト流路131Hに切り替えた後、さらに駆動軸137を回転させることでピストン133を摺動させて薬液の吸入及び排出を行うようにした。
[4. Other Embodiments]
[4-1. Other Embodiment 1]
In the above-described embodiment, in the delivery unit 130, the cylinder 132 and the piston 133 are integrally rotated by rotating the drive shaft 137 so that the connection destination of the cylinder port 132F is the in-flow path 131G or the out-flow path. After switching to 131H, the drive shaft 137 was further rotated to slide the piston 133 to inhale and discharge the chemical solution.
 これに限らず、このような機構とは異なる機構で、シリンダ口の接続先を切り替えて薬液の吸入及び排出を行うようにしてもよい。 However, the present invention is not limited to this, and a mechanism different from such a mechanism may be used to switch the connection destination of the cylinder port to suck and discharge the chemical liquid.
 例えば、図22に示す送出部500は、送出部130と同様、弁を有さないバルブレスポンプであり、一端部が開口している円筒状のシリンダ部501の内部空間(シリンダ内部空間)501A内に一端側から円柱状のピストン502が挿入される。 For example, the delivery unit 500 shown in FIG. 22 is a valveless pump that does not have a valve, like the delivery unit 130, and is in the internal space (cylinder internal space) 501A of the cylindrical cylinder portion 501 that is open at one end. A cylindrical piston 502 is inserted from one end side.
 尚、ここでも、シリンダ部501の一端側を下側、他端側を上側と定義して、送出部500の各部について説明することとする。 In addition, also here, each part of the sending part 500 will be described by defining one end side of the cylinder part 501 as a lower side and the other end side as an upper side.
 シリンダ部501の内周面の中央部には、環状の溝503が形成される。この溝503は、内周面の中央部の所定位置S1から周方向に沿って半周分だけ延在する半円弧状の第1の半円弧状溝503Aと、この第1の半円弧状溝503Aの末端の位置S2から軸方向に沿って下方に延在する所定長さの直線状の第1の直線状溝503Bと、この第1の直線状溝503Bの末端の位置S3から周方向に沿って半周分だけ延在する半円弧状の第2の半円弧状溝503Cと、この第2の半円弧状溝503Cの末端の位置S4と第1の半円弧状溝503Aの先端の位置(上述の所定位置)S1とを繋ぐ、軸方向に沿って延在する直線状の第2の直線状溝503Dとでなる。 An annular groove 503 is formed at the center of the inner peripheral surface of the cylinder portion 501. The groove 503 includes a semicircular arc-shaped first semicircular arc-shaped groove 503A extending from the predetermined position S1 at the center of the inner peripheral surface along the circumferential direction, and the first semicircular arc-shaped groove 503A. A first linear groove 503B having a predetermined length extending downward in the axial direction from the end position S2 of the first end, and a circumferential direction from the end position S3 of the first straight groove 503B. A semicircular arc-shaped second semicircular groove 503C extending by a half circumference, a position S4 of the end of the second semicircular arc groove 503C, and a position of the tip of the first semicircular arc groove 503A (described above) And a second linear groove 503D that extends along the axial direction and connects to S1.
 尚、第1の半円弧状溝503Aと第2の半円弧状溝503Cは、シリンダ部501の中心軸を挟んで対向する位置となっている。ゆえに、図22(C)に示すように、シリンダ部501を真上から見ると、溝503は円環状に見える。 Note that the first semicircular groove 503 </ b> A and the second semicircular groove 503 </ b> C are positioned to face each other across the central axis of the cylinder portion 501. Therefore, as shown in FIG. 22C, when the cylinder portion 501 is viewed from directly above, the groove 503 looks like an annular shape.
 また第1の半円弧状溝503Aは、図22(B)に示すように、先端の位置S1よりも末端の位置S2の方がわずかに下方に位置していて、先端の位置S1から末端の位置S2に向かって下方になだらかに傾いている。さらに、第2の半円弧状溝503Cは、先端の位置S3よりも末端の位置S4の方がわずかに上方に位置していて、先端の位置S3から末端の位置S4に向かって上方になだらかに傾いている。 Further, as shown in FIG. 22B, the first semicircular groove 503A is located slightly lower at the end position S2 than at the end position S1, and from the end position S1 to the end position S1. It is gently inclined downward toward the position S2. Further, the second semicircular groove 503C is located slightly higher at the distal end position S4 than at the distal end position S3, and is gently upward from the distal end position S3 toward the distal end position S4. Tilted.
 さらにシリンダ部501の上端部を形成する円板状の蓋部501Bには、半円弧状の長孔であるシリンダ口501Cがシリンダ内部空間501Aと連通して設けられる。このシリンダ口501Cは、蓋部501Bの中心軸(シリンダ部501の中心軸と同軸)から所定量だけずれた位置に設けられる。 Further, a disc-shaped lid portion 501B that forms the upper end portion of the cylinder portion 501 is provided with a cylinder port 501C, which is a semicircular arc-shaped long hole, in communication with the cylinder internal space 501A. The cylinder port 501C is provided at a position shifted by a predetermined amount from the central axis of the lid portion 501B (coaxial with the central axis of the cylinder portion 501).
 このシリンダ口501Cは、図22(C)に示すように、シリンダ部501を真上から見たときに、第1の半円弧状溝503Aの先端の位置S1と末端の位置S2の手前までの円弧の内側に位置する。 As shown in FIG. 22 (C), this cylinder port 501C is located between the front end position S1 and the front end position S2 of the first semicircular arc groove 503A when the cylinder portion 501 is viewed from directly above. Located inside the arc.
 ピストン502は、外周面の上部に、ピストン502とシリンダ内部空間501Aの内壁周面との間に隙間ができないように、周方向に沿って例えばXリング又はOリングのパッキン504が設けられている。 The piston 502 is provided with, for example, an X ring or O ring packing 504 along the circumferential direction so that there is no gap between the piston 502 and the inner wall peripheral surface of the cylinder internal space 501A at the upper part of the outer peripheral surface. .
 またピストン502は、外周面の下部に、外方に突する突起部502Aが1個形成される。この突起部502Aは、右のみ回転するベアリングの周辺にゴム等の滑り止めを施した構造にてシリンダ部501の溝503に摺動自在に嵌合される。 Also, the piston 502 is formed with one protrusion 502A protruding outward at the lower part of the outer peripheral surface. The protrusion 502A is slidably fitted into the groove 503 of the cylinder 501 with a structure in which a rubber or the like is prevented from slipping around the bearing that rotates only to the right.
 この突起部502Aは、ピストンが下死点から上死点に向かって押されると、シリンダ部501の溝503Cに沿って摺動すると、シリンダ部501が右に回転する。 When the piston is pushed from the bottom dead center toward the top dead center, when the piston slides along the groove 503C of the cylinder portion 501, the cylinder portion 501 rotates to the right.
 突起部502Aは、ピストン502の軸方向に対してほぼ直交しわずかに傾斜している第2の半円弧状溝503C及び第1の半円弧状溝503Aに沿って摺動するときには、ピストン502にくわえられる軸方向の力を、軸方向に対して直交する回転方向の力としてシリンダ部501に伝達する。 When the protrusion 502A slides along the second semicircular groove 503C and the first semicircular groove 503A which are substantially orthogonal to the axial direction of the piston 502 and slightly inclined, the protrusion 502A The axial force that is added is transmitted to the cylinder portion 501 as a rotational force orthogonal to the axial direction.
 よって、突起部502Aが第1の半円弧状溝503A及び第2の半円弧状溝503Cに沿って摺動している間に、シリンダ部501は半回転することになる。 Therefore, the cylinder portion 501 rotates halfway while the protrusion 502A slides along the first semicircular groove 503A and the second semicircular groove 503C.
 送出部500は、このようにしてシリンダ部501を半回転させることで、シリンダ口501Cの接続先を、吸入用の流路管106又は排出用の流路管107に切り替える。 The sending section 500 switches the connection destination of the cylinder port 501C to the suction flow pipe 106 or the discharge flow pipe 107 by rotating the cylinder 501 halfway in this way.
 一方で、突起部502Aがピストン502の軸方向に対して平行な第1の直線状溝503B、及び第2の直線状溝503Dに沿って摺動するときには、シリンダ部501に回転方向の力は伝達されない。 On the other hand, when the projection 502A slides along the first linear groove 503B and the second linear groove 503D parallel to the axial direction of the piston 502, the force in the rotational direction is applied to the cylinder portion 501. Not transmitted.
 ゆえに、突起部502Aが第1の直線状溝503B及び第2の直線状溝503Dに沿って摺動している間、シリンダ部501が回転することなく、ピストン502が軸方向に摺動することになる。 Therefore, the piston 502 slides in the axial direction without rotating the cylinder portion 501 while the protrusion 502A slides along the first linear groove 503B and the second linear groove 503D. become.
 実際、送出部500のシリンダ部501内に薬液を吸引する場合、まず初期状態として、ピストン502が上死点に位置する。またこのとき、ピストン502の突起部502Aが第1の半円弧状溝503Aの先端の位置S1に位置する。 Actually, when the chemical solution is sucked into the cylinder part 501 of the delivery part 500, the piston 502 is first located at the top dead center as an initial state. At this time, the protrusion 502A of the piston 502 is located at the position S1 of the tip of the first semicircular arc groove 503A.
 この初期状態から、ピストン502に対して上死点から下死点へと摺動させる方向(下方向)に力をくわえると、ピストン502の突起部502Aが第1の半円弧状溝503Aに沿って摺動すると共にシリンダ部501が右に回転する。少しシリンダ部501が回転すると、この時シリンダ口501C(シリンダ部501の上部に設置した半円弧状の長孔)が流路管106と繋がり、シリンダ部501内部と流路管106が連結される。さらにピストン502が下死点に向けて摺動すると、シリンダ部501は、シリンダ部501内部と流路管106が連通したまま、さらに回転し、下死点で流路管106とシリンダ口501Cの端で連通して止まる。 From this initial state, when a force is applied in a direction (downward) in which the piston 502 is slid from the top dead center to the bottom dead center, the protrusion 502A of the piston 502 extends along the first semicircular arc groove 503A. And the cylinder portion 501 rotates to the right. When the cylinder portion 501 is rotated a little, the cylinder port 501C (a semicircular long hole installed in the upper portion of the cylinder portion 501) is connected to the flow channel pipe 106, and the inside of the cylinder portion 501 and the flow channel tube 106 are connected. . When the piston 502 further slides toward the bottom dead center, the cylinder portion 501 further rotates while the inside of the cylinder portion 501 and the flow path pipe 106 are in communication with each other, and the flow path pipe 106 and the cylinder port 501C are connected at the bottom dead center. Communicate at the end and stop.
 そして、突起部502Aが、第1の半円弧状溝503Aの末端の位置S2に到達すると、このときシリンダ部501の回転が停止する。 When the protrusion 502A reaches the position S2 at the end of the first semicircular groove 503A, the rotation of the cylinder 501 stops at this time.
 すると、薬液バッグ110に装填された薬液が、フィルタ部120、流路管106、シリンダ口501Cを通って、シリンダ部501内の蓋部501Bとピストン502との間の空間に注入される。 Then, the chemical solution loaded in the chemical solution bag 110 is injected into the space between the lid portion 501B in the cylinder portion 501 and the piston 502 through the filter portion 120, the flow path pipe 106, and the cylinder port 501C.
 その後、突起部502Aが第1の直線状溝503Bの末端の位置S3に到達すると、このときピストン502が下死点に到達したことになる。ゆえに、突起部502Aが第1の直線状溝503Bの末端の位置S3に到達した時点でピストン502の摺動が停止するようにピストン502の摺動が制御される。 Thereafter, when the projection 502A reaches the position S3 at the end of the first linear groove 503B, the piston 502 has reached the bottom dead center at this time. Therefore, the sliding of the piston 502 is controlled so that the sliding of the piston 502 stops when the protrusion 502A reaches the position S3 at the end of the first linear groove 503B.
 このようにして、送出部500では、シリンダ部501内に薬液を吸引する。 In this way, the delivery unit 500 sucks the chemical into the cylinder unit 501.
 つづけて、シリンダ部501内に吸引した薬液を排出する場合、ピストン502に対して下死点から上死点へと摺動させる方向(上方向)に力をくわえる。 Subsequently, when the chemical liquid sucked into the cylinder portion 501 is discharged, a force is applied in a direction (upward) in which the piston 502 is slid from the bottom dead center to the top dead center.
 さらにピストン502に対して上方向の力をくわえると、今度は、突起部502Aが第1の直線状溝503Cに沿って摺動して、シリンダ部501が右に回転する。シリンダ部501がS3からわずかに回転するとシリンダ口501Cが流路管107と繋がりはじめる。 Further, when an upward force is applied to the piston 502, the protrusion 502A slides along the first linear groove 503C, and the cylinder 501 rotates to the right. When the cylinder portion 501 is slightly rotated from S3, the cylinder port 501C starts to be connected to the flow path pipe 107.
 そして、突起部502Aが、第2の半円弧状溝503Cの末端の位置S4に到達すると、このときシリンダ部501の回転が停止する。 Then, when the protrusion 502A reaches the position S4 at the end of the second semicircular arc groove 503C, the rotation of the cylinder 501 stops at this time.
 さらにピストン502に対して上方向の力をくわえると、今度は、突起部502Aが第2の直線状溝503Dに沿って摺動すると共にピストン502が下死点から上死点へと摺動する。 Further, when an upward force is applied to the piston 502, the protrusion 502A slides along the second linear groove 503D and the piston 502 slides from the bottom dead center to the top dead center. .
 すると、シリンダ部501内の蓋部501Bとピストン502との間の空間に注入された薬液が、シリンダ口501C、流路管107を通って、弁体108へと排出される。 Then, the chemical solution injected into the space between the lid portion 501B and the piston 502 in the cylinder portion 501 is discharged to the valve body 108 through the cylinder port 501C and the flow path pipe 107.
 その後、突起部502Aが第2の直線状溝503Dの末端の位置S1に到達すると、このときピストン502が上死点に到達したことになる。ゆえに、突起部502Aが第2の直線状溝503Dの末端の位置S1に到達した時点でピストン502の摺動が停止するようにピストン502の摺動が制御される。 Thereafter, when the protrusion 502A reaches the position S1 at the end of the second linear groove 503D, the piston 502 has reached the top dead center at this time. Therefore, the sliding of the piston 502 is controlled so that the sliding of the piston 502 stops when the protrusion 502A reaches the end position S1 of the second linear groove 503D.
 このようにして、送出部500では、シリンダ部501から薬液を排出する。 In this way, the delivery unit 500 discharges the chemical solution from the cylinder unit 501.
 このような機構により、送出部500は、シリンダ口501の接続先を切り替えて薬液の吸入及び排出を行う。 With such a mechanism, the delivery unit 500 switches the connection destination of the cylinder port 501 and sucks and discharges the chemical solution.
 尚、ピストン502は、例えば、クランク機構等を介して、駆動用磁石138の回転軸139と接続されることで、軸方向に直線運動するようになっている。 The piston 502 is linearly moved in the axial direction by being connected to the rotating shaft 139 of the driving magnet 138 via a crank mechanism or the like, for example.
 ところで、送出部500では、ピストン502の突起部502Aを位置S1から摺動させるときに、第2の直線状溝503D側ではなく、第1の半円弧状溝503A側に摺動させる必要がある。 By the way, when the projecting portion 502A of the piston 502 is slid from the position S1, the delivery portion 500 needs to slide not on the second linear groove 503D side but on the first semicircular groove 503A side. .
 そこで、送出部500では、突起部502Aの外周が右にしか回らないような構造にすると共に、外周にゴム等の滑り止めを施したり、第2の直線状溝503Dの末端の幅が狭くなるように末端に凸部を設けたり、末端を他の部分よりも細く形成するなどして、突起部502Aが位置S1から第2の直線状溝503D側に摺動しにくくすることで、突起部502Aを第2の直線状溝503D側ではなく、第1の半円弧状溝503A側に摺動させるようになっている。 Therefore, the delivery unit 500 has a structure in which the outer periphery of the projecting portion 502A is rotated only to the right, and is provided with a slip stopper such as rubber on the outer periphery, or the width of the end of the second linear groove 503D is reduced. Thus, the protrusion 502A is made difficult to slide from the position S1 to the second linear groove 503D by providing a protrusion at the end or by forming the end narrower than the other parts. 502A is slid not on the second linear groove 503D side but on the first semicircular groove 503A side.
 同様に、送出部500では、突起部502Aを位置S3から摺動させるときに、第1の直線状溝503B側ではなく、第2の半円弧状溝503C側に摺動させる必要がある。 Similarly, when the projecting portion 502A is slid from the position S3, the delivery portion 500 needs to be slid not to the first linear groove 503B but to the second semicircular groove 503C.
 そこで、突起部502Aの外周が右にしか回らないような構造にすると共に、外周にゴム等の滑り止めを施したり、この第1の直線状溝503Bの末端の幅が狭くなるように末端に凸部を設けたり、末端を他の部分よりも細く形成するなどして、突起部502Aが位置S3から第1の直線状溝503B側に摺動しにくくすることで、突起部502Aを第1の直線状溝503B側ではなく、第2の半円弧状溝503C側に摺動させるようになっている。 Therefore, the protrusion 502A has a structure in which the outer periphery turns only to the right, and a rubber or the like is provided on the outer periphery, or the end of the first linear groove 503B is narrowed at the end. The protrusion 502A is made difficult to slide from the position S3 to the first linear groove 503B side by providing a protrusion or by forming the end narrower than the other parts. Instead of the linear groove 503B, the second semicircular groove 503C is slid.
〔4-2.他の実施の形態2〕
 さらに上述した実施の形態では、シリンダ部132を半回転(180度)させることで、シリンダ口132Fの接続先を、イン流路131G又はアウト流路131Hに切り替えるようにした。
[4-2. Other Embodiment 2]
Further, in the above-described embodiment, the connection destination of the cylinder port 132F is switched to the in-flow path 131G or the out-flow path 131H by rotating the cylinder part 132 halfway (180 degrees).
 これに限らず、シリンダ部132を回転させることでシリンダ口132Fの接続先を切り替えることができるように構成されていれば、シリンダ部132の回転は、半回転に限らず、例えば1/4回転であってもよいし、2/3回転であってもよい。 However, the rotation of the cylinder part 132 is not limited to a half rotation, for example, 1/4 rotation as long as the connection destination of the cylinder port 132F can be switched by rotating the cylinder part 132. Or 2/3 rotation.
〔4-3.他の実施の形態3〕
 さらに上述した実施の形態では、シリンダ部132の回転を半回転に制限するストッパとして機能する溝131Dを筐体部131側に設け、この溝131Dに嵌合する突起部132Eをシリンダ部132側に設けるようにした。
[4-3. Other Embodiment 3]
Furthermore, in the above-described embodiment, the groove 131D that functions as a stopper that restricts the rotation of the cylinder part 132 to a half rotation is provided on the housing part 131 side, and the protruding part 132E that fits into the groove 131D is provided on the cylinder part 132 side. I tried to provide it.
 これに限らず、溝131Dと同様に機能する溝をシリンダ部132の外周面の上端に設け、この溝に嵌合する突起部を筐体部131の内壁周面の上端に設けるようにしてもよい。 Not limited to this, a groove that functions in the same manner as the groove 131D is provided at the upper end of the outer peripheral surface of the cylinder portion 132, and a protrusion that fits into the groove is provided at the upper end of the inner wall peripheral surface of the housing portion 131. Good.
 また溝と突起部に限らず、シリンダ部132の回転を制限可能なストッパとして機能する機構であれば、この他種々の機構を用いるようにしてもよい。 In addition to the grooves and the protrusions, various other mechanisms may be used as long as the mechanism functions as a stopper capable of limiting the rotation of the cylinder part 132.
〔4-4.他の実施の形態4〕
 さらに上述した実施の形態では、ピストン軸133Aを上方に付勢することで、ピストン軸133Aのオネジ133Cとシリンダ部132のメネジ132Bとの摩擦力が、シリンダ部132と筐体内部空間131Aを形成する内壁との摩擦力より大きくなることを利用して、シリンダ部132とピストン133とを一体に回転させるようにした。
[4-4. Other Embodiment 4]
Further, in the above-described embodiment, by urging the piston shaft 133A upward, the frictional force between the male screw 133C of the piston shaft 133A and the female screw 132B of the cylinder portion 132 forms the cylinder portion 132 and the housing internal space 131A. The cylinder portion 132 and the piston 133 are rotated together by utilizing the fact that the friction force is larger than the frictional force with the inner wall.
 これに限らず、例えば、ピストン133やパッキン136の大きさや材質を適宜選定することで、ピストン133とシリンダ内部空間132Aを形成する内壁との摩擦力が、シリンダ部132と筐体内部空間131Aを形成する内壁との摩擦力より大きくなるようにして、シリンダ部132とピストン133とを一体に回転させるようにしてもよい。 Not limited to this, for example, by appropriately selecting the size and material of the piston 133 and the packing 136, the frictional force between the piston 133 and the inner wall forming the cylinder inner space 132A causes the cylinder part 132 and the housing inner space 131A to move. The cylinder part 132 and the piston 133 may be rotated integrally so as to be larger than the frictional force with the inner wall to be formed.
 このようにすれば、例えば、ピストン軸133Aを上方に付勢するコイルバネ141を省略した構成とすることもできる。 In this way, for example, the coil spring 141 that urges the piston shaft 133A upward can be omitted.
 また、シリンダ部132と筐体内部空間131Aを形成する内壁との摩擦力がより小さくなるように、シリンダ部132と筐体内部空間131Aを形成する内壁との間の滑りをよくするシリコンなどの潤滑材を、例えば筐体内部空間131Aを形成する内壁に塗布するなどしてもよい。 Further, silicon or the like that improves the sliding between the cylinder part 132 and the inner wall forming the housing inner space 131A so that the frictional force between the cylinder part 132 and the inner wall forming the housing inner space 131A becomes smaller. For example, the lubricant may be applied to the inner wall forming the housing internal space 131A.
〔4-5.他の実施の形態5〕
 さらに上述した実施の形態では、ピストン133の外周面に、ピストン133とシリンダ内部空間132Aの内壁周面との間に隙間ができないように、周方向に沿って例えばXリング又はOリングのパッキン136を設けるようにした。
[4-5. Other Embodiment 5]
Further, in the above-described embodiment, for example, an X ring or O ring packing 136 along the circumferential direction so that there is no gap on the outer circumferential surface of the piston 133 between the piston 133 and the inner wall circumferential surface of the cylinder inner space 132A. It was made to provide.
 これに限らず、ピストン133側にではなく、シリンダ内部空間132Aの内壁周面側に、周方向に沿って例えばXリング又はOリングのパッキンを設けるようにしてもよいし、ピストン133にシリコンゴムやブタジエンゴムなどで構成されるガスケットを取り付けるようにしてもよい。 For example, X-ring or O-ring packing may be provided along the circumferential direction on the inner wall circumferential surface side of the cylinder inner space 132A, not on the piston 133 side, and silicon rubber may be provided on the piston 133. Alternatively, a gasket made of butadiene rubber or the like may be attached.
〔4-6.他の実施の形態6〕
 さらに上述した実施の形態では、ピストン軸133Aを上方(軸方向)に付勢する付勢部材として、コイルバネ141を用いるようにした。
[4-6. Other Embodiment 6]
Furthermore, in the above-described embodiment, the coil spring 141 is used as the biasing member that biases the piston shaft 133A upward (in the axial direction).
 これに限らず、ピストン軸133Aを上方に付勢できる部材であれば、コイルバネ以外の部材をコイルバネの代わりに用いるようにしてもよい。 However, the present invention is not limited thereto, and any member other than the coil spring may be used instead of the coil spring as long as the member can bias the piston shaft 133A upward.
 さらに上述した実施の形態では、シリンダ部132を上方(シリンダ口132F側)に付勢する付勢部材として、コイルバネ134を用いるようにした。 Furthermore, in the above-described embodiment, the coil spring 134 is used as a biasing member that biases the cylinder portion 132 upward (on the cylinder port 132F side).
 これに限らず、シリンダ部132を上方に付勢できる部材であれば、コイルバネ以外の部材をコイルバネの代わりに用いるようにしてもよい。 Any member other than the coil spring may be used instead of the coil spring as long as the member can bias the cylinder portion 132 upward.
 本発明は、例えば医療分野に適用することができる。 The present invention can be applied to the medical field, for example.
 1……薬液投与システム、2……薬液投与装置、3……コントローラ、4……充電器、10……薬液貯蔵送出部、20……駆動制御部、30……穿刺流路部、106、107……流路管、110……薬液バッグ、130……送出部、131……筐体部、131D……溝、131G……イン流路、131H……アウト流路、132……シリンダ部、132B……メネジ、132E……突起部、132F……シリンダ口、133……ピストン、133A……ピストン軸、133C……オネジ、134、141……コイルバネ DESCRIPTION OF SYMBOLS 1 ... Chemical solution administration system, 2 ... Chemical solution administration apparatus, 3 ... Controller, 4 ... Charger, 10 ... Chemical solution storage and delivery part, 20 ... Drive control part, 30 ... Puncture flow path part, 106, 107 …… Flow path pipe, 110 …… Chemical solution bag, 130 …… Sending part, 131 …… Case part, 131D …… Groove, 131G …… In flow path, 131H …… Out flow path, 132 …… Cylinder part 132B: Female thread 132E: Protruding part 132F ... Cylinder port 133 133 Piston 133A Piston shaft 133C Male thread 134 134 141 Coil spring

Claims (4)

  1.  薬液を貯蔵する薬液貯蔵部と
     前記薬液貯蔵部から薬液を吸入するときに使用する流入側流路と薬液を排出するときに使用する流出側流路とが設けられた筐体部と、
     前記筐体部内に回転可能に嵌入されたシリンダ部と、
     前記シリンダ部内で回転及び摺動可能なピストンと、
     前記筐体部に対する前記シリンダ部の回転範囲を制限するストッパと、
     前記ピストンに固定されたピストン軸と前記シリンダ部の内壁とのそれぞれに互いに噛み合うように設けられ、前記シリンダ部に対して前記ピストン軸が回転したときに、前記ピストンを軸方向に摺動させるネジと
     を有し、
     前記シリンダ部には、該シリンダ部が前記ストッパにより制限される回転範囲の一端まで回転したときに前記流入側流路と接続し、該シリンダ部が前記回転範囲の他端まで回転したときに前記流出側流路と接続するシリンダ口が設けられ、
     前記ピストンは、
     前記シリンダ部が前記回転範囲の一端又は他端に到達するまでの間は、前記シリンダ部と一体になって回転し、前記シリンダ部が前記回転範囲の一端又は他端に到達することで前記シリンダ口が前記流入側流路又は前記流出側流路と接続した以降は、前記シリンダ部に対して前記ピストン軸が回転することにより前記シリンダ部内を摺動する
     ことを特徴とする薬液投与装置。
    A case part provided with a chemical solution storage part for storing a chemical solution, an inflow side channel used for inhaling the chemical solution from the chemical solution storage unit, and an outflow side channel used for discharging the chemical solution;
    A cylinder part rotatably fitted in the housing part;
    A piston capable of rotating and sliding in the cylinder part;
    A stopper for limiting the rotation range of the cylinder part with respect to the housing part;
    A screw that is provided so as to mesh with each of a piston shaft fixed to the piston and an inner wall of the cylinder portion, and that causes the piston to slide in the axial direction when the piston shaft rotates with respect to the cylinder portion. And
    The cylinder portion is connected to the inflow side flow path when the cylinder portion rotates to one end of a rotation range limited by the stopper, and the cylinder portion rotates to the other end of the rotation range. Cylinder port connected to the outflow side flow path is provided,
    The piston is
    Until the cylinder part reaches one end or the other end of the rotation range, the cylinder part rotates integrally with the cylinder part, and the cylinder part reaches the one end or the other end of the rotation range so that the cylinder After the mouth is connected to the inflow side flow path or the outflow side flow path, the piston shaft slides with respect to the cylinder part to slide in the cylinder part.
  2.  前記ピストン軸と前記シリンダ部の内壁とのそれぞれに互いに噛み合うように設けられたネジ同士の摩擦力が、前記筐体部と前記シリンダ部との摩擦力よりも大きくなるように、前記ピストン軸を軸方向に付勢する付勢部材を有する
     ことを特徴とする請求項1に記載の薬液投与装置。
    The piston shaft is adjusted so that the frictional force between the screws provided so as to mesh with each other of the piston shaft and the inner wall of the cylinder portion is larger than the frictional force between the housing portion and the cylinder portion. The medicinal-solution administration device according to claim 1, further comprising an urging member that urges in the axial direction.
  3.  前記ストッパは、
     前記筐体部と前記シリンダ部のうちの一方にシリンダ部の回転方向と平行に設けられた溝と、前記筐体部と前記シリンダ部のうちの他方に設けられ、該溝に摺動自在に嵌合する突起部とでなり、前記突起部の摺動範囲を前記溝の一端部から他端部までに制限することで、前記シリンダ部の回転範囲を制限する
     ことを特徴とする請求項1に記載の薬液投与装置。
    The stopper is
    A groove provided in one of the housing part and the cylinder part in parallel with the rotation direction of the cylinder part, and a groove provided in the other of the housing part and the cylinder part, and slidable in the groove The rotation range of the cylinder portion is limited by limiting the sliding range of the projection portion from one end portion to the other end portion of the groove. The chemical | medical solution administration apparatus of description.
  4.  前記シリンダ部をシリンダ口側に付勢する付勢部材を有する
     ことを特徴とする請求項1に記載の薬液投与装置。
    The medicinal-solution administration device according to claim 1, further comprising an urging member that urges the cylinder portion toward the cylinder port.
PCT/JP2013/001719 2012-03-16 2013-03-14 Drug administration device WO2013136801A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012-060915 2012-03-16
JP2012060915 2012-03-16

Publications (1)

Publication Number Publication Date
WO2013136801A1 true WO2013136801A1 (en) 2013-09-19

Family

ID=49160725

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2013/001719 WO2013136801A1 (en) 2012-03-16 2013-03-14 Drug administration device

Country Status (1)

Country Link
WO (1) WO2013136801A1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4310434Y1 (en) * 1966-06-28 1968-05-07
US3680558A (en) * 1970-05-27 1972-08-01 Robert F Kapelowitz Syringe with multiple compartments
JPS58137883U (en) * 1982-03-12 1983-09-16 西原 義晃 fluid discharge device
JPH03260377A (en) * 1990-03-09 1991-11-20 Nippon Fuiidaa Kogyo Kk Reciprocating pump
WO1994012227A1 (en) * 1992-12-01 1994-06-09 Tetsuro Higashikawa Syringe
JP2010501283A (en) * 2006-08-23 2010-01-21 メドトロニック ミニメド インコーポレイテッド Infusion medium delivery device and method using a drive device for driving a plunger in a storage container

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4310434Y1 (en) * 1966-06-28 1968-05-07
US3680558A (en) * 1970-05-27 1972-08-01 Robert F Kapelowitz Syringe with multiple compartments
JPS58137883U (en) * 1982-03-12 1983-09-16 西原 義晃 fluid discharge device
JPH03260377A (en) * 1990-03-09 1991-11-20 Nippon Fuiidaa Kogyo Kk Reciprocating pump
WO1994012227A1 (en) * 1992-12-01 1994-06-09 Tetsuro Higashikawa Syringe
JP2010501283A (en) * 2006-08-23 2010-01-21 メドトロニック ミニメド インコーポレイテッド Infusion medium delivery device and method using a drive device for driving a plunger in a storage container

Similar Documents

Publication Publication Date Title
WO2013047855A1 (en) Liquid-drug administration device, puncturing device, liquid-drug filling device, liquid-drug filling method, and liquid-drug filling system
CN112566680B (en) Ambulatory infusion pump and assembly for use therewith
CN108883230B (en) Portable infusion pump and assembly for use therewith
CN103127573B (en) Module skin-adherable system for medical fluid delivery
JP4509100B2 (en) Infusion device attachable to skin with removable needle insertion actuation
US8562590B2 (en) Systems and methods for sustained medical infusion and devices related thereto
US8679062B2 (en) Apparatus and method for pumping fluid
JP4376636B2 (en) Transdermal fluid delivery system
US9138534B2 (en) Positive displacement pump
JP2013192637A (en) Drug solution delivery device
JP2006507028A (en) Infusion pump
CN105327418A (en) Systems, devices and methods for sustained delivery of therapeutic fluid
WO2013136802A1 (en) Drug administration device
WO2013136801A1 (en) Drug administration device
JP2013192639A (en) Drug solution delivery device
JP2013070716A (en) Liquid-drug administration device
JP5766082B2 (en) Puncture device and drug solution administration device
JP2013070713A (en) Medical fluid administration device
JP2013070718A (en) Liquid-drug administration system and liquid-drug administration device
JP2013192640A (en) Drug solution delivery device
JP2013192638A (en) Drug solution delivery device
JP2013070717A (en) Liquid-drug filling device and liquid-drug filling method
JP2013070715A (en) Liquid-drug administration device
JP2013070714A (en) Medical fluid administration device
CN113573757B (en) Liquid medicine throwing device

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13760994

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13760994

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP